Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS.
Retraction of a clot resulting from contraction of PLATELET pseudopods attached to FIBRIN strands. The retraction is dependent on the contractile protein thrombosthenin. Clot retraction is used as a measure of platelet function.
The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot.
A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot.
Blocking of a blood vessel by fat deposits in the circulation. It is often seen after fractures of large bones or after administration of CORTICOSTEROIDS.
Blocking of a blood vessel by an embolus which can be a blood clot or other undissolved material in the blood stream.
The natural enzymatic dissolution of FIBRIN.
Blocking of a blood vessel in the SKULL by an EMBOLUS which can be a blood clot (THROMBUS) or other undissolved material in the blood stream. Most emboli are of cardiac origin and are associated with HEART DISEASES. Other non-cardiac sources of emboli are usually associated with VASCULAR DISEASES.
Use of a thrombelastograph, which provides a continuous graphic record of the physical shape of a clot during fibrin formation and subsequent lysis.
Blockage of an artery due to passage of a clot (THROMBUS) from a systemic vein to a systemic artery without its passing through the lung which acts as a filter to remove blood clots from entering the arterial circulation. Paradoxical embolism occurs when there is a defect that allows a clot to cross directly from the right to the left side of the heart as in the cases of ATRIAL SEPTAL DEFECTS or open FORAMEN OVALE. Once in the arterial circulation, a clot can travel to the brain, block an artery, and cause a STROKE.
Formation and development of a thrombus or blood clot in the blood vessel.
A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases.
Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products.
Embolism or thrombosis involving blood vessels which supply intracranial structures. Emboli may originate from extracranial or intracranial sources. Thrombosis may occur in arterial or venous structures.
Blocking of maternal circulation by AMNIOTIC FLUID that is forced into uterine VEINS by strong UTERINE CONTRACTION near the end of pregnancy. It is characterized by the sudden onset of severe respiratory distress and HYPOTENSION that can lead to maternal DEATH.
Activated form of FACTOR XIII, a transglutaminase, which stabilizes the formation of the fibrin polymer (clot) culminating the blood coagulation cascade.
Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN.
Laboratory tests for evaluating the individual's clotting mechanism.
The use of focused, high-frequency sound waves to produce local hyperthermia in certain diseased or injured parts of the body or to destroy the diseased tissue.
Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure.
Precursor of plasmin (FIBRINOLYSIN). It is a single-chain beta-globulin of molecular weight 80-90,000 found mostly in association with fibrinogen in plasma; plasminogen activators change it to fibrinolysin. It is used in wound debriding and has been investigated as a thrombolytic agent.
An abnormal hemoglobin composed of four beta chains. It is caused by the reduced synthesis of the alpha chain. This abnormality results in ALPHA-THALASSEMIA.
A member of the serpin superfamily found in plasma that inhibits the lysis of fibrin clots which are induced by plasminogen activator. It is a glycoprotein, molecular weight approximately 70,000 that migrates in the alpha 2 region in immunoelectrophoresis. It is the principal plasmin inactivator in blood, rapidly forming a very stable complex with plasmin.
The use of focused, high-frequency sound waves to destroy tissue. It is sometimes used in conjunction with but is distinct from INTERVENTIONAL ULTRASONOGRAPHY.
Use of infusions of FIBRINOLYTIC AGENTS to destroy or dissolve thrombi in blood vessels or bypass grafts.
The process which spontaneously arrests the flow of BLOOD from vessels carrying blood under pressure. It is accomplished by contraction of the vessels, adhesion and aggregation of formed blood elements (eg. ERYTHROCYTE AGGREGATION), and the process of BLOOD COAGULATION.
Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions.
A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins.
A fibrin-stabilizing plasma enzyme (TRANSGLUTAMINASES) that is activated by THROMBIN and CALCIUM to form FACTOR XIIIA. It is important for stabilizing the formation of the fibrin polymer (clot) which culminates the coagulation cascade.
Blocking of a blood vessel by CHOLESTEROL-rich atheromatous deposits, generally occurring in the flow from a large artery to small arterial branches. It is also called arterial-arterial embolization or atheroembolism which may be spontaneous or iatrogenic. Patients with spontaneous atheroembolism often have painful, cyanotic digits of acute onset.
Streptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase (STREPTODORNASE AND STREPTOKINASE). EC 3.4.-.
An enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN.
The formation or presence of a blood clot (THROMBUS) within a vein.
Bleeding into one or both CEREBRAL HEMISPHERES including the BASAL GANGLIA and the CEREBRAL CORTEX. It is often associated with HYPERTENSION and CRANIOCEREBRAL TRAUMA.
Surgical removal of an obstructing clot or foreign material which has been transported from a distant vessel by the bloodstream. Removal of a clot at its original site is called THROMBECTOMY.
A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts.
Agents that prevent clotting.
Bleeding or escape of blood from a vessel.
Bleeding into the intracranial or spinal SUBARACHNOID SPACE, most resulting from INTRACRANIAL ANEURYSM rupture. It can occur after traumatic injuries (SUBARACHNOID HEMORRHAGE, TRAUMATIC). Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable neurological deficits and reduced mental status.
The ratio of alveolar ventilation to simultaneous alveolar capillary blood flow in any part of the lung. (Stedman, 25th ed)
A heterogeneous group of proteolytic enzymes that convert PLASMINOGEN to FIBRINOLYSIN. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation.
Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation.
A series of progressive, overlapping events, triggered by exposure of the PLATELETS to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.
The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
Elements of limited time intervals, contributing to particular results or situations.
Mechanical devices inserted in the inferior vena cava that prevent the migration of blood clots from deep venous thrombosis of the leg.
Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream.
The species Oryctolagus cuniculus, in the family Leporidae, order LAGOMORPHA. Rabbits are born in burrows, furless, and with eyes and ears closed. In contrast with HARES, rabbits have 22 chromosome pairs.
Inflammation of a vein associated with a blood clot (THROMBUS).
The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065)
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
Proteins prepared by recombinant DNA technology.
A measurement of the time needed for FIBRINOLYSIS to occur.
Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues using a transducer placed in the esophagus.
Radiography of blood vessels after injection of a contrast medium.
Tomography using x-ray transmission and a computer algorithm to reconstruct the image.
A condition in which the FORAMEN OVALE in the ATRIAL SEPTUM fails to close shortly after birth. This results in abnormal communications between the two upper chambers of the heart. An isolated patent ovale foramen without other structural heart defects is usually of no hemodynamic significance.
Disease having a short and relatively severe course.
Obstruction of a vein or VEINS (embolism) by a blood clot (THROMBUS) in the blood stream.
A condition in which the RIGHT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE or MYOCARDIAL INFARCTION, and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the right ventricular wall.
The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs.
Computed tomography where there is continuous X-ray exposure to the patient while being transported in a spiral or helical pattern through the beam of irradiation. This provides improved three-dimensional contrast and spatial resolution compared to conventional computed tomography, where data is obtained and computed from individual sequential exposures.
An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide.
Surgical removal of an obstructing clot or foreign material from a blood vessel at the point of its formation. Removal of a clot arising from a distant site is called EMBOLECTOMY.
Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA).
Radiographic visualization or recording of a vein after the injection of contrast medium.
The vein accompanying the femoral artery in the same sheath; it is a continuation of the popliteal vein and becomes the external iliac vein.
Developmental abnormalities in any portion of the ATRIAL SEPTUM resulting in abnormal communications between the two upper chambers of the heart. Classification of atrial septal defects is based on location of the communication and types of incomplete fusion of atrial septa with the ENDOCARDIAL CUSHIONS in the fetal heart. They include ostium primum, ostium secundum, sinus venosus, and coronary sinus defects.
A collective term for pathological conditions which are caused by the formation of a blood clot (THROMBUS) in a blood vessel, or by blocking of a blood vessel with an EMBOLUS, undissolved materials in the blood stream.
Fibrinogens which have a functional defect as the result of one or more amino acid substitutions in the amino acid sequence of normal fibrinogen. Abnormalities of the fibrinogen molecule may impair any of the major steps involved in the conversion of fibrinogen into stabilized fibrin, such as cleavage of the fibrinopeptides by thrombin, polymerization and cross-linking of fibrin. The resulting dysfibrinogenemias can be clinically silent or can be associated with bleeding, thrombosis or defective wound healing.
The rate dynamics in chemical or physical systems.
Pathological conditions involving the HEART including its structural and functional abnormalities.
Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
The vein formed by the union of the anterior and posterior tibial veins; it courses through the popliteal space and becomes the femoral vein.
Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism.
The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).
The return of a sign, symptom, or disease after a remission.
Complications that affect patients during surgery. They may or may not be associated with the disease for which the surgery is done, or within the same surgical procedure.
Chemical analysis based on the phenomenon whereby light, passing through a medium with dispersed particles of a different refractive index from that of the medium, is attenuated in intensity by scattering. In turbidimetry, the intensity of light transmitted through the medium, the unscattered light, is measured. In nephelometry, the intensity of the scattered light is measured, usually, but not necessarily, at right angles to the incident light beam.
Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.
Formation or presence of a blood clot (THROMBUS) in a blood vessel within the SKULL. Intracranial thrombosis can lead to thrombotic occlusions and BRAIN INFARCTION. The majority of the thrombotic occlusions are associated with ATHEROSCLEROSIS.
A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in cardiovascular and cerebral circulation.
Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic.
Plant tissue that carries water up the root and stem. Xylem cell walls derive most of their strength from LIGNIN. The vessels are similar to PHLOEM sieve tubes but lack companion cells and do not have perforated sides and pores.
The venous trunk which receives blood from the lower extremities and from the pelvic and abdominal organs.
A metallocarboxypeptidase that removes C-terminal lysine and arginine from biologically active peptides and proteins thereby regulating their activity. It is a zinc enzyme with no preference shown for lysine over arginine. Pro-carboxypeptidase U in human plasma is activated by thrombin or plasmin during clotting to form the unstable carboxypeptidase U.
Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders.
A vein on either side of the body which is formed by the union of the external and internal iliac veins and passes upward to join with its fellow of the opposite side to form the inferior vena cava.
Postmortem examination of the body.
A proteolytic enzyme that converts PLASMINOGEN to FIBRINOLYSIN where the preferential cleavage is between ARGININE and VALINE. It was isolated originally from human URINE, but is found in most tissues of most VERTEBRATES.
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
A disorder of HEMOSTASIS in which there is a tendency for the occurrence of THROMBOSIS.
The chambers of the heart, to which the BLOOD returns from the circulation.
In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.
Expectoration or spitting of blood originating from any part of the RESPIRATORY TRACT, usually from hemorrhage in the lung parenchyma (PULMONARY ALVEOLI) and the BRONCHIAL ARTERIES.
Two small peptide chains removed from the N-terminal segment of the beta chains of fibrinogen by the action of thrombin. Each peptide chain contains 20 amino acid residues. The removal of fibrinopeptides B is not required for coagulation.
Parts of plants that usually grow vertically upwards towards the light and support the leaves, buds, and reproductive structures. (From Concise Dictionary of Biology, 1990)
NECROSIS of lung tissue that is cause by the lack of OXYGEN or blood supply. The most common cause of pulmonary infarction is a blood clot in the lung.
Low-molecular-weight fragment of heparin, having a 4-enopyranosuronate sodium structure at the non-reducing end of the chain. It is prepared by depolymerization of the benzylic ester of porcine mucosal heparin. Therapeutically, it is used as an antithrombotic agent. (From Merck Index, 11th ed)
The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988)
The creation and display of functional images showing where the blood flow reaches by following the distribution of tracers injected into the blood stream.
The removal of secretions, gas or fluid from hollow or tubular organs or cavities by means of a tube and a device that acts on negative pressure.
Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis.
System established by the World Health Organization and the International Committee on Thrombosis and Hemostasis for monitoring and reporting blood coagulation tests. Under this system, results are standardized using the International Sensitivity Index for the particular test reagent/instrument combination used.
The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases, new or old, in the population at a given time.
A benign neoplasm derived from connective tissue, consisting chiefly of polyhedral and stellate cells that are loosely embedded in a soft mucoid matrix, thereby resembling primitive mesenchymal tissue. It occurs frequently intramuscularly where it may be mistaken for a sarcoma. It appears also in the jaws and the skin. (From Stedman, 25th ed)
The therapeutic intermittent administration of oxygen in a chamber at greater than sea-level atmospheric pressures (three atmospheres). It is considered effective treatment for air and gas embolisms, smoke inhalation, acute carbon monoxide poisoning, caisson disease, clostridial gangrene, etc. (From Segen, Dictionary of Modern Medicine, 1992). The list of treatment modalities includes stroke.
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood.
Radiography of the vascular system of the brain after injection of a contrast medium.
Clotting time of PLASMA mixed with a THROMBIN solution. It is a measure of the conversion of FIBRINOGEN to FIBRIN, which is prolonged by AFIBRINOGENEMIA, abnormal fibrinogen, or the presence of inhibitory substances, e.g., fibrin-fibrinogen degradation products, or HEPARIN. BATROXOBIN, a thrombin-like enzyme unaffected by the presence of heparin, may be used in place of thrombin.
A condition occurring as a result of exposure to a rapid fall in ambient pressure. Gases, nitrogen in particular, come out of solution and form bubbles in body fluid and blood. These gas bubbles accumulate in joint spaces and the peripheral circulation impairing tissue oxygenation causing disorientation, severe pain, and potentially death.
Non-invasive method of vascular imaging and determination of internal anatomy without injection of contrast media or radiation exposure. The technique is used especially in CEREBRAL ANGIOGRAPHY as well as for studies of other vascular structures.
Tumors in any part of the heart. They include primary cardiac tumors and metastatic tumors to the heart. Their interference with normal cardiac functions can cause a wide variety of symptoms including HEART FAILURE; CARDIAC ARRHYTHMIAS; or EMBOLISM.
An indandione that has been used as an anticoagulant. Phenindione has actions similar to WARFARIN, but it is now rarely employed because of its higher incidence of severe adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p234)
A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Unstable isotopes of xenon that decay or disintegrate emitting radiation. Xe atoms with atomic weights 121-123, 125, 127, 133, 135, 137-145 are radioactive xenon isotopes.
Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION.
A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS.
Procedures in which placement of CARDIAC CATHETERS is performed for therapeutic or diagnostic procedures.
A localized bulging or dilatation in the muscle wall of a heart (MYOCARDIUM), usually in the LEFT VENTRICLE. Blood-filled aneurysms are dangerous because they may burst. Fibrous aneurysms interfere with the heart function through the loss of contractility. True aneurysm is bound by the vessel wall or cardiac wall. False aneurysms are HEMATOMA caused by myocardial rupture.
Blood clot formation in any part of the CAROTID ARTERIES. This may produce CAROTID STENOSIS or occlusion of the vessel, leading to TRANSIENT ISCHEMIC ATTACK; CEREBRAL INFARCTION; or AMAUROSIS FUGAX.
Hypertrophy and dilation of the RIGHT VENTRICLE of the heart that is caused by PULMONARY HYPERTENSION. This condition is often associated with pulmonary parenchymal or vascular diseases, such as CHRONIC OBSTRUCTIVE PULMONARY DISEASE and PULMONARY EMBOLISM.
Tight coverings for the foot and leg that are worn to aid circulation in the legs, and prevent the formation of EDEMA and DEEP VEIN THROMBOSIS. PNEUMATIC COMPRESSION STOCKINGS serve a similar purpose especially for bedridden patients, and following surgery.
The vessels carrying blood away from the capillary beds.
A pathological condition manifested by failure to perfuse or oxygenate vital organs.
The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS.
A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
A proteolytic enzyme obtained from the venom of fer-de-lance (Bothrops atrox). It is used as a plasma clotting agent for fibrinogen and for the detection of fibrinogen degradation products. The presence of heparin does not interfere with the clotting test. Hemocoagulase is a mixture containing batroxobin and factor X activator. EC 3.4.21.-.
The inferior part of the lower extremity between the KNEE and the ANKLE.
Activated form of factor X that participates in both the intrinsic and extrinsic pathways of blood coagulation. It catalyzes the conversion of prothrombin to thrombin in conjunction with other cofactors.
The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph.
Removal of an implanted therapeutic or prosthetic device.
Formation of an infarct, which is NECROSIS in tissue due to local ISCHEMIA resulting from obstruction of BLOOD CIRCULATION, most commonly by a THROMBUS or EMBOLUS.
A deficiency or absence of FIBRINOGEN in the blood.
Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.
A plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta. They are evergreen, pyramidal trees with whorled branches and thin, scaly bark. Each of the linear, spirally arranged leaves is jointed near the stem on a separate woody base.
Use or insertion of a tubular device into a duct, blood vessel, hollow organ, or body cavity for injecting or withdrawing fluids for diagnostic or therapeutic purposes. It differs from INTUBATION in that the tube here is used to restore or maintain patency in obstructions.
A plant family of the order Rhamnales, subclass Rosidae, class Magnoliopsida, best known for the VITIS genus, the source of grapes.
Procedures to cause the disintegration of THROMBI by physical interventions.
The act of blowing a powder, vapor, or gas into any body cavity for experimental, diagnostic, or therapeutic purposes.
Instruments that generate intermittent forces, uniformed or graduated, to facilitate the emptying of VEINS. These devices are used to reduce limb EDEMA and prevent venous THROMBOEMBOLISM, such as deep vein thrombosis in the legs.
Two small peptide chains removed from the N-terminal segment of the alpha chains of fibrinogen by the action of thrombin during the blood coagulation process. Each peptide chain contains 18 amino acid residues. In vivo, fibrinopeptide A is used as a marker to determine the rate of conversion of fibrinogen to fibrin by thrombin.
The co-occurrence of pregnancy and a cardiovascular disease. The disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS.
Placement of an intravenous CATHETER in the subclavian, jugular, or other central vein.
Inflammation of the inner lining of the heart (ENDOCARDIUM), the continuous membrane lining the four chambers and HEART VALVES. It is often caused by microorganisms including bacteria, viruses, fungi, and rickettsiae. Left untreated, endocarditis can damage heart valves and become life-threatening.
Migration of a foreign body from its original location to some other location in the body.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
A non-invasive technique using ultrasound for the measurement of cerebrovascular hemodynamics, particularly cerebral blood flow velocity and cerebral collateral flow. With a high-intensity, low-frequency pulse probe, the intracranial arteries may be studied transtemporally, transorbitally, or from below the foramen magnum.
Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques.
Measurement of oxygen and carbon dioxide in the blood.
Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)
A deficiency of blood coagulation FACTOR XIII or fibrin stabilizing factor (FSF) that prevents blood clot formation and results in a clinical hemorrhagic diathesis.
Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs.
The time required by whole blood to produce a visible clot.
X-ray visualization of the chest and organs of the thoracic cavity. It is not restricted to visualization of the lungs.
Ethyl ester of iodinated fatty acid of poppyseed oil. It contains 37% organically bound iodine and has been used as a diagnostic aid (radiopaque medium) and as an antineoplastic agent when part of the iodine is 131-I. (From Merck Index, 11th ed)
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
Coagulation of blood in any of the CORONARY VESSELS. The presence of a blood clot (THROMBUS) often leads to MYOCARDIAL INFARCTION.
Simple rapid heartbeats caused by rapid discharge of impulses from the SINOATRIAL NODE, usually between 100 and 180 beats/min in adults. It is characterized by a gradual onset and termination. Sinus tachycardia is common in infants, young children, and adults during strenuous physical activities.
The circulation of the BLOOD through the LUNGS.
Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
Substances used to allow enhanced visualization of tissues.
Agents that cause clotting.
The thin membrane-like muscular structure separating the right and the left upper chambers (HEART ATRIA) of a heart.
Diagnostic and therapeutic procedures that are invasive or surgical in nature, and require the expertise of a specially trained radiologist. In general, they are more invasive than diagnostic imaging but less invasive than major surgery. They often involve catheterization, fluoroscopy, or computed tomography. Some examples include percutaneous transhepatic cholangiography, percutaneous transthoracic biopsy, balloon angioplasty, and arterial embolization.
Ultrasonography applying the Doppler effect combined with real-time imaging. The real-time image is created by rapid movement of the ultrasound beam. A powerful advantage of this technique is the ability to estimate the velocity of flow from the Doppler shift frequency.
Insertion of a catheter into a peripheral artery, vein, or airway for diagnostic or therapeutic purposes.

A pulmonary embolism (PE) is a medical condition that occurs when a blood clot, often formed in the deep veins of the legs (deep vein thrombosis), breaks off and travels to the lungs, blocking one or more pulmonary arteries. This blockage can lead to various symptoms such as shortness of breath, chest pain, rapid heart rate, and coughing up blood. In severe cases, it can cause life-threatening complications like low oxygen levels, hypotension, and even death if not promptly diagnosed and treated with anticoagulant medications or thrombolytic therapy to dissolve the clot.

Clot retraction is the process that occurs during blood clotting where the platelets in the blood contract and pull together the edges of the clot, causing it to shrink. This process helps to seal off injured blood vessels and prevent further bleeding. Clot retraction also aids in the healing process by helping to remove damaged tissue and debris from the wound site. The proteins in the blood, called fibrin, form a mesh that traps red and white blood cells and platelets, creating a clot. As the platelets contract, they pull on the fibrin mesh, causing it to tighten and the clot to shrink. This process is an important part of the body's natural healing response to injury.

Blood coagulation, also known as blood clotting, is a complex process that occurs in the body to prevent excessive bleeding when a blood vessel is damaged. This process involves several different proteins and chemical reactions that ultimately lead to the formation of a clot.

The coagulation cascade is initiated when blood comes into contact with tissue factor, which is exposed after damage to the blood vessel wall. This triggers a series of enzymatic reactions that activate clotting factors, leading to the formation of a fibrin clot. Fibrin is a protein that forms a mesh-like structure that traps platelets and red blood cells to form a stable clot.

Once the bleeding has stopped, the coagulation process is regulated and inhibited to prevent excessive clotting. The fibrinolytic system degrades the clot over time, allowing for the restoration of normal blood flow.

Abnormalities in the blood coagulation process can lead to bleeding disorders or thrombotic disorders such as deep vein thrombosis and pulmonary embolism.

Fibrin is defined as a protein that is formed from fibrinogen during the clotting of blood. It plays an essential role in the formation of blood clots, also known as a clotting or coagulation cascade. When an injury occurs and bleeding starts, fibrin threads form a net-like structure that entraps platelets and red blood cells to create a stable clot, preventing further loss of blood.

The process of forming fibrin from fibrinogen is initiated by thrombin, another protein involved in the coagulation cascade. Thrombin cleaves fibrinogen into fibrin monomers, which then polymerize to form long strands of fibrin. These strands cross-link with each other through a process catalyzed by factor XIIIa, forming a stable clot that protects the wound and promotes healing.

It is important to note that abnormalities in fibrin formation or breakdown can lead to bleeding disorders or thrombotic conditions, respectively. Proper regulation of fibrin production and degradation is crucial for maintaining healthy hemostasis and preventing excessive clotting or bleeding.

Fat embolism is a medical condition that occurs when fat globules enter the bloodstream and block small blood vessels (arterioles and capillaries) in various tissues and organs. This can lead to inflammation, tissue damage, and potentially life-threatening complications.

Fat embolism typically occurs as a result of trauma, such as long bone fractures or orthopedic surgeries, where fat cells from the marrow of the broken bone enter the bloodstream. It can also occur in other conditions that cause fat to be released into the circulation, such as pancreatitis, decompression sickness, and certain medical procedures like liposuction.

Symptoms of fat embolism may include respiratory distress, fever, confusion, petechial rash (small purple or red spots on the skin), and a decrease in oxygen levels. In severe cases, it can lead to acute respiratory distress syndrome (ARDS) and even death. Treatment typically involves supportive care, such as oxygen therapy, mechanical ventilation, and medications to manage symptoms and prevent complications.

An embolism is a medical condition that occurs when a substance, such as a blood clot or an air bubble, blocks a blood vessel. This can happen in any part of the body, but it is particularly dangerous when it affects the brain (causing a stroke) or the lungs (causing a pulmonary embolism). Embolisms can cause serious harm by preventing oxygen and nutrients from reaching the tissues and organs that need them. They are often the result of underlying medical conditions, such as heart disease or deep vein thrombosis, and may require immediate medical attention to prevent further complications.

Fibrinolysis is the natural process in the body that leads to the dissolution of blood clots. It is a vital part of hemostasis, the process that regulates bleeding and wound healing. Fibrinolysis occurs when plasminogen activators convert plasminogen to plasmin, an enzyme that breaks down fibrin, the insoluble protein mesh that forms the structure of a blood clot. This process helps to prevent excessive clotting and maintains the fluidity of the blood. In medical settings, fibrinolysis can also refer to the therapeutic use of drugs that stimulate this process to dissolve unwanted or harmful blood clots, such as those that cause deep vein thrombosis or pulmonary embolism.

An intracranial embolism is a medical condition that occurs when a blood clot or other foreign material (embolus) forms elsewhere in the body and travels to the blood vessels within the brain. This embolus then blocks the flow of blood in the cerebral arteries, leading to potential damage or death of brain tissue. Common sources of intracranial emboli include heart conditions such as atrial fibrillation, valvular heart disease, or following a heart attack; or from large-vessel atherosclerosis in the carotid arteries. Symptoms can vary depending on the location and size of the obstruction, but may include sudden weakness or numbness, confusion, difficulty speaking, vision loss, severe headache, or even loss of consciousness. Immediate medical attention is required to diagnose and treat intracranial embolism, often involving anticoagulation therapy, endovascular procedures, or surgery.

Thromboelastography (TEG) is a viscoelastic method used to assess the kinetics of clot formation, clot strength, and fibrinolysis in whole blood. It provides a global assessment of hemostasis by measuring the mechanical properties of a clot as it forms and dissolves over time. The TEG graph displays several parameters that reflect the different stages of clotting, including reaction time (R), clot formation time (K), angle of clot formation (α), maximum amplitude (MA), and percentage lysis at 30 minutes (LY30). These parameters can help guide transfusion therapy and inform decisions regarding the management of coagulopathy in various clinical settings, such as trauma, cardiac surgery, liver transplantation, and obstetrics.

Paradoxical embolism is a medical condition that occurs when a blood clot or other material (embolus) from a vein passes through an abnormal connection between the right and left sides of the heart and lodges in an artery in the systemic circulation. This is considered "paradoxical" because the embolus originates from the venous system but bypasses the lungs and travels directly to the arterial system.

Under normal circumstances, blood flows from the body's veins into the right atrium of the heart, then through the tricuspid valve into the right ventricle, where it is pumped through the pulmonary artery into the lungs for oxygenation. The now oxygen-rich blood returns to the left atrium via the pulmonary veins, passes through the mitral valve into the left ventricle, and is then pumped out to the body's arteries.

However, in certain conditions such as a patent foramen ovale (PFO) or an atrial septal defect (ASD), there can be an abnormal communication between the right and left atria. This allows for the possibility of a paradoxical embolism to occur when a clot or other material from the venous system passes through this connection into the arterial system, bypassing filtration and oxygenation in the lungs.

Paradoxical embolism can lead to serious consequences, such as stroke, transient ischemic attack (TIA), or tissue damage in various organs, depending on where the embolus lodges. Treatment typically involves addressing the underlying cause of the paradoxical embolism and may include anticoagulation therapy, surgical closure of the abnormal connection, or other interventions as necessary.

Thrombosis is the formation of a blood clot (thrombus) inside a blood vessel, obstructing the flow of blood through the circulatory system. When a clot forms in an artery, it can cut off the supply of oxygen and nutrients to the tissues served by that artery, leading to damage or tissue death. If a thrombus forms in the heart, it can cause a heart attack. If a thrombus breaks off and travels through the bloodstream, it can lodge in a smaller vessel, causing blockage and potentially leading to damage in the organ that the vessel supplies. This is known as an embolism.

Thrombosis can occur due to various factors such as injury to the blood vessel wall, abnormalities in blood flow, or changes in the composition of the blood. Certain medical conditions, medications, and lifestyle factors can increase the risk of thrombosis. Treatment typically involves anticoagulant or thrombolytic therapy to dissolve or prevent further growth of the clot, as well as addressing any underlying causes.

Tissue Plasminogen Activator (tPA) is a thrombolytic enzyme, which means it dissolves blood clots. It is naturally produced by the endothelial cells that line the interior surface of blood vessels. tPA activates plasminogen, a zymogen, to convert it into plasmin, a protease that breaks down fibrin, the structural protein in blood clots. This enzyme is used medically as a thrombolytic drug under various brand names, such as Activase and Alteplase, to treat conditions like acute ischemic stroke, pulmonary embolism, and deep vein thrombosis by dissolving the clots and restoring blood flow.

Fibrinogen is a soluble protein present in plasma, synthesized by the liver. It plays an essential role in blood coagulation. When an injury occurs, fibrinogen gets converted into insoluble fibrin by the action of thrombin, forming a fibrin clot that helps to stop bleeding from the injured site. Therefore, fibrinogen is crucial for hemostasis, which is the process of stopping bleeding and starting the healing process after an injury.

1. Intracranial Embolism: This is a medical condition that occurs when a blood clot or other particle (embolus) formed elsewhere in the body, travels through the bloodstream and lodges itself in the intracranial blood vessels, blocking the flow of blood to a part of the brain. This can lead to various neurological symptoms such as weakness, numbness, speech difficulties, or even loss of consciousness, depending on the severity and location of the blockage.

2. Intracranial Thrombosis: This is a medical condition that occurs when a blood clot (thrombus) forms within the intracranial blood vessels. The clot can partially or completely obstruct the flow of blood, leading to various symptoms such as headache, confusion, seizures, or neurological deficits, depending on the severity and location of the thrombosis. Intracranial thrombosis can occur due to various factors including atherosclerosis, hypertension, diabetes, and other medical conditions that increase the risk of blood clot formation.

An amniotic fluid embolism (AFE) is a rare but serious condition that can occur during pregnancy, labor, or shortly after delivery. It occurs when amniotic fluid, fetal cells, hair, or other debris enter the mother's bloodstream and block the flow of blood to the lungs or other parts of the body. This can cause a range of symptoms including sudden shortness of breath, rapid heartbeat, low blood pressure, chills, and in severe cases, cardiac arrest or seizures. AFE is a medical emergency that requires immediate treatment.

The exact causes of amniotic fluid embolism are not well understood, but it is thought to occur when there is a disruption in the placental barrier that allows amniotic fluid and fetal debris to enter the mother's bloodstream. Risk factors for AFE include advanced maternal age, cesarean delivery, placenta previa, and other pregnancy complications.

Treatment for AFE typically involves supportive care, such as oxygen therapy, medications to support blood pressure and heart function, and in some cases, surgery to remove the blockage from the blood vessels. Despite treatment, AFE can be a life-threatening condition with significant morbidity and mortality rates.

Factor XIIIa is a protein involved in the blood clotting process. It is a activated form of Factor XIII, which is a protransglutaminase enzyme that plays a role in stabilizing blood clots. Factor XIIIa cross-links fibrin molecules in the clot to form a more stable and insoluble clot. This action helps prevent further bleeding from the site of injury.

Factor XIIIa is formed when thrombin, another protein involved in blood clotting, cleaves and activates Factor XIII. Once activated, Factor XIIIa catalyzes the formation of covalent bonds between fibrin molecules, creating a mesh-like structure that strengthens the clot.

Deficiencies or dysfunctions in Factor XIIIa can lead to bleeding disorders, including factor XIII deficiency, which is a rare but serious condition characterized by prolonged bleeding and an increased risk of spontaneous hemorrhage.

Fibrinolytic agents are medications that dissolve or break down blood clots by activating plasminogen, which is converted into plasmin. Plasmin is a proteolytic enzyme that degrades fibrin, the structural protein in blood clots. Fibrinolytic agents are used medically to treat conditions such as acute ischemic stroke, deep vein thrombosis, pulmonary embolism, and myocardial infarction (heart attack) by restoring blood flow in occluded vessels. Examples of fibrinolytic agents include alteplase, reteplase, and tenecteplase. It is important to note that these medications carry a risk of bleeding complications and should be administered with caution.

Blood coagulation tests, also known as coagulation studies or clotting tests, are a series of medical tests used to evaluate the blood's ability to clot. These tests measure the functioning of various clotting factors and regulatory proteins involved in the coagulation cascade, which is a complex process that leads to the formation of a blood clot to prevent excessive bleeding.

The most commonly performed coagulation tests include:

1. Prothrombin Time (PT): Measures the time it takes for a sample of plasma to clot after the addition of calcium and tissue factor, which activates the extrinsic pathway of coagulation. The PT is reported in seconds and can be converted to an International Normalized Ratio (INR) to monitor anticoagulant therapy.
2. Activated Partial Thromboplastin Time (aPTT): Measures the time it takes for a sample of plasma to clot after the addition of calcium, phospholipid, and a contact activator, which activates the intrinsic pathway of coagulation. The aPTT is reported in seconds and is used to monitor heparin therapy.
3. Thrombin Time (TT): Measures the time it takes for a sample of plasma to clot after the addition of thrombin, which directly converts fibrinogen to fibrin. The TT is reported in seconds and can be used to detect the presence of fibrin degradation products or abnormalities in fibrinogen function.
4. Fibrinogen Level: Measures the amount of fibrinogen, a protein involved in clot formation, present in the blood. The level is reported in grams per liter (g/L) and can be used to assess bleeding risk or the effectiveness of fibrinogen replacement therapy.
5. D-dimer Level: Measures the amount of D-dimer, a protein fragment produced during the breakdown of a blood clot, present in the blood. The level is reported in micrograms per milliliter (µg/mL) and can be used to diagnose or exclude venous thromboembolism (VTE), such as deep vein thrombosis (DVT) or pulmonary embolism (PE).

These tests are important for the diagnosis, management, and monitoring of various bleeding and clotting disorders. They can help identify the underlying cause of abnormal bleeding or clotting, guide appropriate treatment decisions, and monitor the effectiveness of therapy. It is essential to interpret these test results in conjunction with a patient's clinical presentation and medical history.

Ultrasonic therapy, also known as therapeutic ultrasound, is a treatment method used in physical therapy and rehabilitation that utilizes sound waves with frequencies higher than the upper limit of human hearing. In most cases, the frequency ranges from 800,000 to 2,000,000 Hz (cycles per second).

During ultrasonic therapy, a small device called a transducer is placed in direct contact with the patient's skin. The transducer emits ultrasonic waves that are primarily absorbed by soft tissues directly beneath the skin's surface, including muscles, tendons, and ligaments. These sound waves cause microscopic vibrations in the tissue molecules, which can produce various therapeutic effects:

1. Deep heating: The vibration of tissue molecules generates heat within the treated area, increasing local blood flow, reducing muscle tension, and promoting healing. This effect is particularly beneficial for treating chronic pain, muscle spasms, joint stiffness, and soft tissue injuries.
2. Cavitation: High-intensity ultrasonic waves can create tiny gas bubbles in the fluid surrounding the tissue cells. When these bubbles collapse (a process called cavitation), they generate intense localized pressure that may help break down scar tissue, reduce adhesions, and improve tissue mobility.
3. Non-thermal effects: Low-intensity ultrasonic waves can stimulate cellular processes without causing significant heating. These non-thermal effects include enhanced metabolism, increased collagen production, and improved nutrient exchange in the treated tissues, which may contribute to faster healing and tissue regeneration.

Ultrasonic therapy is generally considered safe when performed by a trained healthcare professional. However, it should be avoided in certain situations, such as over areas with malignant tumors, infected tissues, or near metal implants (due to the risk of heating). Pregnant women should also avoid therapeutic ultrasound, especially during the first trimester, due to potential risks to fetal development.

Hemostatics are substances or agents that promote bleeding cessation or prevent the spread of bleeding. They can act in various ways, such as by stimulating the body's natural clotting mechanisms, constricting blood vessels to reduce blood flow, or forming a physical barrier to block the bleeding site.

Hemostatics are often used in medical settings to manage wounds, injuries, and surgical procedures. They can be applied directly to the wound as a powder, paste, or gauze, or they can be administered systemically through intravenous injection. Examples of hemostatic agents include fibrin sealants, collagen-based products, thrombin, and oxidized regenerated cellulose.

It's important to note that while hemostatics can be effective in controlling bleeding, they should be used with caution and only under the guidance of a healthcare professional. Inappropriate use or overuse of hemostatic agents can lead to complications such as excessive clotting, thrombosis, or tissue damage.

Plasminogen is a glycoprotein that is present in human plasma, and it is the inactive precursor of the enzyme plasmin. Plasmin is a serine protease that plays a crucial role in the dissolution of blood clots by degrading fibrin, one of the major components of a blood clot.

Plasminogen can be activated to form plasmin through the action of various activators, such as tissue plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA). Once activated, plasmin can break down fibrin and other proteins, helping to prevent excessive clotting and promoting the normal turnover of extracellular matrix components.

Abnormalities in plasminogen activation have been implicated in various diseases, including thrombosis, fibrosis, and cancer. Therefore, understanding the regulation and function of plasminogen is important for developing therapies to treat these conditions.

Hemoglobin H (Hb H) is a type of abnormal hemoglobin that can occur in individuals with certain genetic disorders, such as hemoglobinopathies. It is formed when four beta-globin chains come together, instead of the usual two alpha and two beta chains found in normal adult hemoglobin (Hb A).

This abnormal structure can result from a mutation that causes the absence or deficiency of alpha-globin chains, leading to an excess of beta-globin chains. Hemoglobin H is often associated with conditions such as thalassemia, particularly when there is a severe deficiency of alpha-globin chain production (alpha-thalassemia).

Hemoglobin H can cause hemolytic anemia, which means that the red blood cells are destroyed prematurely. The severity of the condition depends on the degree of imbalance between alpha and beta chains and other genetic factors. Symptoms may include fatigue, jaundice, and splenomegaly (enlarged spleen).

Alpha-2-antiplasmin (α2AP) is a protein found in the blood plasma that inhibits fibrinolysis, the process by which blood clots are broken down. It does this by irreversibly binding to and inhibiting plasmin, an enzyme that degrades fibrin clots.

Alpha-2-antiplasmin is one of the most important regulators of fibrinolysis, helping to maintain a balance between clot formation and breakdown. Deficiencies or dysfunction in alpha-2-antiplasmin can lead to an increased risk of bleeding due to uncontrolled plasmin activity.

High-Intensity Focused Ultrasound (HIFU) ablation is a minimally invasive medical procedure that uses high-frequency ultrasound energy to generate heat and destroy targeted tissue. The ultrasound beam is focused on a specific point within the body, raising the temperature at that spot to between 65 and 90°C, which causes coagulative necrosis and ablation of the targeted tissue.

HIFU ablation is often used in the treatment of various types of tumors, including prostate, liver, kidney, and breast cancer. It can also be used to treat benign conditions such as uterine fibroids. The procedure does not require incisions, which reduces the risk of complications and speeds up recovery time compared to traditional surgical procedures.

During the procedure, an ultrasound probe is inserted into the body and positioned near the targeted tissue. High-intensity ultrasound waves are then emitted from the probe and focused on a small area within the tissue. The energy from the ultrasound waves causes the temperature at the focal point to rise rapidly, destroying the targeted tissue.

HIFU ablation is typically performed as an outpatient procedure, and patients can usually return to their normal activities within a few days. However, the effectiveness of HIFU ablation varies depending on the size and location of the tumor, as well as other factors. Therefore, it is important for patients to discuss the potential benefits and risks of HIFU ablation with their healthcare provider before undergoing the procedure.

Thrombolytic therapy, also known as thrombolysis, is a medical treatment that uses medications called thrombolytics or fibrinolytics to dissolve or break down blood clots (thrombi) in blood vessels. These clots can obstruct the flow of blood to vital organs such as the heart, lungs, or brain, leading to serious conditions like myocardial infarction (heart attack), pulmonary embolism, or ischemic stroke.

The goal of thrombolytic therapy is to restore blood flow as quickly and efficiently as possible to prevent further damage to the affected organ and potentially save lives. Commonly used thrombolytic drugs include alteplase (tPA), reteplase, and tenecteplase. It's essential to administer these medications as soon as possible after the onset of symptoms for optimal treatment outcomes. However, there are risks associated with thrombolytic therapy, such as an increased chance of bleeding complications, which must be carefully weighed against its benefits in each individual case.

Hemostasis is the physiological process that occurs to stop bleeding (bleeding control) when a blood vessel is damaged. This involves the interaction of platelets, vasoconstriction, and blood clotting factors leading to the formation of a clot. The ultimate goal of hemostasis is to maintain the integrity of the vascular system while preventing excessive blood loss.

Blood coagulation disorders, also known as bleeding disorders or clotting disorders, refer to a group of medical conditions that affect the body's ability to form blood clots properly. Normally, when a blood vessel is injured, the body's coagulation system works to form a clot to stop the bleeding and promote healing.

In blood coagulation disorders, there can be either an increased tendency to bleed due to problems with the formation of clots (hemorrhagic disorder), or an increased tendency for clots to form inappropriately even without injury, leading to blockages in the blood vessels (thrombotic disorder).

Examples of hemorrhagic disorders include:

1. Hemophilia - a genetic disorder that affects the ability to form clots due to deficiencies in clotting factors VIII or IX.
2. Von Willebrand disease - another genetic disorder caused by a deficiency or abnormality of the von Willebrand factor, which helps platelets stick together to form a clot.
3. Liver diseases - can lead to decreased production of coagulation factors, increasing the risk of bleeding.
4. Disseminated intravascular coagulation (DIC) - a serious condition where clotting and bleeding occur simultaneously due to widespread activation of the coagulation system.

Examples of thrombotic disorders include:

1. Factor V Leiden mutation - a genetic disorder that increases the risk of inappropriate blood clot formation.
2. Antithrombin III deficiency - a genetic disorder that impairs the body's ability to break down clots, increasing the risk of thrombosis.
3. Protein C or S deficiencies - genetic disorders that lead to an increased risk of thrombosis due to impaired regulation of the coagulation system.
4. Antiphospholipid syndrome (APS) - an autoimmune disorder where the body produces antibodies against its own clotting factors, increasing the risk of thrombosis.

Treatment for blood coagulation disorders depends on the specific diagnosis and may include medications to manage bleeding or prevent clots, as well as lifestyle changes and monitoring to reduce the risk of complications.

Fibrinolysin is defined as a proteolytic enzyme that dissolves or breaks down fibrin, a protein involved in the clotting of blood. This enzyme is produced by certain cells, such as endothelial cells that line the interior surface of blood vessels, and is an important component of the body's natural mechanism for preventing excessive blood clotting and maintaining blood flow.

Fibrinolysin works by cleaving specific bonds in the fibrin molecule, converting it into soluble degradation products that can be safely removed from the body. This process is known as fibrinolysis, and it helps to maintain the balance between clotting and bleeding in the body.

In medical contexts, fibrinolysin may be used as a therapeutic agent to dissolve blood clots that have formed in the blood vessels, such as those that can occur in deep vein thrombosis or pulmonary embolism. It is often administered in combination with other medications that help to enhance its activity and specificity for fibrin.

Factor XIII, also known as fibrin stabilizing factor, is a protein involved in the clotting process of blood. It is a transglutaminase enzyme that cross-links fibrin molecules to form a stable clot. Factor XIII becomes activated during the coagulation cascade, and its activity helps strengthen the clot and protect it from premature degradation by proteolytic enzymes. A deficiency in Factor XIII can lead to a bleeding disorder characterized by prolonged bleeding after injury or surgery.

Cholesterol embolism is a medical condition that occurs when cholesteral crystals or plaque debris from an atherosclerotic lesion in the aorta or its major branches dislodge and travel to smaller vessels, where they obstruct blood flow. This can lead to tissue damage or infarction in various organs, depending on the location of the embolism.

Cholesterol emboli are typically small, crystalline, and composed of cholesterol, calcium, and other debris from atherosclerotic plaques. They can cause inflammation and damage to the endothelial cells lining the blood vessels, leading to further narrowing or occlusion of the vessel lumen.

Symptoms of cholesterol embolism depend on the location and extent of the obstruction. Common sites for embolization include the kidneys, brain, eyes, skin, and extremities. Symptoms can range from mild to severe and may include sudden pain, weakness, or numbness in the affected area; skin discoloration or ulcerations; vision changes; kidney dysfunction; and stroke-like symptoms.

Cholesterol embolism is often a complication of invasive procedures such as angiography, coronary artery bypass grafting, or aortic surgery. It can also occur spontaneously in patients with advanced atherosclerosis or those who have recently undergone anticoagulation therapy.

Diagnosis of cholesterol embolism is often challenging due to its nonspecific symptoms and variable presentation. Imaging studies, such as angiography or CT scans, may be used to visualize the location and extent of the obstruction. Blood tests and biopsy of affected tissues can also provide diagnostic clues.

Treatment of cholesterol embolism is primarily supportive and aimed at managing symptoms and preventing further complications. Antiplatelet therapy, statins, and anti-inflammatory agents may be used to reduce the risk of recurrent embolization and improve outcomes. In severe cases, surgical intervention or endovascular procedures may be necessary to remove the obstruction or restore blood flow.

Streptokinase is a thrombolytic or clot-busting enzyme produced by certain strains of streptococcus bacteria. It functions by converting plasminogen to plasmin, which then degrades fibrin, a protein that forms the structural framework of blood clots. This activity helps in dissolving blood clots and restoring blood flow in areas obstructed by them. In a medical context, streptokinase is often used as a medication to treat conditions associated with abnormal blood clotting, such as heart attacks, pulmonary embolisms, and deep vein thromboses. However, its use carries the risk of bleeding complications due to excessive fibrinolysis or clot dissolution.

Thrombin is a serine protease enzyme that plays a crucial role in the coagulation cascade, which is a complex series of biochemical reactions that leads to the formation of a blood clot (thrombus) to prevent excessive bleeding during an injury. Thrombin is formed from its precursor protein, prothrombin, through a process called activation, which involves cleavage by another enzyme called factor Xa.

Once activated, thrombin converts fibrinogen, a soluble plasma protein, into fibrin, an insoluble protein that forms the structural framework of a blood clot. Thrombin also activates other components of the coagulation cascade, such as factor XIII, which crosslinks and stabilizes the fibrin network, and platelets, which contribute to the formation and growth of the clot.

Thrombin has several regulatory mechanisms that control its activity, including feedback inhibition by antithrombin III, a plasma protein that inactivates thrombin and other serine proteases, and tissue factor pathway inhibitor (TFPI), which inhibits the activation of factor Xa, thereby preventing further thrombin formation.

Overall, thrombin is an essential enzyme in hemostasis, the process that maintains the balance between bleeding and clotting in the body. However, excessive or uncontrolled thrombin activity can lead to pathological conditions such as thrombosis, atherosclerosis, and disseminated intravascular coagulation (DIC).

Venous thrombosis is a medical condition characterized by the formation of a blood clot (thrombus) in the deep veins, often in the legs (deep vein thrombosis or DVT), but it can also occur in other parts of the body such as the arms, pelvis, or lungs (pulmonary embolism).

The formation of a venous thrombus can be caused by various factors, including injury to the blood vessel wall, changes in blood flow, and alterations in the composition of the blood. These factors can lead to the activation of clotting factors and platelets, which can result in the formation of a clot that blocks the vein.

Symptoms of venous thrombosis may include swelling, pain, warmth, and redness in the affected area. In some cases, the clot can dislodge and travel to other parts of the body, causing potentially life-threatening complications such as pulmonary embolism.

Risk factors for venous thrombosis include advanced age, obesity, smoking, pregnancy, use of hormonal contraceptives or hormone replacement therapy, cancer, recent surgery or trauma, prolonged immobility, and a history of previous venous thromboembolism. Treatment typically involves the use of anticoagulant medications to prevent further clotting and dissolve existing clots.

A cerebral hemorrhage, also known as an intracranial hemorrhage or intracerebral hemorrhage, is a type of stroke that results from bleeding within the brain tissue. It occurs when a weakened blood vessel bursts and causes localized bleeding in the brain. This bleeding can increase pressure in the skull, damage nearby brain cells, and release toxic substances that further harm brain tissues.

Cerebral hemorrhages are often caused by chronic conditions like hypertension (high blood pressure) or cerebral amyloid angiopathy, which weakens the walls of blood vessels over time. Other potential causes include trauma, aneurysms, arteriovenous malformations, illicit drug use, and brain tumors. Symptoms may include sudden headache, weakness, numbness, difficulty speaking or understanding speech, vision problems, loss of balance, and altered level of consciousness. Immediate medical attention is required to diagnose and manage cerebral hemorrhage through imaging techniques, supportive care, and possible surgical interventions.

An embolectomy is a surgical procedure to remove an embolus, which is a blockage in a blood vessel caused by a clot or air bubble that has traveled from another part of the body. During an embolectomy, the surgeon makes an incision in the affected blood vessel and removes the embolus using specialized surgical instruments. This procedure is often performed as an emergency treatment to restore blood flow and prevent tissue damage in the affected area of the body.

Heparin is defined as a highly sulfated glycosaminoglycan (a type of polysaccharide) that is widely present in many tissues, but is most commonly derived from the mucosal tissues of mammalian lungs or intestinal mucosa. It is an anticoagulant that acts as an inhibitor of several enzymes involved in the blood coagulation cascade, primarily by activating antithrombin III which then neutralizes thrombin and other clotting factors.

Heparin is used medically to prevent and treat thromboembolic disorders such as deep vein thrombosis, pulmonary embolism, and certain types of heart attacks. It can also be used during hemodialysis, cardiac bypass surgery, and other medical procedures to prevent the formation of blood clots.

It's important to note that while heparin is a powerful anticoagulant, it does not have any fibrinolytic activity, meaning it cannot dissolve existing blood clots. Instead, it prevents new clots from forming and stops existing clots from growing larger.

Anticoagulants are a class of medications that work to prevent the formation of blood clots in the body. They do this by inhibiting the coagulation cascade, which is a series of chemical reactions that lead to the formation of a clot. Anticoagulants can be given orally, intravenously, or subcutaneously, depending on the specific drug and the individual patient's needs.

There are several different types of anticoagulants, including:

1. Heparin: This is a naturally occurring anticoagulant that is often used in hospitalized patients who require immediate anticoagulation. It works by activating an enzyme called antithrombin III, which inhibits the formation of clots.
2. Low molecular weight heparin (LMWH): LMWH is a form of heparin that has been broken down into smaller molecules. It has a longer half-life than standard heparin and can be given once or twice daily by subcutaneous injection.
3. Direct oral anticoagulants (DOACs): These are newer oral anticoagulants that work by directly inhibiting specific clotting factors in the coagulation cascade. Examples include apixaban, rivaroxaban, and dabigatran.
4. Vitamin K antagonists: These are older oral anticoagulants that work by inhibiting the action of vitamin K, which is necessary for the formation of clotting factors. Warfarin is an example of a vitamin K antagonist.

Anticoagulants are used to prevent and treat a variety of conditions, including deep vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation, and prosthetic heart valve thrombosis. It is important to note that anticoagulants can increase the risk of bleeding, so they must be used with caution and regular monitoring of blood clotting times may be required.

Hemorrhage is defined in the medical context as an excessive loss of blood from the circulatory system, which can occur due to various reasons such as injury, surgery, or underlying health conditions that affect blood clotting or the integrity of blood vessels. The bleeding may be internal, external, visible, or concealed, and it can vary in severity from minor to life-threatening, depending on the location and extent of the bleeding. Hemorrhage is a serious medical emergency that requires immediate attention and treatment to prevent further blood loss, organ damage, and potential death.

A subarachnoid hemorrhage is a type of stroke that results from bleeding into the space surrounding the brain, specifically within the subarachnoid space which contains cerebrospinal fluid (CSF). This space is located between the arachnoid membrane and the pia mater, two of the three layers that make up the meninges, the protective covering of the brain and spinal cord.

The bleeding typically originates from a ruptured aneurysm, a weakened area in the wall of a cerebral artery, or less commonly from arteriovenous malformations (AVMs) or head trauma. The sudden influx of blood into the CSF-filled space can cause increased intracranial pressure, irritation to the brain, and vasospasms, leading to further ischemia and potential additional neurological damage.

Symptoms of a subarachnoid hemorrhage may include sudden onset of severe headache (often described as "the worst headache of my life"), neck stiffness, altered mental status, nausea, vomiting, photophobia, and focal neurological deficits. Rapid diagnosis and treatment are crucial to prevent further complications and improve the chances of recovery.

The Ventilation-Perfusion (V/Q) ratio is a measure used in respiratory physiology to describe the relationship between the amount of air that enters the alveoli (ventilation) and the amount of blood that reaches the alveoli to pick up oxygen (perfusion).

In a healthy lung, these two processes are well-matched, meaning that well-ventilated areas of the lung also have good blood flow. This results in a V/Q ratio close to 1.0.

However, certain lung conditions such as emphysema or pulmonary embolism can cause ventilation and perfusion to become mismatched, leading to a V/Q ratio that is either higher (ventilation exceeds perfusion) or lower (perfusion exceeds ventilation) than normal. This mismatch can result in impaired gas exchange and lead to hypoxemia (low oxygen levels in the blood).

The V/Q ratio is often used in clinical settings to assess lung function and diagnose respiratory disorders.

Plasminogen activators are a group of enzymes that play a crucial role in the body's fibrinolytic system, which is responsible for breaking down and removing blood clots. These enzymes activate plasminogen, a zymogen (inactive precursor) found in circulation, converting it into plasmin - a protease that degrades fibrin, the insoluble protein mesh that forms the structural basis of a blood clot.

There are two main types of plasminogen activators:

1. Tissue Plasminogen Activator (tPA): This is a serine protease primarily produced by endothelial cells lining blood vessels. tPA has a higher affinity for fibrin-bound plasminogen and is therefore more specific in activating plasmin at the site of a clot, helping to localize fibrinolysis and minimize bleeding risks.
2. Urokinase Plasminogen Activator (uPA): This is another serine protease found in various tissues and body fluids, including urine. uPA can be produced by different cell types, such as macrophages and fibroblasts. Unlike tPA, uPA does not have a strong preference for fibrin-bound plasminogen and can activate plasminogen in a more general manner, which might contribute to its role in processes like tissue remodeling and cancer progression.

Plasminogen activators are essential for maintaining vascular homeostasis by ensuring the proper removal of blood clots and preventing excessive fibrin accumulation. They have also been implicated in various pathological conditions, including thrombosis, hemorrhage, and tumor metastasis.

Blood platelets, also known as thrombocytes, are small, colorless cell fragments in our blood that play an essential role in normal blood clotting. They are formed in the bone marrow from large cells called megakaryocytes and circulate in the blood in an inactive state until they are needed to help stop bleeding. When a blood vessel is damaged, platelets become activated and change shape, releasing chemicals that attract more platelets to the site of injury. These activated platelets then stick together to form a plug, or clot, that seals the wound and prevents further blood loss. In addition to their role in clotting, platelets also help to promote healing by releasing growth factors that stimulate the growth of new tissue.

Platelet activation is the process by which platelets (also known as thrombocytes) become biologically active and change from their inactive discoid shape to a spherical shape with pseudopodia, resulting in the release of chemical mediators that are involved in hemostasis and thrombosis. This process is initiated by various stimuli such as exposure to subendothelial collagen, von Willebrand factor, or thrombin during vascular injury, leading to platelet aggregation and the formation of a platelet plug to stop bleeding. Platelet activation also plays a role in inflammation, immune response, and wound healing.

Blood is the fluid that circulates in the body of living organisms, carrying oxygen and nutrients to the cells and removing carbon dioxide and other waste products. It is composed of red and white blood cells suspended in a liquid called plasma. The main function of blood is to transport oxygen from the lungs to the body's tissues and carbon dioxide from the tissues to the lungs. It also transports nutrients, hormones, and other substances to the cells and removes waste products from them. Additionally, blood plays a crucial role in the body's immune system by helping to fight infection and disease.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

Vena cava filters are medical devices that are implanted into the inferior vena cava, which is the largest vein in the body that returns blood from the lower half of the body to the heart. These filters are designed to trap blood clots that form in the deep veins of the legs (deep vein thrombosis or DVT) and prevent them from traveling to the lungs (pulmonary embolism or PE), which can be a life-threatening condition.

The filter is typically implanted using a catheter-based procedure, and it has legs or arms that extend out to trap the blood clots as they flow through the vein. Over time, the trapped clots may dissolve on their own or become organized and incorporated into the wall of the vein.

Vena cava filters are typically used in patients who are at high risk for PE but cannot take anticoagulation medication or have failed anticoagulation therapy. However, there is some controversy surrounding the use of these devices due to concerns about their long-term safety and effectiveness.

Thromboembolism is a medical condition that refers to the obstruction of a blood vessel by a thrombus (blood clot) that has formed elsewhere in the body and then been transported by the bloodstream to a narrower vessel, where it becomes lodged. This process can occur in various parts of the body, leading to different types of thromboembolisms:

1. Deep Vein Thrombosis (DVT): A thrombus forms in the deep veins, usually in the legs or pelvis, and then breaks off and travels to the lungs, causing a pulmonary embolism.
2. Pulmonary Embolism (PE): A thrombus formed elsewhere, often in the deep veins of the legs, dislodges and travels to the lungs, blocking one or more pulmonary arteries. This can lead to shortness of breath, chest pain, and potentially life-threatening complications if not treated promptly.
3. Cerebral Embolism: A thrombus formed in another part of the body, such as the heart or carotid artery, dislodges and travels to the brain, causing a stroke or transient ischemic attack (TIA).
4. Arterial Thromboembolism: A thrombus forms in an artery and breaks off, traveling to another part of the body and blocking blood flow to an organ or tissue, leading to potential damage or loss of function. Examples include mesenteric ischemia (intestinal damage due to blocked blood flow) and retinal artery occlusion (vision loss due to blocked blood flow in the eye).

Prevention, early detection, and appropriate treatment are crucial for managing thromboembolism and reducing the risk of severe complications.

I believe there may be some confusion in your question. "Rabbits" is a common name used to refer to the Lagomorpha species, particularly members of the family Leporidae. They are small mammals known for their long ears, strong legs, and quick reproduction.

However, if you're referring to "rabbits" in a medical context, there is a term called "rabbit syndrome," which is a rare movement disorder characterized by repetitive, involuntary movements of the fingers, resembling those of a rabbit chewing. It is also known as "finger-chewing chorea." This condition is usually associated with certain medications, particularly antipsychotics, and typically resolves when the medication is stopped or adjusted.

Thrombophlebitis is a medical condition characterized by the inflammation and clotting of blood in a vein, usually in the legs. The term thrombophlebitis comes from two words: "thrombo" which means blood clot, and "phlebitis" which refers to inflammation of the vein.

The condition can occur in superficial or deep veins. Superficial thrombophlebitis affects the veins just below the skin's surface, while deep vein thrombophlebitis (DVT) occurs in the deeper veins. DVT is a more serious condition as it can lead to complications such as pulmonary embolism if the blood clot breaks off and travels to the lungs.

Symptoms of thrombophlebitis may include redness, warmth, pain, swelling, or discomfort in the affected area. In some cases, there may be visible surface veins that are hard, tender, or ropy to touch. If left untreated, thrombophlebitis can lead to chronic venous insufficiency and other long-term complications. Treatment typically involves medications such as anticoagulants, antiplatelet agents, or thrombolytics, along with compression stockings and other supportive measures.

I believe there might be a misunderstanding in your question. "Dogs" is not a medical term or condition. It is the common name for a domesticated carnivore of the family Canidae, specifically the genus Canis, which includes wolves, foxes, and other extant and extinct species of mammals. Dogs are often kept as pets and companions, and they have been bred in a wide variety of forms and sizes for different purposes, such as hunting, herding, guarding, assisting police and military forces, and providing companionship and emotional support.

If you meant to ask about a specific medical condition or term related to dogs, please provide more context so I can give you an accurate answer.

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

A stroke, also known as cerebrovascular accident (CVA), is a serious medical condition that occurs when the blood supply to part of the brain is interrupted or reduced, leading to deprivation of oxygen and nutrients to brain cells. This can result in the death of brain tissue and cause permanent damage or temporary impairment to cognitive functions, speech, memory, movement, and other body functions controlled by the affected area of the brain.

Strokes can be caused by either a blockage in an artery that supplies blood to the brain (ischemic stroke) or the rupture of a blood vessel in the brain (hemorrhagic stroke). A transient ischemic attack (TIA), also known as a "mini-stroke," is a temporary disruption of blood flow to the brain that lasts only a few minutes and does not cause permanent damage.

Symptoms of a stroke may include sudden weakness or numbness in the face, arm, or leg; difficulty speaking or understanding speech; vision problems; loss of balance or coordination; severe headache with no known cause; and confusion or disorientation. Immediate medical attention is crucial for stroke patients to receive appropriate treatment and prevent long-term complications.

Animal disease models are specialized animals, typically rodents such as mice or rats, that have been genetically engineered or exposed to certain conditions to develop symptoms and physiological changes similar to those seen in human diseases. These models are used in medical research to study the pathophysiology of diseases, identify potential therapeutic targets, test drug efficacy and safety, and understand disease mechanisms.

The genetic modifications can include knockout or knock-in mutations, transgenic expression of specific genes, or RNA interference techniques. The animals may also be exposed to environmental factors such as chemicals, radiation, or infectious agents to induce the disease state.

Examples of animal disease models include:

1. Mouse models of cancer: Genetically engineered mice that develop various types of tumors, allowing researchers to study cancer initiation, progression, and metastasis.
2. Alzheimer's disease models: Transgenic mice expressing mutant human genes associated with Alzheimer's disease, which exhibit amyloid plaque formation and cognitive decline.
3. Diabetes models: Obese and diabetic mouse strains like the NOD (non-obese diabetic) or db/db mice, used to study the development of type 1 and type 2 diabetes, respectively.
4. Cardiovascular disease models: Atherosclerosis-prone mice, such as ApoE-deficient or LDLR-deficient mice, that develop plaque buildup in their arteries when fed a high-fat diet.
5. Inflammatory bowel disease models: Mice with genetic mutations affecting intestinal barrier function and immune response, such as IL-10 knockout or SAMP1/YitFc mice, which develop colitis.

Animal disease models are essential tools in preclinical research, but it is important to recognize their limitations. Differences between species can affect the translatability of results from animal studies to human patients. Therefore, researchers must carefully consider the choice of model and interpret findings cautiously when applying them to human diseases.

Recombinant proteins are artificially created proteins produced through the use of recombinant DNA technology. This process involves combining DNA molecules from different sources to create a new set of genes that encode for a specific protein. The resulting recombinant protein can then be expressed, purified, and used for various applications in research, medicine, and industry.

Recombinant proteins are widely used in biomedical research to study protein function, structure, and interactions. They are also used in the development of diagnostic tests, vaccines, and therapeutic drugs. For example, recombinant insulin is a common treatment for diabetes, while recombinant human growth hormone is used to treat growth disorders.

The production of recombinant proteins typically involves the use of host cells, such as bacteria, yeast, or mammalian cells, which are engineered to express the desired protein. The host cells are transformed with a plasmid vector containing the gene of interest, along with regulatory elements that control its expression. Once the host cells are cultured and the protein is expressed, it can be purified using various chromatography techniques.

Overall, recombinant proteins have revolutionized many areas of biology and medicine, enabling researchers to study and manipulate proteins in ways that were previously impossible.

Fibrin clot lysis time, also known as fibrinolytic time, is the measurement of the amount of time it takes for a blood clot to dissolve or lyse. This is typically measured in a laboratory setting using specialized tests such as the thromboelastography (TEG) or rotational thromboelastometry (ROTEM) assays. These tests measure the viscoelastic properties of a clot and can provide information about the rate of fibrinolysis, which is the natural process by which the body breaks down and removes blood clots.

Increased fibrin clot lysis time may indicate an impaired fibrinolytic system, which can lead to an increased risk of thrombosis or blood clot formation. Decreased fibrin clot lysis time may indicate an overactive fibrinolytic system, which can lead to an increased risk of bleeding.

It's important to note that the fibrin clot lysis time is just one factor among many that are considered when evaluating a patient's coagulation status and risk of thrombosis or bleeding. Other factors, such as platelet function, coagulation factor levels, and the presence of inhibitors or anticoagulants, must also be taken into account.

Transesophageal echocardiography (TEE) is a type of echocardiogram, which is a medical test that uses sound waves to create detailed images of the heart. In TEE, a special probe containing a transducer is passed down the esophagus (the tube that connects the mouth to the stomach) to obtain views of the heart from behind. This allows for more detailed images of the heart structures and function compared to a standard echocardiogram, which uses a probe placed on the chest. TEE is often used in patients with poor image quality from a standard echocardiogram or when more detailed images are needed to diagnose or monitor certain heart conditions. It is typically performed by a trained cardiologist or sonographer under the direction of a cardiologist.

Angiography is a medical procedure in which an x-ray image is taken to visualize the internal structure of blood vessels, arteries, or veins. This is done by injecting a radiopaque contrast agent (dye) into the blood vessel using a thin, flexible catheter. The dye makes the blood vessels visible on an x-ray image, allowing doctors to diagnose and treat various medical conditions such as blockages, narrowing, or malformations of the blood vessels.

There are several types of angiography, including:

* Cardiac angiography (also called coronary angiography) - used to examine the blood vessels of the heart
* Cerebral angiography - used to examine the blood vessels of the brain
* Peripheral angiography - used to examine the blood vessels in the limbs or other parts of the body.

Angiography is typically performed by a radiologist, cardiologist, or vascular surgeon in a hospital setting. It can help diagnose conditions such as coronary artery disease, aneurysms, and peripheral arterial disease, among others.

X-ray computed tomography (CT or CAT scan) is a medical imaging method that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional (tomographic) images (virtual "slices") of the body. These cross-sectional images can then be used to display detailed internal views of organs, bones, and soft tissues in the body.

The term "computed tomography" is used instead of "CT scan" or "CAT scan" because the machines take a series of X-ray measurements from different angles around the body and then use a computer to process these data to create detailed images of internal structures within the body.

CT scanning is a noninvasive, painless medical test that helps physicians diagnose and treat medical conditions. CT imaging provides detailed information about many types of tissue including lung, bone, soft tissue and blood vessels. CT examinations can be performed on every part of the body for a variety of reasons including diagnosis, surgical planning, and monitoring of therapeutic responses.

In computed tomography (CT), an X-ray source and detector rotate around the patient, measuring the X-ray attenuation at many different angles. A computer uses this data to construct a cross-sectional image by the process of reconstruction. This technique is called "tomography". The term "computed" refers to the use of a computer to reconstruct the images.

CT has become an important tool in medical imaging and diagnosis, allowing radiologists and other physicians to view detailed internal images of the body. It can help identify many different medical conditions including cancer, heart disease, lung nodules, liver tumors, and internal injuries from trauma. CT is also commonly used for guiding biopsies and other minimally invasive procedures.

In summary, X-ray computed tomography (CT or CAT scan) is a medical imaging technique that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional images of the body. It provides detailed internal views of organs, bones, and soft tissues in the body, allowing physicians to diagnose and treat medical conditions.

Patent Foramen Ovale (PFO) is a medical condition where the foramen ovale, an opening between the left and right atria of the heart in a fetus, does not close completely after birth. This results in a small flap-like opening that allows blood to pass from the right atrium to the left atrium. While this condition is typically harmless in itself, it can potentially allow blood clots to pass from the right side of the heart to the left, which could then travel to the brain and cause a stroke. Patent Foramen Ovale is usually an incidental finding during tests for other conditions.

An acute disease is a medical condition that has a rapid onset, develops quickly, and tends to be short in duration. Acute diseases can range from minor illnesses such as a common cold or flu, to more severe conditions such as pneumonia, meningitis, or a heart attack. These types of diseases often have clear symptoms that are easy to identify, and they may require immediate medical attention or treatment.

Acute diseases are typically caused by an external agent or factor, such as a bacterial or viral infection, a toxin, or an injury. They can also be the result of a sudden worsening of an existing chronic condition. In general, acute diseases are distinct from chronic diseases, which are long-term medical conditions that develop slowly over time and may require ongoing management and treatment.

Examples of acute diseases include:

* Acute bronchitis: a sudden inflammation of the airways in the lungs, often caused by a viral infection.
* Appendicitis: an inflammation of the appendix that can cause severe pain and requires surgical removal.
* Gastroenteritis: an inflammation of the stomach and intestines, often caused by a viral or bacterial infection.
* Migraine headaches: intense headaches that can last for hours or days, and are often accompanied by nausea, vomiting, and sensitivity to light and sound.
* Myocardial infarction (heart attack): a sudden blockage of blood flow to the heart muscle, often caused by a buildup of plaque in the coronary arteries.
* Pneumonia: an infection of the lungs that can cause coughing, chest pain, and difficulty breathing.
* Sinusitis: an inflammation of the sinuses, often caused by a viral or bacterial infection.

It's important to note that while some acute diseases may resolve on their own with rest and supportive care, others may require medical intervention or treatment to prevent complications and promote recovery. If you are experiencing symptoms of an acute disease, it is always best to seek medical attention to ensure proper diagnosis and treatment.

Venous Thromboembolism (VTE) is a medical condition that includes both deep vein thrombosis (DVT) and pulmonary embolism (PE). DVT is a blood clot that forms in the deep veins, usually in the legs, while PE occurs when a clot breaks off and travels to the lungs, blocking a pulmonary artery or one of its branches. This condition can be life-threatening if not diagnosed and treated promptly.

The medical definition of Venous Thromboembolism is:

"The formation of a blood clot (thrombus) in a deep vein, most commonly in the legs, which can then dislodge and travel to the lungs, causing a potentially life-threatening blockage of the pulmonary artery or one of its branches (pulmonary embolism). VTE is a complex disorder resulting from an interplay of genetic and environmental factors that affect the balance between thrombosis and fibrinolysis."

Some common risk factors for VTE include immobility, surgery, trauma, cancer, hormonal therapy, pregnancy, advanced age, and inherited or acquired thrombophilia. Symptoms of DVT may include swelling, pain, warmth, and redness in the affected limb, while symptoms of PE can range from shortness of breath and chest pain to coughing up blood or even sudden death. Diagnosis typically involves a combination of clinical assessment, imaging studies (such as ultrasound, CT scan, or MRI), and laboratory tests (such as D-dimer). Treatment usually includes anticoagulation therapy to prevent further clot formation and reduce the risk of recurrence.

Right ventricular dysfunction is a condition characterized by the impaired ability of the right ventricle (one of the two pumping chambers in the heart) to fill with blood during the diastolic phase or eject blood during the systolic phase. This results in reduced cardiac output from the right ventricle, which can lead to various complications such as fluid accumulation in the body, particularly in the abdomen and lower extremities, and ultimately congestive heart failure if left untreated.

Right ventricular dysfunction can be caused by various factors, including damage to the heart muscle due to a heart attack, high blood pressure in the lungs (pulmonary hypertension), chronic lung diseases, congenital heart defects, viral infections, and certain medications. Symptoms of right ventricular dysfunction may include shortness of breath, fatigue, swelling in the legs, ankles, or abdomen, and a decreased tolerance for physical activity.

Diagnosis of right ventricular dysfunction typically involves a combination of medical history, physical examination, imaging tests such as echocardiography, cardiac MRI, or CT scan, and other diagnostic procedures such as electrocardiogram (ECG) or cardiac catheterization. Treatment options depend on the underlying cause but may include medications to reduce fluid buildup, improve heart function, and manage symptoms, as well as lifestyle modifications such as reducing salt intake and increasing physical activity levels. In severe cases, more invasive treatments such as surgery or implantable devices like pacemakers or ventricular assist devices may be necessary.

The pulmonary artery is a large blood vessel that carries deoxygenated blood from the right ventricle of the heart to the lungs for oxygenation. It divides into two main branches, the right and left pulmonary arteries, which further divide into smaller vessels called arterioles, and then into a vast network of capillaries in the lungs where gas exchange occurs. The thin walls of these capillaries allow oxygen to diffuse into the blood and carbon dioxide to diffuse out, making the blood oxygen-rich before it is pumped back to the left side of the heart through the pulmonary veins. This process is crucial for maintaining proper oxygenation of the body's tissues and organs.

Spiral Computed Tomography (CT), also known as Helical CT, is a type of computed tomography scan in which the X-ray tube and detector rotate around the patient in a spiral path, capturing data as the table moves the patient through the scanner. This continuous spiral motion allows for faster and more detailed volumetric imaging of internal organs and structures, reducing the need for multiple slices and providing improved image reconstruction. It is commonly used to diagnose and monitor various medical conditions, including cancer, heart disease, and trauma injuries.

Warfarin is a anticoagulant medication that works by inhibiting the vitamin K-dependent activation of several coagulation factors (factors II, VII, IX, and X). This results in prolonged clotting times and reduced thrombus formation. It is commonly used to prevent and treat blood clots in conditions such as atrial fibrillation, deep vein thrombosis, and pulmonary embolism. Warfarin is also known by its brand names Coumadin and Jantoven.

It's important to note that warfarin has a narrow therapeutic index, meaning that the difference between an effective dose and a toxic one is small. Therefore, it requires careful monitoring of the patient's coagulation status through regular blood tests (INR) to ensure that the dosage is appropriate and to minimize the risk of bleeding complications.

A thrombectomy is a medical procedure that involves the removal of a blood clot (thrombus) from a blood vessel. This is typically performed to restore blood flow in cases where the clot is causing significant blockage, which can lead to serious complications such as tissue damage or organ dysfunction.

During a thrombectomy, a surgeon makes an incision and accesses the affected blood vessel, often with the help of imaging guidance. Specialized tools are then used to extract the clot, after which the blood vessel is usually repaired. Thrombectomies can be performed on various blood vessels throughout the body, including those in the brain, heart, lungs, and limbs.

This procedure may be recommended for patients with deep vein thrombosis (DVT), pulmonary embolism (PE), or certain types of stroke, depending on the specific circumstances and the patient's overall health. It is generally considered when anticoagulation therapy or clot-dissolving medications are not sufficient or appropriate to treat the blood clot.

"Swine" is a common term used to refer to even-toed ungulates of the family Suidae, including domestic pigs and wild boars. However, in a medical context, "swine" often appears in the phrase "swine flu," which is a strain of influenza virus that typically infects pigs but can also cause illness in humans. The 2009 H1N1 pandemic was caused by a new strain of swine-origin influenza A virus, which was commonly referred to as "swine flu." It's important to note that this virus is not transmitted through eating cooked pork products; it spreads from person to person, mainly through respiratory droplets produced when an infected person coughs or sneezes.

Phlebography is a medical imaging technique used to visualize and assess the veins, particularly in the legs. It involves the injection of a contrast agent into the veins, followed by X-ray imaging to capture the flow of the contrast material through the veins. This allows doctors to identify any abnormalities such as blood clots, blockages, or malformations in the venous system.

There are different types of phlebography, including ascending phlebography (where the contrast agent is injected into a foot vein and travels up the leg) and descending phlebography (where the contrast agent is injected into a vein in the groin or neck and travels down the leg).

Phlebography is an invasive procedure that requires careful preparation and monitoring, and it is typically performed by radiologists or vascular specialists. It has largely been replaced by non-invasive imaging techniques such as ultrasound and CT angiography in many clinical settings.

The femoral vein is the large vein that runs through the thigh and carries oxygen-depleted blood from the lower limbs back to the heart. It is located in the femoral triangle, along with the femoral artery and nerve. The femoral vein begins at the knee as the popliteal vein, which then joins with the deep vein of the thigh to form the femoral vein. As it moves up the leg, it is joined by several other veins, including the great saphenous vein, before it becomes the external iliac vein at the inguinal ligament in the groin.

Atrial septal defect (ASD) is a type of congenital heart defect that involves the septum, which is the wall that separates the two upper chambers of the heart (atria). An ASD is a hole or abnormal opening in the atrial septum, allowing oxygen-rich blood to leak into the oxygen-poor blood chambers in the heart. This leads to an overload of blood in the right side of the heart, which can cause enlargement of the heart and increased work for the right ventricle.

ASDs can vary in size, and small defects may not cause any symptoms or require treatment. Larger defects, however, can result in symptoms such as shortness of breath, fatigue, and heart rhythm abnormalities. Over time, if left untreated, ASDs can lead to complications like pulmonary hypertension, atrial fibrillation, and stroke.

Treatment for ASD typically involves surgical closure of the defect or catheter-based procedures using devices to close the hole. The choice of treatment depends on factors such as the size and location of the defect, the patient's age and overall health, and the presence of any coexisting conditions.

Embolism: An embolism is the obstruction of a blood vessel by an embolus, a foreign body that travels through the bloodstream from another part of the body. Common sources of emboli include blood clots (thrombi), fat globules, air bubbles, or pieces of tumors. When an embolus lodges in a blood vessel, it can partially or completely block blood flow, leading to tissue damage or death if not promptly treated.

Thrombosis: Thrombosis is the formation of a thrombus, a blood clot that develops within a blood vessel and remains attached to its interior surface. Thrombi can form in response to various factors, such as injury to the blood vessel wall, hypercoagulability (increased tendency for blood clotting), or stasis (reduced blood flow). A thrombus can partially or completely obstruct blood flow, leading to tissue damage or dysfunction. If a piece of the thrombus breaks off and travels through the bloodstream, it becomes an embolus, which can cause an embolism in another part of the body.

Abnormal fibrinogen refers to any variation in the structure, function, or concentration of fibrinogen proteins outside of their normal physiological range. Fibrinogen is a soluble glycoprotein complex produced by the liver that plays a crucial role in blood coagulation. It is composed of three pairs of nonidentical polypeptide chains (Aα, Bβ, and γ) and is converted into fibrin by thrombin during the coagulation cascade.

Abnormalities in fibrinogen can be quantitative or qualitative and may result from genetic mutations, acquired conditions, or medications. Examples of abnormal fibrinogens include:

1. Hypofibrinogenemia: A decrease in the concentration of fibrinogen below the normal range (200-400 mg/dL). This can be caused by genetic defects, liver disease, or consumption during disseminated intravascular coagulation (DIC).
2. Afibrinogenemia: A rare autosomal recessive disorder characterized by the complete absence of fibrinogen due to mutations in the genes encoding its subunits. This condition results in a severe bleeding diathesis.
3. Dysfibrinogenemia: A qualitative defect in fibrinogen structure or function caused by genetic mutations affecting the assembly, configuration, or stability of the fibrinogen complex. These abnormalities can lead to impaired clot formation, increased fibrinolysis, or both, resulting in a bleeding diathesis or thrombotic tendency.
4. Dysproteinemias: Abnormal fibrinogens may also be observed in various dysproteinemias, such as dysglobulinemias and paraproteinemias, where monoclonal immunoglobulins produced by plasma cell dyscrasias can interfere with fibrinogen function.
5. Medication-induced abnormalities: Certain medications, like fibrinolytic agents (e.g., tissue plasminogen activator), can lower fibrinogen levels or impair its function by promoting premature fibrin degradation.

In summary, various genetic and acquired conditions can lead to the production of abnormal fibrinogens with altered structure, stability, or function. These defects may result in bleeding diatheses, thrombotic tendencies, or both, depending on the specific nature of the abnormality.

In the context of medicine and pharmacology, "kinetics" refers to the study of how a drug moves throughout the body, including its absorption, distribution, metabolism, and excretion (often abbreviated as ADME). This field is called "pharmacokinetics."

1. Absorption: This is the process of a drug moving from its site of administration into the bloodstream. Factors such as the route of administration (e.g., oral, intravenous, etc.), formulation, and individual physiological differences can affect absorption.

2. Distribution: Once a drug is in the bloodstream, it gets distributed throughout the body to various tissues and organs. This process is influenced by factors like blood flow, protein binding, and lipid solubility of the drug.

3. Metabolism: Drugs are often chemically modified in the body, typically in the liver, through processes known as metabolism. These changes can lead to the formation of active or inactive metabolites, which may then be further distributed, excreted, or undergo additional metabolic transformations.

4. Excretion: This is the process by which drugs and their metabolites are eliminated from the body, primarily through the kidneys (urine) and the liver (bile).

Understanding the kinetics of a drug is crucial for determining its optimal dosing regimen, potential interactions with other medications or foods, and any necessary adjustments for special populations like pediatric or geriatric patients, or those with impaired renal or hepatic function.

Heart disease is a broad term for a class of diseases that involve the heart or blood vessels. It's often used to refer to conditions that include:

1. Coronary artery disease (CAD): This is the most common type of heart disease. It occurs when the arteries that supply blood to the heart become hardened and narrowed due to the buildup of cholesterol and other substances, which can lead to chest pain (angina), shortness of breath, or a heart attack.

2. Heart failure: This condition occurs when the heart is unable to pump blood efficiently to meet the body's needs. It can be caused by various conditions, including coronary artery disease, high blood pressure, and cardiomyopathy.

3. Arrhythmias: These are abnormal heart rhythms, which can be too fast, too slow, or irregular. They can lead to symptoms such as palpitations, dizziness, and fainting.

4. Valvular heart disease: This involves damage to one or more of the heart's four valves, which control blood flow through the heart. Damage can be caused by various conditions, including infection, rheumatic fever, and aging.

5. Cardiomyopathy: This is a disease of the heart muscle that makes it harder for the heart to pump blood efficiently. It can be caused by various factors, including genetics, viral infections, and drug abuse.

6. Pericardial disease: This involves inflammation or other problems with the sac surrounding the heart (pericardium). It can cause chest pain and other symptoms.

7. Congenital heart defects: These are heart conditions that are present at birth, such as a hole in the heart or abnormal blood vessels. They can range from mild to severe and may require medical intervention.

8. Heart infections: The heart can become infected by bacteria, viruses, or parasites, leading to various symptoms and complications.

It's important to note that many factors can contribute to the development of heart disease, including genetics, lifestyle choices, and certain medical conditions. Regular check-ups and a healthy lifestyle can help reduce the risk of developing heart disease.

A fatal outcome is a term used in medical context to describe a situation where a disease, injury, or illness results in the death of an individual. It is the most severe and unfortunate possible outcome of any medical condition, and is often used as a measure of the severity and prognosis of various diseases and injuries. In clinical trials and research, fatal outcome may be used as an endpoint to evaluate the effectiveness and safety of different treatments or interventions.

Prospective studies, also known as longitudinal studies, are a type of cohort study in which data is collected forward in time, following a group of individuals who share a common characteristic or exposure over a period of time. The researchers clearly define the study population and exposure of interest at the beginning of the study and follow up with the participants to determine the outcomes that develop over time. This type of study design allows for the investigation of causal relationships between exposures and outcomes, as well as the identification of risk factors and the estimation of disease incidence rates. Prospective studies are particularly useful in epidemiology and medical research when studying diseases with long latency periods or rare outcomes.

Medical Definition:

"Risk factors" are any attribute, characteristic or exposure of an individual that increases the likelihood of developing a disease or injury. They can be divided into modifiable and non-modifiable risk factors. Modifiable risk factors are those that can be changed through lifestyle choices or medical treatment, while non-modifiable risk factors are inherent traits such as age, gender, or genetic predisposition. Examples of modifiable risk factors include smoking, alcohol consumption, physical inactivity, and unhealthy diet, while non-modifiable risk factors include age, sex, and family history. It is important to note that having a risk factor does not guarantee that a person will develop the disease, but rather indicates an increased susceptibility.

Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.

Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.

The popliteal vein is the continuation of the tibial and fibular (or anterior and posterior tibial) veins, forming in the lower leg's back portion or popliteal fossa. It carries blood from the leg towards the heart. The popliteal vein is located deep within the body and is accompanied by the popliteal artery, which supplies oxygenated blood to the lower leg. This venous structure is a crucial part of the venous system in the lower extremities and is often assessed during physical examinations for signs of venous insufficiency or deep vein thrombosis (DVT).

Low-molecular-weight heparin (LMWH) is a type of heparin used as an anticoagulant, which refers to a group of medications that prevent the formation of blood clots. Heparin is a naturally occurring substance in the body, and low-molecular-weight heparins are obtained through the depolymerization of standard heparin.

LMWH has a lower molecular weight than standard heparin, which results in several pharmacological differences. LMWHs have a more predictable dose response, longer half-life, and higher bioavailability when administered subcutaneously compared to standard heparin. They also exhibit greater anti-factor Xa activity relative to their antithrombin (anti-IIa) activity, which contributes to their anticoagulant effects.

LMWHs are used for the prevention and treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and other thromboembolic disorders. Common LMWHs include enoxaparin, dalteparin, tinzaparin, and nadroparin.

It is essential to monitor the patient's kidney function when using LMWH since they are primarily cleared by the kidneys. In patients with renal impairment, dose adjustments or alternative anticoagulants may be necessary to reduce the risk of bleeding complications.

Cerebral infarction, also known as a "stroke" or "brain attack," is the sudden death of brain cells caused by the interruption of their blood supply. It is most commonly caused by a blockage in one of the blood vessels supplying the brain (an ischemic stroke), but can also result from a hemorrhage in or around the brain (a hemorrhagic stroke).

Ischemic strokes occur when a blood clot or other particle blocks a cerebral artery, cutting off blood flow to a part of the brain. The lack of oxygen and nutrients causes nearby brain cells to die. Hemorrhagic strokes occur when a weakened blood vessel ruptures, causing bleeding within or around the brain. This bleeding can put pressure on surrounding brain tissues, leading to cell death.

Symptoms of cerebral infarction depend on the location and extent of the affected brain tissue but may include sudden weakness or numbness in the face, arm, or leg; difficulty speaking or understanding speech; vision problems; loss of balance or coordination; and severe headache with no known cause. Immediate medical attention is crucial for proper diagnosis and treatment to minimize potential long-term damage or disability.

Recurrence, in a medical context, refers to the return of symptoms or signs of a disease after a period of improvement or remission. It indicates that the condition has not been fully eradicated and may require further treatment. Recurrence is often used to describe situations where a disease such as cancer comes back after initial treatment, but it can also apply to other medical conditions. The likelihood of recurrence varies depending on the type of disease and individual patient factors.

Intraoperative complications refer to any unforeseen problems or events that occur during the course of a surgical procedure, once it has begun and before it is completed. These complications can range from minor issues, such as bleeding or an adverse reaction to anesthesia, to major complications that can significantly impact the patient's health and prognosis.

Examples of intraoperative complications include:

1. Bleeding (hemorrhage) - This can occur due to various reasons such as injury to blood vessels or organs during surgery.
2. Infection - Surgical site infections can develop if the surgical area becomes contaminated during the procedure.
3. Anesthesia-related complications - These include adverse reactions to anesthesia, difficulty maintaining the patient's airway, or cardiovascular instability.
4. Organ injury - Accidental damage to surrounding organs can occur during surgery, leading to potential long-term consequences.
5. Equipment failure - Malfunctioning surgical equipment can lead to complications and compromise the safety of the procedure.
6. Allergic reactions - Patients may have allergies to certain medications or materials used during surgery, causing an adverse reaction.
7. Prolonged operative time - Complications may arise if a surgical procedure takes longer than expected, leading to increased risk of infection and other issues.

Intraoperative complications require prompt identification and management by the surgical team to minimize their impact on the patient's health and recovery.

Nephelometry and turbidimetry are methods used in clinical laboratories to measure the amount of particles, such as proteins or cells, present in a liquid sample. The main difference between these two techniques lies in how they detect and quantify the particles.

1. Nephelometry: This is a laboratory method that measures the amount of light scattered by suspended particles in a liquid medium at a 90-degree angle to the path of the incident light. When light passes through a sample containing particles, some of the light is absorbed, while some is scattered in various directions. In nephelometry, a light beam is shone into the sample, and a detector measures the intensity of the scattered light at a right angle to the light source. The more particles present in the sample, the higher the intensity of scattered light, which correlates with the concentration of particles in the sample. Nephelometry is often used to measure the levels of immunoglobulins, complement components, and other proteins in serum or plasma.

2. Turbidimetry: This is another laboratory method that measures the amount of light blocked or absorbed by suspended particles in a liquid medium. In turbidimetry, a light beam is shone through the sample, and the intensity of the transmitted light is measured. The more particles present in the sample, the more light is absorbed or scattered, resulting in lower transmitted light intensity. Turbidimetric measurements are typically reported as percent transmittance, which is the ratio of the intensity of transmitted light to that of the incident light expressed as a percentage. Turbidimetry can be used to measure various substances, such as proteins, cells, and crystals, in body fluids like urine, serum, or plasma.

In summary, nephelometry measures the amount of scattered light at a 90-degree angle, while turbidimetry quantifies the reduction in transmitted light intensity due to particle presence. Both methods are useful for determining the concentration of particles in liquid samples and are commonly used in clinical laboratories for diagnostic purposes.

Postoperative complications refer to any unfavorable condition or event that occurs during the recovery period after a surgical procedure. These complications can vary in severity and may include, but are not limited to:

1. Infection: This can occur at the site of the incision or inside the body, such as pneumonia or urinary tract infection.
2. Bleeding: Excessive bleeding (hemorrhage) can lead to a drop in blood pressure and may require further surgical intervention.
3. Blood clots: These can form in the deep veins of the legs (deep vein thrombosis) and can potentially travel to the lungs (pulmonary embolism).
4. Wound dehiscence: This is when the surgical wound opens up, which can lead to infection and further complications.
5. Pulmonary issues: These include atelectasis (collapsed lung), pneumonia, or respiratory failure.
6. Cardiovascular problems: These include abnormal heart rhythms (arrhythmias), heart attack, or stroke.
7. Renal failure: This can occur due to various reasons such as dehydration, blood loss, or the use of certain medications.
8. Pain management issues: Inadequate pain control can lead to increased stress, anxiety, and decreased mobility.
9. Nausea and vomiting: These can be caused by anesthesia, opioid pain medication, or other factors.
10. Delirium: This is a state of confusion and disorientation that can occur in the elderly or those with certain medical conditions.

Prompt identification and management of these complications are crucial to ensure the best possible outcome for the patient.

Intracranial thrombosis refers to the formation of a blood clot (thrombus) within the intracranial vessels, which supply blood to the brain. This condition can occur in any of the cerebral arteries or veins and can lead to serious complications such as ischemic stroke, transient ischemic attack (TIA), or venous sinus thrombosis.

The formation of an intracranial thrombus can be caused by various factors, including atherosclerosis, cardiac embolism, vasculitis, sickle cell disease, hypercoagulable states, and head trauma. Symptoms may vary depending on the location and extent of the thrombosis but often include sudden onset of headache, weakness or numbness in the face or limbs, difficulty speaking or understanding speech, vision changes, and loss of balance or coordination.

Diagnosis of intracranial thrombosis typically involves imaging studies such as computed tomography (CT) angiography, magnetic resonance angiography (MRA), or digital subtraction angiography (DSA). Treatment options may include anticoagulation therapy, thrombolysis, endovascular intervention, or surgical intervention, depending on the underlying cause and severity of the condition.

Technetium Tc 99m Aggregated Albumin is a radiopharmaceutical preparation used in diagnostic imaging. It consists of radioactive technetium-99m (^99m^Tc) chemically bonded to human serum albumin, which has been aggregated to increase its size and alter its clearance from the body.

The resulting compound is injected into the patient's bloodstream, where it accumulates in the reticuloendothelial system (RES), including the liver, spleen, and bone marrow. The radioactive emission of technetium-99m can then be detected by a gamma camera, producing images that reflect the distribution and function of the RES.

This imaging technique is used to diagnose and monitor various conditions, such as liver disease, inflammation, or tumors. It provides valuable information about the patient's health status and helps guide medical decision-making.

Echocardiography is a medical procedure that uses sound waves to produce detailed images of the heart's structure, function, and motion. It is a non-invasive test that can help diagnose various heart conditions, such as valve problems, heart muscle damage, blood clots, and congenital heart defects.

During an echocardiogram, a transducer (a device that sends and receives sound waves) is placed on the chest or passed through the esophagus to obtain images of the heart. The sound waves produced by the transducer bounce off the heart structures and return to the transducer, which then converts them into electrical signals that are processed to create images of the heart.

There are several types of echocardiograms, including:

* Transthoracic echocardiography (TTE): This is the most common type of echocardiogram and involves placing the transducer on the chest.
* Transesophageal echocardiography (TEE): This type of echocardiogram involves passing a specialized transducer through the esophagus to obtain images of the heart from a closer proximity.
* Stress echocardiography: This type of echocardiogram is performed during exercise or medication-induced stress to assess how the heart functions under stress.
* Doppler echocardiography: This type of echocardiogram uses sound waves to measure blood flow and velocity in the heart and blood vessels.

Echocardiography is a valuable tool for diagnosing and managing various heart conditions, as it provides detailed information about the structure and function of the heart. It is generally safe, non-invasive, and painless, making it a popular choice for doctors and patients alike.

Xylem is a term used in the field of botany and plant anatomy, but I understand you're asking for a medical definition. In human anatomy, there isn't a direct structure equivalent to xylem. However, I can provide the general definition of xylem from its botanical context:

Xylem is one of the two types of vascular tissues in plants (the other being phloem). It is responsible for transporting water and dissolved nutrients from the roots to various parts of the plant, including stems, leaves, and flowers. Xylem consists of several types of cells, including vessels, tracheids, xylem fibers, and xylem parenchyma. The transportation in xylem occurs due to the cohesion-tension mechanism, where water is pulled up through the plant via transpiration pull.

The inferior vena cava (IVC) is the largest vein in the human body that carries deoxygenated blood from the lower extremities, pelvis, and abdomen to the right atrium of the heart. It is formed by the union of the left and right common iliac veins at the level of the fifth lumbar vertebra. The inferior vena cava is a retroperitoneal structure, meaning it lies behind the peritoneum, the lining that covers the abdominal cavity. It ascends through the posterior abdominal wall and passes through the central tendon of the diaphragm to enter the thoracic cavity.

The inferior vena cava is composed of three parts:

1. The infrarenal portion, which lies below the renal veins
2. The renal portion, which receives blood from the renal veins
3. The suprahepatic portion, which lies above the liver and receives blood from the hepatic veins before draining into the right atrium of the heart.

The inferior vena cava plays a crucial role in maintaining venous return to the heart and contributing to cardiovascular function.

Carboxypeptidase U is also known as thiol protease or thiol carboxypeptidase. It is a type of enzyme that belongs to the peptidase family, specifically the serine proteases. This enzyme plays a role in the regulation of blood pressure by cleaving and inactivating bradykinin, a potent vasodilator peptide. Carboxypeptidase U is primarily produced in the kidneys and is released into the circulation in response to various stimuli, such as renin and angiotensin II. It functions by removing the C-terminal arginine residue from bradykinin, thereby reducing its biological activity and helping to maintain blood pressure homeostasis.

Antifibrinolytic agents are a class of medications that inhibit the breakdown of blood clots. They work by blocking the action of enzymes called plasminogen activators, which convert plasminogen to plasmin, the main enzyme responsible for breaking down fibrin, a protein that forms the framework of a blood clot.

By preventing the conversion of plasminogen to plasmin, antifibrinolytic agents help to stabilize existing blood clots and prevent their premature dissolution. These medications are often used in clinical settings where excessive bleeding is a concern, such as during or after surgery, childbirth, or trauma.

Examples of antifibrinolytic agents include tranexamic acid, aminocaproic acid, and epsilon-aminocaproic acid. While these medications can be effective in reducing bleeding, they also carry the risk of thromboembolic events, such as deep vein thrombosis or pulmonary embolism, due to their pro-coagulant effects. Therefore, they should be used with caution and only under the close supervision of a healthcare provider.

The iliac veins are a pair of large veins in the human body that carry deoxygenated blood from the lower extremities and the pelvic area back to the heart. They are formed by the union of the common iliac veins, which receive blood from the lower abdomen and legs, at the level of the fifth lumbar vertebra.

The combined iliac vein is called the inferior vena cava, which continues upward to the right atrium of the heart. The iliac veins are located deep within the pelvis, lateral to the corresponding iliac arteries, and are accompanied by the iliac lymphatic vessels.

The left common iliac vein is longer than the right because it must cross the left common iliac artery to join the right common iliac vein. The external and internal iliac veins are the two branches of the common iliac vein, with the external iliac vein carrying blood from the lower limbs and the internal iliac vein carrying blood from the pelvic organs.

It is essential to maintain proper blood flow in the iliac veins to prevent deep vein thrombosis (DVT), a condition that can lead to serious complications such as pulmonary embolism.

An autopsy, also known as a post-mortem examination or obduction, is a medical procedure in which a qualified professional (usually a pathologist) examines a deceased person's body to determine the cause and manner of death. This process may involve various investigative techniques, such as incisions to study internal organs, tissue sampling, microscopic examination, toxicology testing, and other laboratory analyses. The primary purpose of an autopsy is to gather objective evidence about the medical conditions and factors contributing to the individual's demise, which can be essential for legal, insurance, or public health purposes. Additionally, autopsies can provide valuable insights into disease processes and aid in advancing medical knowledge.

Urokinase-type plasminogen activator (uPA) is a serine protease enzyme that plays a crucial role in the degradation of the extracellular matrix and cell migration. It catalyzes the conversion of plasminogen to plasmin, which then breaks down various proteins in the extracellular matrix, leading to tissue remodeling and repair.

uPA is synthesized as a single-chain molecule, pro-uPA, which is activated by cleavage into two chains, forming the mature and active enzyme. uPA binds to its specific receptor, uPAR, on the cell surface, where it exerts its proteolytic activity.

Abnormal regulation of uPA and uPAR has been implicated in various pathological conditions, including cancer, where they contribute to tumor invasion and metastasis. Therefore, uPA is a potential target for therapeutic intervention in cancer and other diseases associated with excessive extracellular matrix degradation.

Follow-up studies are a type of longitudinal research that involve repeated observations or measurements of the same variables over a period of time, in order to understand their long-term effects or outcomes. In medical context, follow-up studies are often used to evaluate the safety and efficacy of medical treatments, interventions, or procedures.

In a typical follow-up study, a group of individuals (called a cohort) who have received a particular treatment or intervention are identified and then followed over time through periodic assessments or data collection. The data collected may include information on clinical outcomes, adverse events, changes in symptoms or functional status, and other relevant measures.

The results of follow-up studies can provide important insights into the long-term benefits and risks of medical interventions, as well as help to identify factors that may influence treatment effectiveness or patient outcomes. However, it is important to note that follow-up studies can be subject to various biases and limitations, such as loss to follow-up, recall bias, and changes in clinical practice over time, which must be carefully considered when interpreting the results.

Atrial fibrillation (A-tre-al fi-bru-la'shun) is a type of abnormal heart rhythm characterized by rapid and irregular beating of the atria, the upper chambers of the heart. In this condition, the electrical signals that coordinate heartbeats don't function properly, causing the atria to quiver instead of contracting effectively. As a result, blood may not be pumped efficiently into the ventricles, which can lead to blood clots, stroke, and other complications. Atrial fibrillation is a common type of arrhythmia and can cause symptoms such as palpitations, shortness of breath, fatigue, and dizziness. It can be caused by various factors, including heart disease, high blood pressure, age, and genetics. Treatment options include medications, electrical cardioversion, and surgical procedures to restore normal heart rhythm.

Thrombophilia is a medical condition characterized by an increased tendency to form blood clots (thrombi) due to various genetic or acquired abnormalities in the coagulation system. These abnormalities can lead to a hypercoagulable state, which can cause thrombosis in both veins and arteries. Commonly identified thrombophilias include factor V Leiden mutation, prothrombin G20210A mutation, antithrombin deficiency, protein C deficiency, and protein S deficiency.

Acquired thrombophilias can be caused by various factors such as antiphospholipid antibody syndrome (APS), malignancies, pregnancy, oral contraceptive use, hormone replacement therapy, and certain medical conditions like inflammatory bowel disease or nephrotic syndrome.

It is essential to diagnose thrombophilia accurately, as it may influence the management of venous thromboembolism (VTE) events and guide decisions regarding prophylactic anticoagulation in high-risk situations.

The heart atria are the upper chambers of the heart that receive blood from the veins and deliver it to the lower chambers, or ventricles. There are two atria in the heart: the right atrium receives oxygen-poor blood from the body and pumps it into the right ventricle, which then sends it to the lungs to be oxygenated; and the left atrium receives oxygen-rich blood from the lungs and pumps it into the left ventricle, which then sends it out to the rest of the body. The atria contract before the ventricles during each heartbeat, helping to fill the ventricles with blood and prepare them for contraction.

The Predictive Value of Tests, specifically the Positive Predictive Value (PPV) and Negative Predictive Value (NPV), are measures used in diagnostic tests to determine the probability that a positive or negative test result is correct.

Positive Predictive Value (PPV) is the proportion of patients with a positive test result who actually have the disease. It is calculated as the number of true positives divided by the total number of positive results (true positives + false positives). A higher PPV indicates that a positive test result is more likely to be a true positive, and therefore the disease is more likely to be present.

Negative Predictive Value (NPV) is the proportion of patients with a negative test result who do not have the disease. It is calculated as the number of true negatives divided by the total number of negative results (true negatives + false negatives). A higher NPV indicates that a negative test result is more likely to be a true negative, and therefore the disease is less likely to be present.

The predictive value of tests depends on the prevalence of the disease in the population being tested, as well as the sensitivity and specificity of the test. A test with high sensitivity and specificity will generally have higher predictive values than a test with low sensitivity and specificity. However, even a highly sensitive and specific test can have low predictive values if the prevalence of the disease is low in the population being tested.

Hemoptysis is the medical term for coughing up blood that originates from the lungs or lower respiratory tract. It can range in severity from streaks of blood mixed with mucus to large amounts of pure blood. Hemoptysis may be a sign of various underlying conditions, such as bronchitis, pneumonia, tuberculosis, cancer, or blood disorders. Immediate medical attention is required when hemoptysis occurs, especially if it's in significant quantities, to determine the cause and provide appropriate treatment.

Fibrinopeptide B is a small protein molecule that is cleaved and released from the larger fibrinogen protein during the blood clotting process, also known as coagulation. Fibrinogen is converted to fibrin by the action of thrombin, an enzyme that activates the coagulation cascade. Thrombin cuts specific peptide bonds in fibrinogen, releasing fibrinopeptides A and B from the resulting fibrin monomers.

The release of fibrinopeptide B is a critical step in the formation of a stable blood clot because it allows for the exposure of binding sites on the fibrin molecules that facilitate their polymerization into an insoluble network, trapping platelets and other components to form a clot. The measurement of fibrinopeptide B levels can be used as a marker for thrombin activity and fibrin formation in various clinical settings, such as monitoring the effectiveness of anticoagulant therapy or diagnosing conditions associated with abnormal blood clotting.

A plant stem is not typically defined in a medical context, but rather in the field of botany. However, I can certainly provide a general biological definition for you.

In plants, stems are organs that serve primarily as support structures, holding leaves, flowers, and fruits aloft where they can receive sunlight and exchange gases. They also act as conduits, transporting water, nutrients, and sugars made during photosynthesis between the roots and shoots of a plant.

The stem is usually composed of three main tissue systems: dermal, vascular, and ground. The dermal tissue system forms the outermost layer(s) of the stem, providing protection and sometimes participating in gas exchange. The vascular tissue system contains the xylem (which transports water and nutrients upward) and phloem (which transports sugars and other organic compounds downward). The ground tissue system, located between the dermal and vascular tissues, is responsible for food storage and support.

While not a direct medical definition, understanding the structure and function of plant stems can be relevant in fields such as nutrition, agriculture, and environmental science, which have implications for human health.

Pulmonary infarction is the medical term for the death of lung tissue (lung tissue necrosis) due to blocked blood flow. This blockage usually occurs when a clot or a piece of a clot from another part of the body, most commonly from the heart, travels to the lungs and blocks a small pulmonary artery. The lack of oxygen supply to the lung tissue results in inflammation and eventual infarction (tissue death).

The symptoms of pulmonary infarction can vary but often include sudden onset of sharp chest pain, shortness of breath, cough, sometimes with blood-streaked sputum, rapid heart rate, and fever. The diagnosis is typically made based on the patient's medical history, physical examination, imaging tests such as a chest X-ray or CT scan, and occasionally, blood tests to detect D-dimer, a protein fragment that's produced when a blood clot dissolves. Treatment usually involves anticoagulant therapy (blood thinners) to prevent further clots from forming and, in some cases, thrombolytic therapy (clot-busting drugs) to break up existing clots. In severe cases, surgery may be required to remove the clot or infarcted lung tissue.

Enoxaparin is a low molecular weight heparin (LMWH) medication that is used as an anticoagulant to prevent and treat blood clots. It works by binding to and inhibiting the activity of factor Xa, a clotting factor in the blood. This helps to reduce the risk of clot formation and can help to prevent conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE). Enoxaparin is typically given by injection under the skin (subcutaneously) and is available under the brand names Lovenox and Clexane, among others. It is important to follow the instructions of a healthcare professional when using enoxaparin, as it can increase the risk of bleeding.

Risk assessment in the medical context refers to the process of identifying, evaluating, and prioritizing risks to patients, healthcare workers, or the community related to healthcare delivery. It involves determining the likelihood and potential impact of adverse events or hazards, such as infectious diseases, medication errors, or medical devices failures, and implementing measures to mitigate or manage those risks. The goal of risk assessment is to promote safe and high-quality care by identifying areas for improvement and taking action to minimize harm.

Perfusion imaging is a medical imaging technique used to evaluate the blood flow or perfusion in various organs and tissues of the body. It is often utilized in conjunction with computed tomography (CT), magnetic resonance imaging (MRI), or single-photon emission computed tomography (SPECT) scans.

During a perfusion imaging procedure, a contrast agent is introduced into the patient's bloodstream, and a series of images are captured to track the flow and distribution of the contrast agent over time. This information helps medical professionals assess tissue viability, identify areas of reduced or blocked blood flow, and detect various pathological conditions such as stroke, heart attack, pulmonary embolism, and tumors.

In summary, perfusion imaging is a valuable diagnostic tool for evaluating the circulatory function of different organs and tissues in the body.

In medical terms, suction refers to the process of creating and maintaining a partial vacuum in order to remove fluids or gases from a body cavity or wound. This is typically accomplished using specialized medical equipment such as a suction machine, which uses a pump to create the vacuum, and a variety of different suction tips or catheters that can be inserted into the area being treated.

Suction is used in a wide range of medical procedures and treatments, including wound care, surgical procedures, respiratory therapy, and diagnostic tests. It can help to remove excess fluids such as blood or pus from a wound, clear secretions from the airways during mechanical ventilation, or provide a means of visualizing internal structures during endoscopic procedures.

It is important to use proper technique when performing suctioning, as excessive or improperly applied suction can cause tissue damage or bleeding. Medical professionals are trained in the safe and effective use of suction equipment and techniques to minimize risks and ensure optimal patient outcomes.

Fibrin(ogen) degradation products (FDPs) are a group of proteins that result from the breakdown of fibrinogen and fibrin, which are key components of blood clots. This process occurs during the normal physiological process of fibrinolysis, where clots are dissolved to maintain blood flow.

FDPs can be measured in the blood as a marker for the activation of the coagulation and fibrinolytic systems. Elevated levels of FDPs may indicate the presence of a disorder that causes abnormal clotting or bleeding, such as disseminated intravascular coagulation (DIC), deep vein thrombosis (DVT), pulmonary embolism (PE), or certain types of cancer.

It is important to note that FDPs are not specific to any particular disorder and their measurement should be interpreted in conjunction with other clinical and laboratory findings.

The International Normalized Ratio (INR) is a standardized measurement of the prothrombin time (PT), which is the time it takes for blood to clot. The INR is used to monitor and regulate the effects of anticoagulant medications, such as warfarin, that affect the blood's ability to clot.

The INR is calculated by dividing the patient's PT by a control value (the PT of normal, healthy blood), raised to the power of a sensitivity factor called the International Sensitivity Index (ISI). The ISI is specific to the thromboplastin reagent used in the PT assay.

The INR provides a consistent and comparable way to monitor anticoagulation therapy across different laboratories, regardless of the thromboplastin reagent used. This helps ensure that patients receive appropriate doses of anticoagulant medications and reduces the risk of bleeding or clotting complications.

In general, an INR range of 2.0 to 3.0 is recommended for most people taking anticoagulants for conditions such as atrial fibrillation, deep vein thrombosis, or pulmonary embolism. However, the target INR range may vary depending on individual patient factors and medical indications.

In epidemiology, the incidence of a disease is defined as the number of new cases of that disease within a specific population over a certain period of time. It is typically expressed as a rate, with the number of new cases in the numerator and the size of the population at risk in the denominator. Incidence provides information about the risk of developing a disease during a given time period and can be used to compare disease rates between different populations or to monitor trends in disease occurrence over time.

A myxoma is a type of benign (non-cancerous) tumor that develops in the heart, specifically in the heart's chambers or valves. It is the most common primary cardiac tumor in adults and typically affects the left atrium. Myxomas are composed of gelatinous, mucoid material and may have a stalk-like attachment to the endocardium (the inner lining of the heart).

Myxomas can vary in size and may cause symptoms such as shortness of breath, fatigue, chest pain, coughing, and fever. These symptoms are due to obstruction of blood flow within the heart or embolization (detachment and travel) of tumor fragments to other parts of the body. Surgical removal is usually required to treat myxomas, as they can lead to serious complications if left untreated.

Hyperbaric oxygenation is a medical treatment in which a patient breathes pure oxygen in a pressurized chamber, typically at greater than one atmosphere absolute (ATA). This process results in increased levels of oxygen being dissolved in the blood and delivered to body tissues, thereby promoting healing, reducing inflammation, and combating infection. Hyperbaric oxygen therapy is used to treat various medical conditions, including carbon monoxide poisoning, decompression sickness, gangrene, and wounds that are slow to heal due to diabetes or radiation injury.

Sensitivity and specificity are statistical measures used to describe the performance of a diagnostic test or screening tool in identifying true positive and true negative results.

* Sensitivity refers to the proportion of people who have a particular condition (true positives) who are correctly identified by the test. It is also known as the "true positive rate" or "recall." A highly sensitive test will identify most or all of the people with the condition, but may also produce more false positives.
* Specificity refers to the proportion of people who do not have a particular condition (true negatives) who are correctly identified by the test. It is also known as the "true negative rate." A highly specific test will identify most or all of the people without the condition, but may also produce more false negatives.

In medical testing, both sensitivity and specificity are important considerations when evaluating a diagnostic test. High sensitivity is desirable for screening tests that aim to identify as many cases of a condition as possible, while high specificity is desirable for confirmatory tests that aim to rule out the condition in people who do not have it.

It's worth noting that sensitivity and specificity are often influenced by factors such as the prevalence of the condition in the population being tested, the threshold used to define a positive result, and the reliability and validity of the test itself. Therefore, it's important to consider these factors when interpreting the results of a diagnostic test.

A lung is a pair of spongy, elastic organs in the chest that work together to enable breathing. They are responsible for taking in oxygen and expelling carbon dioxide through the process of respiration. The left lung has two lobes, while the right lung has three lobes. The lungs are protected by the ribcage and are covered by a double-layered membrane called the pleura. The trachea divides into two bronchi, which further divide into smaller bronchioles, leading to millions of tiny air sacs called alveoli, where the exchange of gases occurs.

Cerebral angiography is a medical procedure that involves taking X-ray images of the blood vessels in the brain after injecting a contrast dye into them. This procedure helps doctors to diagnose and treat various conditions affecting the blood vessels in the brain, such as aneurysms, arteriovenous malformations, and stenosis (narrowing of the blood vessels).

During the procedure, a catheter is inserted into an artery in the leg and threaded through the body to the blood vessels in the neck or brain. The contrast dye is then injected through the catheter, and X-ray images are taken to visualize the blood flow through the brain's blood vessels.

Cerebral angiography provides detailed images of the blood vessels in the brain, allowing doctors to identify any abnormalities or blockages that may be causing symptoms or increasing the risk of stroke. Based on the results of the cerebral angiography, doctors can develop a treatment plan to address these issues and prevent further complications.

Thrombin time (TT) is a medical laboratory test that measures the time it takes for a clot to form after thrombin, an enzyme that converts fibrinogen to fibrin in the final step of the coagulation cascade, is added to a plasma sample. This test is used to evaluate the efficiency of the conversion of fibrinogen to fibrin and can be used to detect the presence of abnormalities in the coagulation system, such as the presence of heparin or dysfibrinogenemia. Increased thrombin time may indicate the presence of a systemic anticoagulant or a deficiency in fibrinogen.

Decompression sickness (DCS), also known as "the bends," is a medical condition that results from dissolved gases coming out of solution in the body's tissues and forming bubbles during decompression. This typically occurs when a person who has been exposed to increased pressure at depth, such as scuba divers or compressed air workers, ascends too quickly.

The elevated pressure at depth causes nitrogen to dissolve into the blood and tissues of the body. As the diver ascends and the pressure decreases, the dissolved gases form bubbles, which can cause symptoms ranging from joint pain and rashes to paralysis and death. The risk of DCS is influenced by several factors, including depth, duration of exposure, rate of ascent, and individual susceptibility.

Prevention of DCS involves following established dive tables or using a personal decompression computer to calculate safe ascent rates and decompression stops. Additionally, proper hydration, fitness, and avoiding alcohol and tobacco before diving can reduce the risk of DCS. Treatment typically involves administering oxygen and recompression therapy in a hyperbaric chamber.

Magnetic Resonance Angiography (MRA) is a non-invasive medical imaging technique that uses magnetic fields and radio waves to create detailed images of the blood vessels or arteries within the body. It is a type of Magnetic Resonance Imaging (MRI) that focuses specifically on the circulatory system.

MRA can be used to diagnose and evaluate various conditions related to the blood vessels, such as aneurysms, stenosis (narrowing of the vessel), or the presence of plaques or tumors. It can also be used to plan for surgeries or other treatments related to the vascular system. The procedure does not use radiation and is generally considered safe, although people with certain implants like pacemakers may not be able to have an MRA due to safety concerns.

Heart neoplasms are abnormal growths or tumors that develop within the heart tissue. They can be benign (noncancerous) or malignant (cancerous). Benign tumors, such as myxomas and rhabdomyomas, are typically slower growing and less likely to spread, but they can still cause serious complications if they obstruct blood flow or damage heart valves. Malignant tumors, such as angiosarcomas and rhabdomyosarcomas, are fast-growing and have a higher risk of spreading to other parts of the body. Symptoms of heart neoplasms can include shortness of breath, chest pain, fatigue, and irregular heart rhythms. Treatment options depend on the type, size, and location of the tumor, and may include surgery, radiation therapy, or chemotherapy.

Phenindione is an anticoagulant medication, which is primarily used in the prevention and treatment of thromboembolic disorders such as deep vein thrombosis (DVT), pulmonary embolism (PE), and certain types of strokes. It works by inhibiting the formation of blood clots in the body.

Phenindione is a derivative of indandione, and it functions by blocking the activity of vitamin K-dependent coagulation factors II, VII, IX, and X, thereby prolonging the clotting time of the blood. It is available in oral form as tablets or capsules.

It's important to note that phenindione has largely been replaced by other anticoagulants such as warfarin due to its narrow therapeutic index, higher risk of adverse effects, and interactions with other medications. Therefore, it is not commonly used in clinical practice today.

Dalteparin is a low molecular weight heparin (LMWH) medication that is used as an anticoagulant to prevent and treat blood clots. It works by binding to an enzyme called antithrombin III and enhancing its ability to inhibit clotting factors in the blood.

Dalteparin is available under the brand name Fragmin and is administered subcutaneously (under the skin) once or twice a day, depending on the indication and dosage prescribed by a healthcare professional. Common side effects of dalteparin include bleeding, bruising, pain at the injection site, and elevated liver enzymes.

As with all medications, it is important to use dalteparin only under the supervision of a healthcare provider and to follow their instructions carefully.

Xenon radioisotopes are unstable isotopes of the element xenon that emit radiation as they decay into more stable forms. These isotopes can be produced through various nuclear reactions and have a wide range of applications, including medical imaging and cancer treatment. Examples of commonly used xenon radioisotopes include xenon-127, xenon-131m, xenon-133, and xenon-135.

It's important to note that the use of radioisotopes in medical settings must be carefully regulated and monitored to ensure safety and minimize potential risks to patients and healthcare workers.

Brain ischemia is the medical term used to describe a reduction or interruption of blood flow to the brain, leading to a lack of oxygen and glucose delivery to brain tissue. This can result in brain damage or death of brain cells, known as infarction. Brain ischemia can be caused by various conditions such as thrombosis (blood clot formation), embolism (obstruction of a blood vessel by a foreign material), or hypoperfusion (reduced blood flow). The severity and duration of the ischemia determine the extent of brain damage. Symptoms can range from mild, such as transient ischemic attacks (TIAs or "mini-strokes"), to severe, including paralysis, speech difficulties, loss of consciousness, and even death. Immediate medical attention is required for proper diagnosis and treatment to prevent further damage and potential long-term complications.

Disseminated Intravascular Coagulation (DIC) is a complex medical condition characterized by the abnormal activation of the coagulation cascade, leading to the formation of blood clots in small blood vessels throughout the body. This process can result in the consumption of clotting factors and platelets, which can then lead to bleeding complications. DIC can be caused by a variety of underlying conditions, including sepsis, trauma, cancer, and obstetric emergencies.

The term "disseminated" refers to the widespread nature of the clotting activation, while "intravascular" indicates that the clotting is occurring within the blood vessels. The condition can manifest as both bleeding and clotting complications, which can make it challenging to diagnose and manage.

The diagnosis of DIC typically involves laboratory tests that evaluate coagulation factors, platelet count, fibrin degradation products, and other markers of coagulation activation. Treatment is focused on addressing the underlying cause of the condition while also managing any bleeding or clotting complications that may arise.

Cardiac catheterization is a medical procedure used to diagnose and treat cardiovascular conditions. In this procedure, a thin, flexible tube called a catheter is inserted into a blood vessel in the arm or leg and threaded up to the heart. The catheter can be used to perform various diagnostic tests, such as measuring the pressure inside the heart chambers and assessing the function of the heart valves.

Cardiac catheterization can also be used to treat certain cardiovascular conditions, such as narrowed or blocked arteries. In these cases, a balloon or stent may be inserted through the catheter to open up the blood vessel and improve blood flow. This procedure is known as angioplasty or percutaneous coronary intervention (PCI).

Cardiac catheterization is typically performed in a hospital cardiac catheterization laboratory by a team of healthcare professionals, including cardiologists, radiologists, and nurses. The procedure may be done under local anesthesia with sedation or general anesthesia, depending on the individual patient's needs and preferences.

Overall, cardiac catheterization is a valuable tool in the diagnosis and treatment of various heart conditions, and it can help improve symptoms, reduce complications, and prolong life for many patients.

A heart aneurysm, also known as a ventricular aneurysm, is a localized bulging or ballooning of the heart muscle in the left ventricle, which is the main pumping chamber of the heart. This condition typically occurs following a myocardial infarction (heart attack), where blood flow to a portion of the heart muscle is blocked, leading to tissue death and weakness in the heart wall. As a result, the weakened area may stretch and form a sac-like bulge or aneurysm.

Heart aneurysms can vary in size and may cause complications such as blood clots, arrhythmias (irregular heartbeats), or heart failure. In some cases, they may be asymptomatic and discovered during routine imaging tests. The diagnosis of a heart aneurysm is typically made through echocardiography, cardiac MRI, or cardiac CT scans. Treatment options depend on the size, location, and symptoms of the aneurysm and may include medications, surgical repair, or implantation of a device to support heart function.

Carotid artery thrombosis is a medical condition characterized by the formation of a blood clot (thrombus) inside the carotid artery, which is one of the major blood vessels that supplies oxygenated blood to the head and neck. This condition can lead to serious complications such as a stroke or transient ischemic attack (TIA), also known as a "mini-stroke," if the clot dislodges and travels to the brain, blocking the flow of blood and oxygen.

Carotid artery thrombosis can result from various factors, including atherosclerosis (the buildup of fats, cholesterol, and other substances in the artery walls), hypertension (high blood pressure), diabetes, smoking, and genetic predisposition. Symptoms may include neck pain or stiffness, weakness or numbness in the face or limbs, difficulty speaking or understanding speech, vision problems, and sudden severe headaches. Diagnosis typically involves imaging tests such as ultrasound, CT angiography, or MRI angiography. Treatment options may include anticoagulant or antiplatelet medications, endovascular procedures to remove the clot, or surgery to clean out the artery (carotid endarterectomy).

Pulmonary heart disease, also known as cor pulmonale, is a type of heart disease that occurs as a complication of chronic lung diseases or hypoxia (low oxygen levels in the body). The condition is characterized by enlargement and thickening of the right ventricle of the heart, which results from increased pressure in the pulmonary artery due to damaged or narrowed blood vessels in the lungs. This can lead to symptoms such as shortness of breath, fatigue, swelling in the legs and abdomen, and irregular heart rhythms. The condition can be managed with medications, oxygen therapy, and lifestyle changes, but if left untreated, it can lead to serious complications such as heart failure.

Compression stockings are a specialized type of hosiery that applies pressure to your legs, promoting better blood flow. They are tightest at the ankle and gradually become less constrictive up the leg. This gradient compression helps to counteract the force of gravity and promote venous return, reducing the pooling of blood in the lower extremities.

Compression stockings are often used to help prevent or treat various conditions related to poor circulation, including:

1. Varicose veins: Enlarged, swollen, and twisting veins that are easily visible just under the surface of the skin.
2. Deep vein thrombosis (DVT): A blood clot that forms in the deep veins, usually in the legs. Compression stockings can help reduce the risk of DVT after certain surgeries or during long periods of immobilization.
3. Edema: Swelling in the legs and ankles due to fluid buildup.
4. Chronic venous insufficiency: A condition where the veins have difficulty returning blood from the legs back to the heart, leading to symptoms like leg pain, swelling, and skin changes.
5. Post-thrombotic syndrome (PTS): A long-term complication of DVT characterized by chronic leg pain, swelling, and skin ulcers. Compression stockings can help manage symptoms and prevent further complications.

There are different levels of compression available, ranging from mild (15-20 mmHg) to extra firm (50-60 mmHg). Your healthcare provider will recommend the appropriate level based on your specific condition and needs. It is essential to wear compression stockings correctly for them to be effective and avoid skin irritation or other complications.

Veins are blood vessels that carry deoxygenated blood from the tissues back to the heart. They have a lower pressure than arteries and contain valves to prevent the backflow of blood. Veins have a thin, flexible wall with a larger lumen compared to arteries, allowing them to accommodate more blood volume. The color of veins is often blue or green due to the absorption characteristics of light and the reduced oxygen content in the blood they carry.

In medical terms, shock is a life-threatening condition that occurs when the body is not getting enough blood flow or when the circulatory system is not functioning properly to distribute oxygen and nutrients to the tissues and organs. This results in a state of hypoxia (lack of oxygen) and cellular dysfunction, which can lead to multiple organ failure and death if left untreated.

Shock can be caused by various factors such as severe blood loss, infection, trauma, heart failure, allergic reactions, and severe burns. The symptoms of shock include low blood pressure, rapid pulse, cool and clammy skin, rapid and shallow breathing, confusion, weakness, and a bluish color to the lips and nails. Immediate medical attention is required for proper diagnosis and treatment of shock.

Platelet aggregation is the clumping together of platelets (thrombocytes) in the blood, which is an essential step in the process of hemostasis (the stopping of bleeding) after injury to a blood vessel. When the inner lining of a blood vessel is damaged, exposure of subendothelial collagen and tissue factor triggers platelet activation. Activated platelets change shape, become sticky, and release the contents of their granules, which include ADP (adenosine diphosphate).

ADP then acts as a chemical mediator to attract and bind additional platelets to the site of injury, leading to platelet aggregation. This forms a plug that seals the damaged vessel and prevents further blood loss. Platelet aggregation is also a crucial component in the formation of blood clots (thrombosis) within blood vessels, which can have pathological consequences such as heart attacks and strokes if they obstruct blood flow to vital organs.

Cerebrovascular disorders are a group of medical conditions that affect the blood vessels of the brain. These disorders can be caused by narrowing, blockage, or rupture of the blood vessels, leading to decreased blood flow and oxygen supply to the brain. The most common types of cerebrovascular disorders include:

1. Stroke: A stroke occurs when a blood vessel in the brain becomes blocked or bursts, causing a lack of oxygen and nutrients to reach brain cells. This can lead to permanent damage or death of brain tissue.
2. Transient ischemic attack (TIA): Also known as a "mini-stroke," a TIA occurs when blood flow to the brain is temporarily blocked, often by a blood clot. Symptoms may last only a few minutes to a few hours and typically resolve on their own. However, a TIA is a serious warning sign that a full-blown stroke may occur in the future.
3. Aneurysm: An aneurysm is a weakened or bulging area in the wall of a blood vessel. If left untreated, an aneurysm can rupture and cause bleeding in the brain.
4. Arteriovenous malformation (AVM): An AVM is a tangled mass of abnormal blood vessels that connect arteries and veins. This can lead to bleeding in the brain or stroke.
5. Carotid stenosis: Carotid stenosis occurs when the carotid arteries, which supply blood to the brain, become narrowed or blocked due to plaque buildup. This can increase the risk of stroke.
6. Vertebrobasilar insufficiency: This condition occurs when the vertebral and basilar arteries, which supply blood to the back of the brain, become narrowed or blocked. This can lead to symptoms such as dizziness, vertigo, and difficulty swallowing.

Cerebrovascular disorders are a leading cause of disability and death worldwide. Risk factors for these conditions include age, high blood pressure, smoking, diabetes, high cholesterol, and family history. Treatment may involve medications, surgery, or lifestyle changes to reduce the risk of further complications.

Batroxobin is a serine protease enzyme that is isolated from the venom of Bothrops atrox, also known as the South American fer-de-lance snake. It has thrombin-like activity and can induce fibrinogen to form fibrin, which is an important step in blood clotting. Batroxobin is used medically as a defibrinating agent to treat conditions such as snake envenomation, cerebral infarction, and arterial thrombosis. It may also be used for research purposes to study hemostasis and coagulation.

In medical terms, the leg refers to the lower portion of the human body that extends from the knee down to the foot. It includes the thigh (femur), lower leg (tibia and fibula), foot, and ankle. The leg is primarily responsible for supporting the body's weight and enabling movements such as standing, walking, running, and jumping.

The leg contains several important structures, including bones, muscles, tendons, ligaments, blood vessels, nerves, and joints. These structures work together to provide stability, support, and mobility to the lower extremity. Common medical conditions that can affect the leg include fractures, sprains, strains, infections, peripheral artery disease, and neurological disorders.

Factor Xa is a serine protease that plays a crucial role in the coagulation cascade, which is a series of reactions that lead to the formation of a blood clot. It is one of the activated forms of Factor X, a pro-protein that is converted to Factor Xa through the action of other enzymes in the coagulation cascade.

Factor Xa functions as a key component of the prothrombinase complex, which also includes calcium ions, phospholipids, and activated Factor V (also known as Activated Protein C or APC). This complex is responsible for converting prothrombin to thrombin, which then converts fibrinogen to fibrin, forming a stable clot.

Inhibitors of Factor Xa are used as anticoagulants in the prevention and treatment of thromboembolic disorders such as deep vein thrombosis and pulmonary embolism. These drugs work by selectively inhibiting Factor Xa, thereby preventing the formation of the prothrombinase complex and reducing the risk of clot formation.

Radionuclide imaging, also known as nuclear medicine, is a medical imaging technique that uses small amounts of radioactive material, called radionuclides or radiopharmaceuticals, to diagnose and treat various diseases and conditions. The radionuclides are introduced into the body through injection, inhalation, or ingestion and accumulate in specific organs or tissues. A special camera then detects the gamma rays emitted by these radionuclides and converts them into images that provide information about the structure and function of the organ or tissue being studied.

Radionuclide imaging can be used to evaluate a wide range of medical conditions, including heart disease, cancer, neurological disorders, gastrointestinal disorders, and bone diseases. The technique is non-invasive and generally safe, with minimal exposure to radiation. However, it should only be performed by qualified healthcare professionals in accordance with established guidelines and regulations.

"Device Removal" in a medical context generally refers to the surgical or nonsurgical removal of a medical device that has been previously implanted in a patient's body. The purpose of removing the device may vary, depending on the individual case. Some common reasons for device removal include infection, malfunction, rejection, or when the device is no longer needed.

Examples of medical devices that may require removal include pacemakers, implantable cardioverter-defibrillators (ICDs), artificial joints, orthopedic hardware, breast implants, cochlear implants, and intrauterine devices (IUDs). The procedure for device removal will depend on the type of device, its location in the body, and the reason for its removal.

It is important to note that device removal carries certain risks, such as bleeding, infection, damage to surrounding tissues, or complications related to anesthesia. Therefore, the decision to remove a medical device should be made carefully, considering both the potential benefits and risks of the procedure.

Infarction is the term used in medicine to describe the death of tissue (also known as an "area of necrosis") due to the lack of blood supply. This can occur when a blood vessel that supplies oxygen and nutrients to a particular area of the body becomes blocked or obstructed, leading to the deprivation of oxygen and nutrients necessary for the survival of cells in that region.

The blockage in the blood vessel is usually caused by a clot (thrombus) or an embolus, which is a small particle that travels through the bloodstream and lodges in a smaller vessel. The severity and extent of infarction depend on several factors, including the size and location of the affected blood vessel, the duration of the obstruction, and the presence of collateral circulation (alternative blood vessels that can compensate for the blocked one).

Common examples of infarctions include myocardial infarction (heart attack), cerebral infarction (stroke), and pulmonary infarction (lung tissue death due to obstruction in the lung's blood vessels). Infarctions can lead to various symptoms, depending on the affected organ or tissue, and may require medical intervention to manage complications and prevent further damage.

Afibrinogenemia is a rare genetic disorder characterized by the complete absence or severely decreased levels of fibrinogen, a protein involved in blood clotting. This condition leads to an increased risk of excessive bleeding due to the inability to form proper blood clots. It is caused by mutations in the genes that provide instructions for making the three chains (Aα, Bβ, and γ) that make up the fibrinogen protein. Inheritance is autosomal recessive, meaning an individual must inherit two copies of the defective gene, one from each parent, to have the condition.

A Severity of Illness Index is a measurement tool used in healthcare to assess the severity of a patient's condition and the risk of mortality or other adverse outcomes. These indices typically take into account various physiological and clinical variables, such as vital signs, laboratory values, and co-morbidities, to generate a score that reflects the patient's overall illness severity.

Examples of Severity of Illness Indices include the Acute Physiology and Chronic Health Evaluation (APACHE) system, the Simplified Acute Physiology Score (SAPS), and the Mortality Probability Model (MPM). These indices are often used in critical care settings to guide clinical decision-making, inform prognosis, and compare outcomes across different patient populations.

It is important to note that while these indices can provide valuable information about a patient's condition, they should not be used as the sole basis for clinical decision-making. Rather, they should be considered in conjunction with other factors, such as the patient's overall clinical presentation, treatment preferences, and goals of care.

"Picea" is not a medical term. It is the genus name for a group of evergreen coniferous trees commonly known as spruces, which are part of the pine family (Pinaceae). These trees are native to the northern hemisphere and are widely distributed in North America, Europe, and Asia.

While spruce trees have some medicinal uses, such as extracts from the needles being used in traditional medicine for their antimicrobial and anti-inflammatory properties, "Picea" itself is not a medical term or concept.

Catheterization is a medical procedure in which a catheter (a flexible tube) is inserted into the body to treat various medical conditions or for diagnostic purposes. The specific definition can vary depending on the area of medicine and the particular procedure being discussed. Here are some common types of catheterization:

1. Urinary catheterization: This involves inserting a catheter through the urethra into the bladder to drain urine. It is often performed to manage urinary retention, monitor urine output in critically ill patients, or assist with surgical procedures.
2. Cardiac catheterization: A procedure where a catheter is inserted into a blood vessel, usually in the groin or arm, and guided to the heart. This allows for various diagnostic tests and treatments, such as measuring pressures within the heart chambers, assessing blood flow, or performing angioplasty and stenting of narrowed coronary arteries.
3. Central venous catheterization: A catheter is inserted into a large vein, typically in the neck, chest, or groin, to administer medications, fluids, or nutrition, or to monitor central venous pressure.
4. Peritoneal dialysis catheterization: A catheter is placed into the abdominal cavity for individuals undergoing peritoneal dialysis, a type of kidney replacement therapy.
5. Neurological catheterization: In some cases, a catheter may be inserted into the cerebrospinal fluid space (lumbar puncture) or the brain's ventricular system (ventriculostomy) to diagnose or treat various neurological conditions.

These are just a few examples of catheterization procedures in medicine. The specific definition and purpose will depend on the medical context and the particular organ or body system involved.

"Vitaceae" is not a medical term, but a taxonomic category in botany. It refers to the grape family, which includes around 800 species of plants. Some of these plants are used in traditional medicine and may have some health benefits, but "Vitaceae" itself does not have a specific medical definition.

Mechanical thrombolysis is a procedure used to remove blood clots (thrombi) from the blood vessels by mechanical means, as opposed to pharmacological thrombolysis which uses drugs to dissolve the clots. In mechanical thrombolysis, specialized medical devices are used to physically disrupt, extract or break down the clot, thereby restoring blood flow and preventing further complications such as tissue damage or organ dysfunction.

The procedure is often performed under imaging guidance, such as fluoroscopy or ultrasound, to ensure accurate placement of the device and effective removal of the thrombus. Mechanical thrombolysis may be used in various clinical settings, including deep vein thrombosis (DVT), pulmonary embolism (PE), and arterial thromboembolism, such as stroke or peripheral artery disease.

Some of the commonly used mechanical thrombectomy devices include:

1. Catheter-directed thrombolysis (CDT): A catheter is inserted into the affected blood vessel and a clot-dissolving drug is administered directly to the thrombus.
2. AngioJet Rheolytic Thrombectomy System: This device uses high-pressure saline jets to break up and remove the clot.
3. Rotational or ultrasonic thrombectomy devices: These use rotating or vibrating components to macerate and extract the clot.
4. Aspiration thrombectomy: A catheter with a large lumen is used to aspirate (suction) the clot out of the blood vessel.
5. Stent retriever thrombectomy: A stent-like device is deployed in the affected vessel and then retrieved, taking the clot with it.

The choice of mechanical thrombolysis technique depends on various factors, including the location, size, and composition of the thrombus, as well as the patient's overall clinical condition.

Insufflation is a medical term that refers to the act of introducing a gas or vapor into a body cavity or passage, typically through a tube or surgical instrument. This procedure is often used in medical and surgical settings for various purposes, such as:

* To administer anesthesia during surgery (e.g., introducing nitrous oxide or other gases into the lungs)
* To introduce medication or other substances into the body (e.g., insufflating steroids into a joint)
* To perform diagnostic procedures (e.g., insufflating air or a contrast agent into the gastrointestinal tract to visualize it with X-rays)
* To clean out a body cavity (e.g., irrigating and insufflating the bladder during urological procedures).

It's important to note that insufflation should be performed under controlled conditions, as there are potential risks associated with introducing gases or vapors into the body, such as barotrauma (damage caused by changes in pressure) and infection.

Intermittent Pneumatic Compression (IPC) devices are medical devices that use inflatable garments to apply controlled pressure in a rhythmic, intermittent manner to the extremities of the body, most commonly used on the legs. These devices are designed to help improve venous and lymphatic flow, reduce edema (swelling), and prevent the formation of blood clots (deep vein thrombosis) in patients who are at risk.

The IPC device typically consists of a pump, hoses, and an air-filled garment that covers the affected limb. The pump regulates the pressure and inflation pattern, while the garment applies pressure to the limb. The compression cycle usually starts with low pressure and gradually increases to a peak pressure before decreasing again. This process is repeated at regular intervals, providing intermittent compression that mimics natural muscle contractions and helps promote blood flow.

IPC devices are often used in clinical settings such as hospitals and rehabilitation centers, but they can also be prescribed for home use. They are commonly recommended for patients who have undergone surgery, experienced trauma, or have conditions that increase their risk of developing blood clots, such as prolonged immobilization, varicose veins, or certain medical disorders.

It is essential to follow the healthcare provider's instructions when using IPC devices and report any discomfort, pain, or unusual symptoms during treatment.

Fibrinopeptide A is a small protein molecule that is cleaved and released from the larger fibrinogen protein during the blood clotting process. Specifically, it is removed by the enzyme thrombin as part of the conversion of fibrinogen to fibrin, which is the main structural component of a blood clot. The measurement of Fibrinopeptide A in the blood can be used as a marker for ongoing thrombin activation and fibrin formation, which are key events in coagulation and hemostasis. Increased levels of Fibrinopeptide A may indicate abnormal or excessive blood clotting, such as in disseminated intravascular coagulation (DIC) or deep vein thrombosis (DVT).

Cardiovascular complications in pregnancy refer to conditions that affect the heart and blood vessels, which can arise during pregnancy, childbirth, or after delivery. These complications can be pre-existing or new-onset and can range from mild to severe, potentially threatening the life of both the mother and the fetus. Some examples of cardiovascular complications in pregnancy include:

1. Hypertension disorders: This includes chronic hypertension (high blood pressure before pregnancy), gestational hypertension (high blood pressure that develops after 20 weeks of pregnancy), and preeclampsia/eclampsia (a pregnancy-specific disorder characterized by high blood pressure, proteinuria, and potential organ damage).

2. Cardiomyopathy: A condition in which the heart muscle becomes weakened, leading to an enlarged heart and reduced pumping efficiency. Peripartum cardiomyopathy is a specific type that occurs during pregnancy or in the months following delivery.

3. Arrhythmias: Irregularities in the heart's rhythm, such as tachycardia (rapid heartbeat) or bradycardia (slow heartbeat), can occur during pregnancy and may require medical intervention.

4. Valvular heart disease: Pre-existing valve disorders, like mitral stenosis or aortic insufficiency, can worsen during pregnancy due to increased blood volume and cardiac output. Additionally, new valve issues might develop during pregnancy.

5. Venous thromboembolism (VTE): Pregnancy increases the risk of developing blood clots in the veins, particularly deep vein thrombosis (DVT) or pulmonary embolism (PE).

6. Ischemic heart disease: Although rare, coronary artery disease and acute coronary syndrome can occur during pregnancy, especially in women with risk factors such as obesity, diabetes, or smoking history.

7. Heart failure: Severe cardiac dysfunction leading to fluid accumulation, shortness of breath, and reduced exercise tolerance may develop due to any of the above conditions or other underlying heart diseases.

Early recognition, monitoring, and appropriate management of these cardiovascular complications in pregnancy are crucial for maternal and fetal well-being.

Central venous catheterization is a medical procedure in which a flexible tube called a catheter is inserted into a large vein in the body, usually in the neck (internal jugular vein), chest (subclavian vein), or groin (femoral vein). The catheter is threaded through the vein until it reaches a central location, such as the superior vena cava or the right atrium of the heart.

Central venous catheterization may be performed for several reasons, including:

1. To administer medications, fluids, or nutritional support directly into the bloodstream.
2. To monitor central venous pressure (CVP), which can help assess a patient's volume status and cardiac function.
3. To draw blood samples for laboratory tests.
4. To deliver chemotherapy drugs or other medications that may be harmful to peripheral veins.
5. To provide access for hemodialysis or other long-term therapies.

The procedure requires careful attention to sterile technique to minimize the risk of infection, and it is usually performed under local anesthesia with sedation or general anesthesia. Complications of central venous catheterization may include bleeding, infection, pneumothorax (collapsed lung), arterial puncture, and catheter-related bloodstream infections (CRBSI).

Endocarditis is an inflammation of the inner layer of the heart chambers and heart valves, called the endocardium. This inflammation typically results from a bacterial or, less commonly, fungal infection that travels through the bloodstream and attaches to damaged areas of the heart.

There are two main types of endocarditis:

1. Acute Endocarditis: Develops quickly and can be severe, causing fever, chills, shortness of breath, fatigue, and heart murmurs. It may lead to serious complications like heart failure, embolism (blood clots that travel to other parts of the body), and damage to heart valves.

2. Subacute Endocarditis: Develops more slowly, often causing milder symptoms that can be mistaken for a cold or flu. Symptoms may include fatigue, weakness, fever, night sweats, weight loss, joint pain, and heart murmurs. Subacute endocarditis is more likely to affect people with previously damaged heart valves or congenital heart conditions.

Treatment usually involves several weeks of intravenous antibiotics or antifungal medications, depending on the cause of the infection. In some cases, surgery may be required to repair or replace damaged heart valves. Preventive measures include good oral hygiene and prompt treatment of infections, especially in individuals at a higher risk for endocarditis, such as those with congenital heart defects, artificial heart valves, or previous history of endocarditis.

Foreign-body migration is a medical condition that occurs when a foreign object, such as a surgical implant, tissue graft, or trauma-induced fragment, moves from its original position within the body to a different location. This displacement can cause various complications and symptoms depending on the type of foreign body, the location it migrated to, and the individual's specific physiological response.

Foreign-body migration may result from insufficient fixation or anchoring of the object during implantation, inadequate wound healing, infection, or an inflammatory reaction. Symptoms can include pain, swelling, redness, or infection at the new location, as well as potential damage to surrounding tissues and organs. Diagnosis typically involves imaging techniques like X-rays, CT scans, or MRIs to locate the foreign body, followed by a surgical procedure to remove it and address any resulting complications.

Prognosis is a medical term that refers to the prediction of the likely outcome or course of a disease, including the chances of recovery or recurrence, based on the patient's symptoms, medical history, physical examination, and diagnostic tests. It is an important aspect of clinical decision-making and patient communication, as it helps doctors and patients make informed decisions about treatment options, set realistic expectations, and plan for future care.

Prognosis can be expressed in various ways, such as percentages, categories (e.g., good, fair, poor), or survival rates, depending on the nature of the disease and the available evidence. However, it is important to note that prognosis is not an exact science and may vary depending on individual factors, such as age, overall health status, and response to treatment. Therefore, it should be used as a guide rather than a definitive forecast.

Transcranial Doppler ultrasonography is a non-invasive diagnostic technique that uses high-frequency sound waves to visualize and measure the velocity of blood flow in the cerebral arteries located in the skull. This imaging modality employs the Doppler effect, which describes the change in frequency of sound waves as they reflect off moving red blood cells. By measuring the frequency shift of the reflected ultrasound waves, the velocity and direction of blood flow can be determined.

Transcranial Doppler ultrasonography is primarily used to assess cerebrovascular circulation and detect abnormalities such as stenosis (narrowing), occlusion (blockage), or embolism (obstruction) in the intracranial arteries. It can also help monitor patients with conditions like sickle cell disease, vasospasm following subarachnoid hemorrhage, and evaluate the effectiveness of treatments such as thrombolysis or angioplasty. The procedure is typically performed by placing a transducer on the patient's skull after applying a coupling gel, and it does not involve radiation exposure or contrast agents.

Medical Definition:

Magnetic Resonance Imaging (MRI) is a non-invasive diagnostic imaging technique that uses a strong magnetic field and radio waves to create detailed cross-sectional or three-dimensional images of the internal structures of the body. The patient lies within a large, cylindrical magnet, and the scanner detects changes in the direction of the magnetic field caused by protons in the body. These changes are then converted into detailed images that help medical professionals to diagnose and monitor various medical conditions, such as tumors, injuries, or diseases affecting the brain, spinal cord, heart, blood vessels, joints, and other internal organs. MRI does not use radiation like computed tomography (CT) scans.

Blood gas analysis is a medical test that measures the levels of oxygen and carbon dioxide in the blood, as well as the pH level, which indicates the acidity or alkalinity of the blood. This test is often used to evaluate lung function, respiratory disorders, and acid-base balance in the body. It can also be used to monitor the effectiveness of treatments for conditions such as chronic obstructive pulmonary disease (COPD), asthma, and other respiratory illnesses. The analysis is typically performed on a sample of arterial blood, although venous blood may also be used in some cases.

A Transient Ischemic Attack (TIA), also known as a "mini-stroke," is a temporary period of symptoms similar to those you'd get if you were having a stroke. A TIA doesn't cause permanent damage and is often caused by a temporary decrease in blood supply to part of your brain, which may last as little as five minutes.

Like an ischemic stroke, a TIA occurs when a clot or debris blocks blood flow to part of your nervous system. However, unlike a stroke, a TIA doesn't leave lasting damage because the blockage is temporary.

Symptoms of a TIA can include sudden onset of weakness, numbness or paralysis in your face, arm or leg, typically on one side of your body. You could also experience slurred or garbled speech, or difficulty understanding others. Other symptoms can include blindness in one or both eyes, dizziness, or a severe headache with no known cause.

Even though TIAs usually last only a few minutes, they are a serious condition and should not be ignored. If you suspect you or someone else is experiencing a TIA, seek immediate medical attention. TIAs can be a warning sign that a full-blown stroke is imminent.

Factor XIII deficiency, also known as fibrin stabilizing factor deficiency, is a rare bleeding disorder caused by a lack or dysfunction of Factor XIII, a protein involved in the final stage of blood clotting. This deficiency results in impaired clot stability and increased risk of bleeding. Symptoms can include umbilical cord bleeding at birth, prolonged bleeding after circumcision, easy bruising, nosebleeds, muscle bleeds, gastrointestinal bleeds, and excessive menstrual bleeding. Treatment typically involves replacement of the missing Factor XIII through injections, either prophylactically or on-demand to manage bleeding episodes.

Cardiopulmonary bypass (CPB) is a medical procedure that temporarily takes over the functions of the heart and lungs during major heart surgery. It allows the surgeon to operate on a still, bloodless heart.

During CPB, the patient's blood is circulated outside the body with the help of a heart-lung machine. The machine pumps the blood through a oxygenator, where it is oxygenated and then returned to the body. This bypasses the heart and lungs, hence the name "cardiopulmonary bypass."

CPB involves several components, including a pump, oxygenator, heat exchanger, and tubing. The patient's blood is drained from the heart through cannulas (tubes) and passed through the oxygenator, where it is oxygenated and carbon dioxide is removed. The oxygenated blood is then warmed to body temperature in a heat exchanger before being pumped back into the body.

While on CPB, the patient's heart is stopped with the help of cardioplegia solution, which is infused directly into the coronary arteries. This helps to protect the heart muscle during surgery. The surgeon can then operate on a still and bloodless heart, allowing for more precise surgical repair.

After the surgery is complete, the patient is gradually weaned off CPB, and the heart is restarted with the help of electrical stimulation or medication. The patient's condition is closely monitored during this time to ensure that their heart and lungs are functioning properly.

While CPB has revolutionized heart surgery and allowed for more complex procedures to be performed, it is not without risks. These include bleeding, infection, stroke, kidney damage, and inflammation. However, with advances in technology and technique, the risks associated with CPB have been significantly reduced over time.

Whole Blood Coagulation Time (WBCT) is not a standard term used in medical literature. However, I believe you may be referring to "bleeding time" or "coagulation time" which are tests used to evaluate the function of the blood's clotting system.

Bleeding time is a measure of how long it takes for bleeding to stop after a small cut is made in the skin. It helps assess the function of the platelets and the smaller blood vessels.

Coagulation time, on the other hand, measures the time it takes for a larger clot to form in whole blood. This test is not commonly used in clinical practice.

It's important to note that these tests have largely been replaced by more specific coagulation tests, such as prothrombin time (PT) and activated partial thromboplastin time (aPTT), which provide more detailed information about the different components of the clotting system.

Thoracic radiography is a type of diagnostic imaging that involves using X-rays to produce images of the chest, including the lungs, heart, bronchi, great vessels, and the bones of the spine and chest wall. It is a commonly used tool in the diagnosis and management of various respiratory, cardiovascular, and thoracic disorders such as pneumonia, lung cancer, heart failure, and rib fractures.

During the procedure, the patient is positioned between an X-ray machine and a cassette containing a film or digital detector. The X-ray beam is directed at the chest, and the resulting image is captured on the film or detector. The images produced can help identify any abnormalities in the structure or function of the organs within the chest.

Thoracic radiography may be performed as a routine screening test for certain conditions, such as lung cancer, or it may be ordered when a patient presents with symptoms suggestive of a respiratory or cardiovascular disorder. It is a safe and non-invasive procedure that can provide valuable information to help guide clinical decision making and improve patient outcomes.

Ethiodized oil is a type of poppy seed oil that has been chemically treated with iodine. It is a highly dense form of iodine, which is used as a radiocontrast medium for imaging studies, such as X-rays and CT scans. The iodine in the ethiodized oil absorbs the X-rays and makes certain structures in the body more visible on the images. It is typically used to help diagnose conditions related to the gastrointestinal tract, such as ulcers or tumors.

It's important to note that the use of ethiodized oil as a radiocontrast medium has declined in recent years due to the development of newer, safer contrast agents. Additionally, there are potential risks associated with its use, including allergic reactions and kidney damage, so it is typically used only when other options are not available or have been determined to be inappropriate.

Platelet aggregation inhibitors are a class of medications that prevent platelets (small blood cells involved in clotting) from sticking together and forming a clot. These drugs work by interfering with the ability of platelets to adhere to each other and to the damaged vessel wall, thereby reducing the risk of thrombosis (blood clot formation).

Platelet aggregation inhibitors are often prescribed for people who have an increased risk of developing blood clots due to various medical conditions such as atrial fibrillation, coronary artery disease, peripheral artery disease, stroke, or a history of heart attack. They may also be used in patients undergoing certain medical procedures, such as angioplasty and stenting, to prevent blood clot formation in the stents.

Examples of platelet aggregation inhibitors include:

1. Aspirin: A nonsteroidal anti-inflammatory drug (NSAID) that irreversibly inhibits the enzyme cyclooxygenase, which is involved in platelet activation and aggregation.
2. Clopidogrel (Plavix): A P2Y12 receptor antagonist that selectively blocks ADP-induced platelet activation and aggregation.
3. Prasugrel (Effient): A third-generation thienopyridine P2Y12 receptor antagonist, similar to clopidogrel but with faster onset and greater potency.
4. Ticagrelor (Brilinta): A direct-acting P2Y12 receptor antagonist that does not require metabolic activation and has a reversible binding profile.
5. Dipyridamole (Persantine): An antiplatelet agent that inhibits platelet aggregation by increasing cyclic adenosine monophosphate (cAMP) levels in platelets, which leads to decreased platelet reactivity.
6. Iloprost (Ventavis): A prostacyclin analogue that inhibits platelet aggregation and causes vasodilation, often used in the treatment of pulmonary arterial hypertension.
7. Cilostazol (Pletal): A phosphodiesterase III inhibitor that increases cAMP levels in platelets, leading to decreased platelet activation and aggregation, as well as vasodilation.
8. Ticlopidine (Ticlid): An older P2Y12 receptor antagonist with a slower onset of action and more frequent side effects compared to clopidogrel or prasugrel.

Coronary thrombosis is a medical condition that refers to the formation of a blood clot (thrombus) inside a coronary artery, which supplies oxygenated blood to the heart muscle. The development of a thrombus can partially or completely obstruct blood flow, leading to insufficient oxygen supply to the heart muscle. This can cause chest pain (angina) or a heart attack (myocardial infarction), depending on the severity and duration of the blockage.

Coronary thrombosis often results from the rupture of an atherosclerotic plaque, a buildup of cholesterol, fat, calcium, and other substances in the inner lining (endothelium) of the coronary artery. The ruptured plaque exposes the underlying tissue to the bloodstream, triggering the coagulation cascade and resulting in the formation of a thrombus.

Immediate medical attention is crucial for managing coronary thrombosis, as timely treatment can help restore blood flow, prevent further damage to the heart muscle, and reduce the risk of complications such as heart failure or life-threatening arrhythmias. Treatment options may include medications, such as antiplatelet agents, anticoagulants, and thrombolytic drugs, or interventional procedures like angioplasty and stenting to open the blocked artery. In some cases, surgical intervention, such as coronary artery bypass grafting (CABG), may be necessary.

Sinus tachycardia is a type of rapid heart rate, characterized by an abnormally fast sinus rhythm, with a rate greater than 100 beats per minute in adults. The sinoatrial node (SA node), which is the natural pacemaker of the heart, generates these impulses regularly and at an increased rate.

Sinus tachycardia is usually a physiological response to various stimuli or conditions, such as physical exertion, strong emotions, fever, anxiety, pain, or certain medications. It can also be caused by hormonal imbalances, anemia, hyperthyroidism, or other medical disorders.

In most cases, sinus tachycardia is not harmful and resolves once the underlying cause is addressed. However, if it occurs persistently or is associated with symptoms like palpitations, shortness of breath, dizziness, or chest discomfort, further evaluation by a healthcare professional is recommended to rule out any underlying heart conditions or other medical issues.

Pulmonary circulation refers to the process of blood flow through the lungs, where blood picks up oxygen and releases carbon dioxide. This is a vital part of the overall circulatory system, which delivers nutrients and oxygen to the body's cells while removing waste products like carbon dioxide.

In pulmonary circulation, deoxygenated blood from the systemic circulation returns to the right atrium of the heart via the superior and inferior vena cava. The blood then moves into the right ventricle through the tricuspid valve and gets pumped into the pulmonary artery when the right ventricle contracts.

The pulmonary artery divides into smaller vessels called arterioles, which further branch into a vast network of tiny capillaries in the lungs. Here, oxygen from the alveoli diffuses into the blood, binding to hemoglobin in red blood cells, while carbon dioxide leaves the blood and is exhaled through the nose or mouth.

The now oxygenated blood collects in venules, which merge to form pulmonary veins. These veins transport the oxygen-rich blood back to the left atrium of the heart, where it enters the systemic circulation once again. This continuous cycle enables the body's cells to receive the necessary oxygen and nutrients for proper functioning while disposing of waste products.

Arterial occlusive diseases are medical conditions characterized by the blockage or narrowing of the arteries, which can lead to a reduction in blood flow to various parts of the body. This reduction in blood flow can cause tissue damage and may result in serious complications such as tissue death (gangrene), organ dysfunction, or even death.

The most common cause of arterial occlusive diseases is atherosclerosis, which is the buildup of plaque made up of fat, cholesterol, calcium, and other substances in the inner lining of the artery walls. Over time, this plaque can harden and narrow the arteries, restricting blood flow. Other causes of arterial occlusive diseases include blood clots, emboli (tiny particles that travel through the bloodstream and lodge in smaller vessels), inflammation, trauma, and certain inherited conditions.

Symptoms of arterial occlusive diseases depend on the location and severity of the blockage. Common symptoms include:

* Pain, cramping, or fatigue in the affected limb, often triggered by exercise and relieved by rest (claudication)
* Numbness, tingling, or weakness in the affected limb
* Coldness or discoloration of the skin in the affected area
* Slow-healing sores or wounds on the toes, feet, or legs
* Erectile dysfunction in men

Treatment for arterial occlusive diseases may include lifestyle changes such as quitting smoking, exercising regularly, and eating a healthy diet. Medications to lower cholesterol, control blood pressure, prevent blood clots, or manage pain may also be prescribed. In severe cases, surgical procedures such as angioplasty, stenting, or bypass surgery may be necessary to restore blood flow.

Contrast media are substances that are administered to a patient in order to improve the visibility of internal body structures or processes in medical imaging techniques such as X-rays, CT scans, MRI scans, and ultrasounds. These media can be introduced into the body through various routes, including oral, rectal, or intravenous administration.

Contrast media work by altering the appearance of bodily structures in imaging studies. For example, when a patient undergoes an X-ray examination, contrast media can be used to highlight specific organs, tissues, or blood vessels, making them more visible on the resulting images. In CT and MRI scans, contrast media can help to enhance the differences between normal and abnormal tissues, allowing for more accurate diagnosis and treatment planning.

There are several types of contrast media available, each with its own specific properties and uses. Some common examples include barium sulfate, which is used as a contrast medium in X-ray studies of the gastrointestinal tract, and iodinated contrast media, which are commonly used in CT scans to highlight blood vessels and other structures.

While contrast media are generally considered safe, they can sometimes cause adverse reactions, ranging from mild symptoms such as nausea or hives to more serious complications such as anaphylaxis or kidney damage. As a result, it is important for healthcare providers to carefully evaluate each patient's medical history and individual risk factors before administering contrast media.

Coagulants are substances that promote the process of coagulation or clotting. They are often used in medical settings to help control bleeding and promote healing. Coagulants work by encouraging the formation of a clot, which helps to stop the flow of blood from a wound or cut.

There are several different types of coagulants that may be used in medical treatments. Some coagulants are naturally occurring substances, such as vitamin K, which is essential for the production of certain clotting factors in the body. Other coagulants may be synthetic or semi-synthetic compounds, such as recombinant activated factor VII (rFVIIa), which is used to treat bleeding disorders and prevent excessive bleeding during surgery.

Coagulants are often administered through injection or infusion, but they can also be applied topically to wounds or cuts. In some cases, coagulants may be used in combination with other treatments, such as compression or cauterization, to help control bleeding and promote healing.

It is important to note that while coagulants can be helpful in controlling bleeding and promoting healing, they can also increase the risk of blood clots and other complications. As a result, they should only be used under the guidance and supervision of a qualified healthcare professional.

The atrial septum is the wall of tissue that divides the right and left atria, which are the upper chambers of the heart. This septum ensures that oxygen-rich blood in the left atrium is kept separate from oxygen-poor blood in the right atrium. Defects or abnormalities in the atrial septum, such as a hole or a gap, can result in various heart conditions, including septal defects and congenital heart diseases.

Interventional radiography is a subspecialty of radiology that uses imaging guidance (such as X-ray fluoroscopy, ultrasound, CT, or MRI) to perform minimally invasive diagnostic and therapeutic procedures. These procedures typically involve the insertion of needles, catheters, or other small instruments through the skin or a natural body opening, allowing for targeted treatment with reduced risk, trauma, and recovery time compared to traditional open surgeries.

Examples of interventional radiography procedures include:

1. Angiography: Imaging of blood vessels to diagnose and treat conditions like blockages, narrowing, or aneurysms.
2. Biopsy: The removal of tissue samples for diagnostic purposes.
3. Drainage: The removal of fluid accumulations (e.g., abscesses, cysts) or the placement of catheters to drain fluids continuously.
4. Embolization: The blocking of blood vessels to control bleeding, tumor growth, or reduce the size of an aneurysm.
5. Stenting and angioplasty: The widening of narrowed or blocked vessels using stents (small mesh tubes) or balloon catheters.
6. Radiofrequency ablation: The use of heat to destroy tumors or abnormal tissues.
7. Cryoablation: The use of extreme cold to destroy tumors or abnormal tissues.

Interventional radiologists are medical doctors who have completed specialized training in both diagnostic imaging and interventional procedures, allowing them to provide comprehensive care for patients requiring image-guided treatments.

Ultrasonography, Doppler, and Duplex are diagnostic medical techniques that use sound waves to create images of internal body structures and assess their function. Here are the definitions for each:

1. Ultrasonography: Also known as ultrasound, this is a non-invasive imaging technique that uses high-frequency sound waves to produce images of internal organs and tissues. A small handheld device called a transducer is placed on the skin surface, which emits and receives sound waves. The returning echoes are then processed to create real-time visual images of the internal structures.
2. Doppler: This is a type of ultrasound that measures the velocity and direction of blood flow in the body by analyzing the frequency shift of the reflected sound waves. It can be used to assess blood flow in various parts of the body, such as the heart, arteries, and veins.
3. Duplex: Duplex ultrasonography is a combination of both gray-scale ultrasound and Doppler ultrasound. It provides detailed images of internal structures, as well as information about blood flow velocity and direction. This technique is often used to evaluate conditions such as deep vein thrombosis, carotid artery stenosis, and peripheral arterial disease.

In summary, ultrasonography is a diagnostic imaging technique that uses sound waves to create images of internal structures, Doppler is a type of ultrasound that measures blood flow velocity and direction, and duplex is a combination of both techniques that provides detailed images and information about blood flow.

Peripheral catheterization is a medical procedure that involves the insertion of a thin, flexible tube (catheter) into a peripheral vein, which is a blood vessel located outside of the chest and abdomen. This type of catheterization is typically performed to administer medications, fluids, or nutritional support, or to monitor various physiological parameters such as central venous pressure.

Peripheral catheters are usually inserted into veins in the hands or arms, although they can also be placed in other peripheral veins. The procedure is typically performed using aseptic technique to minimize the risk of infection. Once the catheter is in place, it may be secured with a dressing or suture to prevent movement and dislodgement.

Peripheral catheterization is a relatively safe and common procedure that is routinely performed in hospitals, clinics, and other healthcare settings. However, like any medical procedure, it carries a small risk of complications such as infection, bleeding, or damage to the vein or surrounding tissues.

Typical complications are blood clot formation on the valve or dislodgment of thrombus (embolism); bleeding complications are ... 50mm and risk factors (e.g. high blood pressure) Ascending aortic aneurysm > 50mm and connective tissue disease Ascending ... Blood-thinning may only be necessary if atrial fibrillation occurs or persists in order to prevent blood clot formation in the ... Contrary to valve replacement with mechanical prostheses inhibition of the blood clotting system (anticoagulation) is not ...
When this process is too active due to various problems the risk of blood clots or embolisms increases. As the name indicates ... are a class of anticoagulant drugs that can be used to prevent and treat embolisms and blood clots caused by various diseases. ... Due to this action of DTIs they can both be used for prophylaxis as well as treatment for embolisms/clots. DTIs that fit in the ... All three studies showed that the risk of new thrombosis was decreased with the use of lepirudin, but the risk for major ...
A blood test including platelets and a clotting screen should be performed prior to administration of anticoagulant regimens in ... However, when combined with an additional underlying hypercoagulable states, the risk of thrombosis or embolism may become ... "Venous Thromboembolism (Blood Clots) and Pregnancy". Centers for Disease Control and Prevention. 20 August 2020. Retrieved 24 ... Hypercoagulability in pregnancy is the propensity of pregnant women to develop thrombosis (blood clots). Pregnancy itself is a ...
Pulmonary embolism, a blood clot that forms in the legs and migrates to the lungs. Acute fatty liver of pregnancy is a rare ... However, in combination with an underlying hypercoagulable state, the risk of thrombosis or embolism may become substantial. An ... Hypercoagulability in pregnancy is the propensity of pregnant women to develop thrombosis (blood clots). Pregnancy itself is a ... Blood and urine tests can detect pregnancy by 11 and 14 days, respectively, after fertilization. Blood pregnancy tests are more ...
Pulmonary embolism is blood clots occurring in the lungs. Restricted blood flow in the pulmonary circulation results in alveoli ... Smoking (long-term exposure to chemical irritants) can cause COPD, increasing the risk of lung cancer and heart disease. Asthma ... This might have been caused by blood clotting, heart failure, pulmonary emphysema, or damage in alveolar capillaries. Secondly ... Then the deoxygenated blood returns to the heart via veins, and perfusion begins again after the blood is re-oxygenated through ...
... and of pulmonary embolism. One copy of the mutation increases the risk of a blood clot from 1 in 1,000 per year to 2.5 in 1,000 ... Other blood clotting pathway mutations that increase the risk of clots include factor V Leiden. Prothrombin G20210A was ... Two copies increases the risk to up to 20 in 1,000 per year. Most people never develop a blood clot in their lifetimes. It is ... Occasionally, blood-thinning medication may be indicated to reduce the risk of clotting. Heterozygous carriers who take ...
EE carries a greater risk of blood clot formation and VTE than does natural estradiol, which is thought to be due to structural ... VTE is a blood clot in a vein, and includes deep vein thrombosis (DVT) and pulmonary embolism (PE). Estrogens are known to ... though also result in an increased risk of blood clots and certain other rare adverse effects. EE was developed in the 1930s ... blood clots), due to an increased risk of cardiovascular problems such as venous thromboembolism (VTE), myocardial infarction, ...
Anesthesia can also increase the risk of developing blood clots and lead to pulmonary embolism or deep venous thrombosis. (DVT ... average risk - every year beginning at age 50 FIT: average risk - every year beginning at age 50 Cologuard: average risk - ... Fecal occult blood is a quick test which can be done to test for microscopic traces of blood in the stool. A positive test is ... After 10 years, an intention-to-screen analysis showed a significant relative risk reduction of 18% in the risk of colorectal ...
It is also used to treat atrial fibrillation to lower the risk of stroke caused by a blood clot. Another indication is a ... which can lead to pulmonary embolism. ... Blood coagulation is a complex process by which the blood forms ... clots. It is an essential part of hemostasis and works by stopping blood loss from damaged blood vessels. At the site of injury ... prophylactic treatment for blood clotting (thrombosis) due to atherosclerosis. Rivaroxaban was the first FXa inhibitor on the ...
tPA works to break up the clot. A major risk of tPA is bleeding. Thus, patients must be assessed for their risk of bleeding and ... Causes include any obstruction of blood flow to and from the heart. There are multiple, including pulmonary embolism, cardiac ... Risk factors are conditions that increase the risk of clotting. This includes genetic (factor V Leiden) and acquired conditions ... In pulmonary embolism, the right ventricle will be dilated. Other findings include paradoxical septal motion or clots in the ...
Atrial fibrillation is also a major risk factor for strokes. Atrial fibrillation causes blood clots to form within the heart, ... which may travel to the arteries within the brain and cause an embolism. The embolism prevents blood flow to the brain, which ... Hypertension (high blood pressure) is the most important contributing risk factor for stroke and cerebrovascular diseases as it ... Atherosclerosis narrows blood vessels in the brain, resulting in decreased cerebral perfusion. Other risk factors that ...
The U.S. Food and Drug Administration (FDA) also released warnings about the risk of blood clots. An important side effect of ... tofacitinib may also increase the risk for pulmonary embolism. Prescribers should consider risk factors for pulmonary embolism ... FDA approves Boxed Warning about increased risk of blood clots and death with higher dose of arthritis and ulcerative colitis ... "FDA approves Boxed Warning about increased risk of blood clots and death with higher dose of arthritis and ulcerative colitis ...
It gives an accurate risk profile very early. A second blood screen at 15 to 20 weeks refines the risk more accurately. The ... reduced blood pressure), and abdominal pain, offensive lochia (blood loss) increased lochia, clots, diarrhea and vomiting.[ ... However, when combined with an additional underlying hypercoagulable states, the risk of thrombosis or embolism may become ... blood clots). Pregnancy itself is a factor of hypercoagulability (pregnancy-induced hypercoagulability), as a physiologically ...
Antiplatelet drugs, such as aspirin, as well as anticoagulants, are used to help prevent blood clots and therefore embolisms, ... Small risks of bleeding and infection exist as well. In this type of procedure, a narrowed blood vessel is expanded via ... In this scenario, the clotting becomes too severe and the clot breaks free. The resulting traveling clot is known as an embolus ... Patients with many different cardiovascular diseases have a higher likelihood of experiencing a blood clot or loss of blood ...
... in which blood forms a clot in immobile limbs; the clot can break off and form a pulmonary embolism, lodging in the lung and ... The risk of suicide is worst in the first five years after injury. In young people with SCI, suicide is the leading cause of ... or when a blood clot becomes lodged in a blood vessel and cuts off blood supply to the cord. When systemic blood pressure drops ... If the systolic blood pressure falls below 90 mmHg within days of the injury, blood supply to the spinal cord may be reduced, ...
The risk of blood clots is higher in a person with cancer, as cancer is also a risk factor for blood clots. As many as two ... If a large air embolism is suspected, a syringe can be attached to the catheter cap and pulled pack in an attempt to remove the ... CVCs are a risk factor for forming blood clots (venous thrombosis) including upper extremity deep vein thrombosis. It is ... Anti-clotting drugs such as heparin and fondaparinux have been shown to decrease the incidence of blood clots, specifically ...
If a thrombus breaks off (embolizes) and flows to the lungs to lodge there, it becomes a pulmonary embolism (PE), a blood clot ... "high risk" pulmonary embolism), leading to low blood pressure. Deep vein thrombosis may require thrombolysis if there is a ... blood clot). A common form of venous thrombosis is deep vein thrombosis (DVT), when a blood clot forms in the deep veins. ... An embolism that lodges in the lungs is a pulmonary embolism (PE). A pulmonary embolism is a very serious condition that can be ...
... leading to increased risk for developing blood clots and embolisms, such as deep vein thrombosis and pulmonary embolism. Women ... The increased risk of clots can be attributed to several things. Plasma levels of pro-coagulantion factors increased markedly ... Many factors have been shown to increase the risk of clots in pregnancy, including baseline thrombophilia, cesarean section, ... As a result, carbon dioxide levels in the blood decrease and the pH of the blood becomes more alkaline (i.e. the pH is higher ...
... blood clots) such as: deep venous thrombosis, pulmonary embolism, heart attack, and stroke. Aspirin may decrease the risk. ... A transgender man's hematocrit (the percentage of whole blood made up of red blood cells) should be judged against normal age- ... Therapy is via phlebotomy (periodic therapeutic blood draws similar to blood donation). Tendency to become polycythemic worsens ... Cardiovascular risk factors are more than additive. (If high blood pressure is worth 10 and smoking is worth 10, together they ...
Pulmonary embolism occurs due as a result of deep vein thrombosis, in which blood clots form in the deep veins of the ... In addition to procedure-specific risks, patients also face risks to surgery in general. Pulmonary embolism is another common ... which results in high blood sugars and a range of complications including increased risk of heart attack, retinopathy, kidney ... The risk of death in the period following surgery is less than 1 in 1,000. Each type of procedure exerts its effects through at ...
If the blood clot is too near the saphenofemoral junction there is a higher risk of pulmonary embolism, a potentially life- ... Superficial vein thrombosis (SVT) is a blood clot formed in a superficial vein, a vein near the surface of the body. Usually ... Hypercoagulable states due to genetic conditions that increase the risk of clotting may contribute to the development of SVT, ... such as genetic mutations that increase one's risk for clotting), and is therefore no longer regarded as a benign condition. ...
In rare instances, arterial aneurysm of the popliteal artery has been found to create a blood clot or embolism resulting in ... Treatment depends on many factors, including: Location of lesions Anatomy of lesions Individual risk factors Procedural risk ... Other options include a vascular bypass to route blood flow around the clot. Those unsuitable for surgery may receive ... blood'. In this sense, ischaemia refers to the inhibition of blood flow to/through the limb. Acute limb ischaemia can occur in ...
... blocking blood flow to the brain. Blood clots also can develop in other parts of the head. Other types of vascular ... The risk of complications increases with the severity of the trauma; however even mild traumatic brain injury can result in ... which can cause pulmonary embolism. Other serious complications for patients who are unconscious, in a coma, or in a vegetative ... in which blood vessels constrict and restrict blood flow, and the formation of aneurysms, in which the side of a blood vessel ...
This is done in an attempt to reduce the risk of tissue injury following lack of blood flow. Periods of poor blood flow may be ... This condition may become potentially fatal if the clot travels to the lungs and causes a pulmonary embolism. Another potential ... Bleeding represents a significant danger, due to a decreased clotting threshold caused by hypothermia. The risk of deep vein ... Possible complications may include: infection, bleeding, dysrhythmias and high blood sugar. One review found an increased risk ...
... development of blood clots (thrombosis), blocking of arteries (embolism), and injury to adjacent structures, such as bowel or ... The complication rate associated with ureterostomy procedures is less than 5-10%. Risks during surgery include heart problems, ... blood, urea, nitrogen (BUN); and creatinine. Blood tests, complete blood count (CBC) and electrolytes. Imaging studies of the ... and disease progression in a case of inflammation of blood vessels, or vasculitis (one patient). One patient died of sepsis ( ...
Those with large AVMs are at risk of formation of blood clots in the vascular lesion, which may migrate to the lungs (pulmonary ... embolism). If there is large-volume blood flow through the lesion, high-output heart failure may develop due to the inability ... The greatest issue with KTS syndrome is that the blood flow and/or lymph flow may be impeded, and will pool in the affected ... Such treatment may allow normal blood flow to resume. It is a non-surgical medical procedure and is not nearly as invasive as ...
... or pulmonary embolism have this condition. The risk of developing a clot in a blood vessel depends on whether a person inherits ... may have up to 80 times the usual risk of developing this type of blood clot. Considering that the risk of developing an ... one of several substances that helps blood clot), which causes an increase in blood clotting (hypercoagulability). Due to this ... the presence of other gene alterations related to blood clotting, and circumstantial risk factors, such as surgery, use of oral ...
... irregularities in the vessel wall and turbulence increase the risk of thrombosis (the formation of blood clots) and embolism ( ... After the tear, blood enters the arterial wall and forms a blood clot, thickening the artery wall and often impeding blood flow ... Those with high blood pressure and dissections in multiple arteries may have a higher risk of recurrence. Further episodes of ... Dissection occurs when blood accumulates in the wall of the blood vessel. This is most likely due to a tear in the tunica ...
It is also indicated to reduce the risk of blood clots in people with nonvalvular atrial fibrillation. In the European Union, ... In the United States, edoxaban is indicated to treat deep vein thrombosis and pulmonary embolism following five to ten days of ... Thrombins turn blood-soluble fibrinogens to insoluble fibrins, which are the main components of blood clots. In human, 15-150 ... edoxaban is indicated for preventing blood clots in people with nonvalvular atrial fibrillation who also have at least one risk ...
Such complications often result from blood clots forming in the legs and then traveling to the lungs. If the patient had a ... also known as a cumulative risk). An example of this type of analysis would be the investigation of a pulmonary embolism (PE) ... An example of such a situation occurs when the numerator is a per event risk, and the denominator is a per-time risk ( ... The metric of a case-specific FE analysis of cause is the comparative risk ratio (CRR). The CRR is a unique metric to FE; it ...
When clots break, it travels in the blood causing venous thrombo- embolism. ... Women using newer contraceptive pills had four times increased risk of blood clots. ... Newer Contraceptive Pills Has Blood Clot Risk; Could Lead to Venous Thrombo-Embolism Personalised Printable Document (PDF). ... When a blood clot breaks loose and travels in the blood, it is called a venous thrombo- embolism (VTE). ...
If you or a loved one suffered because your health care provider failed to prevent a blood clot or pulmonary embolism, you may ... Failure to Prevent Blood Clots and Pulmonary Embolisms. What Are Blood Clots and Pulmonary Embolisms?. Blood clots are a risk ... Increased Risks for Blood Clots and Pulmonary Embolism. Usually, "blood clots start as a response to injury of a blood vessel ... Failure to Prevent Blood Clots and Pulmonary Embolisms. Blood clots kill as many as 100,000 people each year. (1) If you or a ...
Pulmonary embolism (PE) may occur if the blood clot travels to the lungs, heart attacks may occur if blood clot travels to the ... NuvaRing Blood Clots and Complications. NuvaRing may increase the risk of blood clot formation as hormones released by the ... NuvaRing has a considerably higher risk of causing blood clots. A study was published in 2011 by the U.S. Food and Drug ... which linked the birth control device to a possible 56 percent increased risk of blood clots. ...
Users of the blood thinner Xarelto had higher risks of recurrent venous thromboembolism and higher risks of bleeding events ... Eliquis More Effective At Preventing Recurring Blood Clots, Embolism, Than Xarelto: Study. The study also found higher risks of ... Tags: Atrial Fibrillation, Bleeding, Blood Clots, Blood Thinners, Deep Vein Thrombosis, Eliquis, Pradaxa, Pulmonary Embolism, ... Eliquis Useful In Preventing Blood Clots, But Side Effects Include Major Bleeding Risks: Study. 12/26/18 ...
... that has come from another part of the body and causes a sudden interruption of blood flow to an organ or body part. ... that has come from another part of the body and causes a sudden interruption of blood flow to an organ or body part. ... Conditions that increase blood clotting Another condition that poses a high risk for embolization (especially to the brain) is ... An arterial embolism may be caused by one or more clots. The clots can get stuck in an artery and block blood flow. The ...
Read about types of surgery, risks, and more here. ... deep vein thrombosis (blood clot). *pulmonary embolism. * ... All surgical procedures have some risks associated with them. A person should talk with a doctor about the risks associated ... children who are not obese and have smaller tonsils may find that recovery and risk are lower if just the adenoids get removed ... Any procedures that require general anesthesia put a person at greater risk. This is due to its effects on breathing, which can ...
See a list of medical and underlying conditions that make adults more at risk for COVID-19, and links to more information for ... Pulmonary embolism (blood clot in the lungs). *Pulmonary hypertension (high blood pressure in the lungs) ... Treatment can reduce your risk of hospitalization by more than 50% and also reduces the risk of death. ... Solid organ or blood stem cell transplant. Having had a solid organ or blood stem cell transplant, which includes bone marrow ...
... understand blood clot screening tools, complete risk factors or signs and symptoms of blood clots. ... understand blood clot screening tools, complete risk factors or signs and symptoms of blood clots. ... According to the National Blood Clot Alliance (NBCA), 274 people die from blood clots on a daily average. Thats over 100,000 ... Then as fast as the doctor had made her first incision, my sisters blood pressure dropped and was never regained. A blood clot ...
... including the benefits and risks, how the procedure works, what to expect after surgery, and more. ... pulmonary embolism (blood clot in the lungs). *organ rejection. One reasonable alternative to a lung transplant is a lung ... Getting you moving as soon as possible will also help prevent blood clot formation. ... You may be placed on a cardiopulmonary bypass machine (heart-lung machine) if your COPD prevents healthy blood flow to your ...
... is a blockage of an artery in the lungs by a blood clot, fat, air or clumped tumor cells. ... Blood Type May Offer Insights Into Risk of Blood Clot in People With Cancer ... Pulmonary embolism. Pulmonary embolism is a blockage of an artery in the lungs by a blood clot, fat, air or clumped tumor cells ... TV Watching Linked With Potentially Fatal Blood Clots. Jan. 19, 2022 Take breaks when binge-watching TV to avoid blood clots, ...
Some people report cases of pulmonary embolism after COVID-19 vaccination. Well explore this potential link, its causes, and ... Those antibodies activate platelets, which help your blood clot. According to a review of studies. , potential risk factors for ... is a very rare blood clotting disorder caused by the J&J vaccine. TTS causes blood clots, including pulmonary embolism (PE), ... A pulmonary embolism (PE) is a blood clot that breaks off from a deep vein and travels to a lung artery, where it blocks blood ...
Typical complications are blood clot formation on the valve or dislodgment of thrombus (embolism); bleeding complications are ... 50mm and risk factors (e.g. high blood pressure) Ascending aortic aneurysm > 50mm and connective tissue disease Ascending ... Blood-thinning may only be necessary if atrial fibrillation occurs or persists in order to prevent blood clot formation in the ... Contrary to valve replacement with mechanical prostheses inhibition of the blood clotting system (anticoagulation) is not ...
Possible risks include:. *Arrhythmias. *Bleeding. *Blood clots that lead to embolism. *Cardiac tamponade ... Arteries carry blood away from the heart while veins carry blood into the heart. The vessels colored blue indicate the ... The vessels colored red indicate the transport of blood with relatively high content of oxygen and low content of carbon ... Risks. The procedure is very safe in most cases. ... Determine whether you are at risk for future heart events, ...
They are recalled for blood or heparin solution leaking from the syringe. ... or blood loss due to leakage. Other risks include the wrong heparin dosage, leading to blood clotting, embolism, and death. ... They are used to draw heparin, a blood thinning medicine used to prevent blood clots. The heparin is then mixed with the blood ... Fresenius Medical Care is recalling its Sanxin Single Use Sterile Syringes due to blood or heparin leaking back or from the ...
Blood Clot ; Patients ; Anticoagulation ; Pulmonary artery structure ; Pulmonary Artery ; Pulmonary Embolism ; Pulmonary valve ... Blood; Right ventricular structure; Risk; Safety; SCHED; Schedule; Speed; Speed (motion); standard of care; success; suid; ... Blood; Blood Clot; Blood Clotting; Blood coagulation; blood loss; blood pump; Cardiac; cardiac failure; cardiac graft; cardiac ... Blood ; Blood Reticuloendothelial System ; Blood coagulation ; Blood Clotting ; success ; Speed (motion) ; Speed ; novel ; ...
... especially if you are at risk of venous thromboembolism (VTE). ... Pulmonary embolism (PE) is a blood clot in the lung, which can ... Taking certain medications can also increase your risk of blood clots. Ask your doctor about whether you are at risk for VTE, ... Venous thromboembolism (VTE) refers to a blood clot in a vein. People with cancer are more likely to develop blood clots, ... Deep vein thrombosis (DVT) is a blood clot in a major vein that leads to the heart. DVT may cause discomfort, and should be ...
... we spoke to Professor Robert Ariëns from the University of Leeds about his latest research into blood clots and how they can be ... with a particularly high risk of clots in the lungs.. If we can reduce pulmonary embolism, this may also greatly help patients ... Tags: Atomic Force Microscopy, B Cell, Bleeding, Blood, Blood Clot, Blood Vessel, Blood Vessels, Breathing, Cardiology, Cell, ... NSAID use linked to higher risk of blood clots in women of reproductive age, association stronger in women on high-risk ...
Our New Jersey medical malpractice lawyers represent victims of pulmonary embolism misdiagnosis and failure to diagnose a blood ... Family history of blood clots. Identifying a patient at increased risk and testing for the presence of a blood clot can allow ... What is Pulmonary Embolism?. Blood clots can develop anywhere; an embolus is a blood clot that develops in one part of the body ... while a blood clot that blocks an artery in the heart can cause a heart attack. A pulmonary embolism occurs when a blood clot ...
... which increases the risk of blood clots, as the reason for her death.. Talk about "natural selection" in reverse! Thats not to ... it merely states that she died of a pulmonary embolism or blood clot. Interestingly, the article says that the CDC cites the ... In fact, Grant reports that another girl died of a blood clot just three hours after receiving the vaccine. Three hours. Just a ... Unvaccinated blood banks? Learn about the growing movement for clean transfusions. *VACCINE-INDUCED TURBO CANCER: T-cell ...
Blood clot in the lung (pulmonary embolism).. *Diabetes.. *High blood pressure (hypertension). ... Living a heart-healthy lifestyle can lower your risk of acute heart failure. ... Echocardiogram to show heart movement and blood flow.. *Angiography or heart catheterization to examine the hearts blood ... BNP (biomarker) blood test to check for hormones that occur when pressures change inside the heart. ...
These may be symptoms of serious blood clots (eg, deep vein thrombosis, pulmonary embolism, arterial thrombosis). ... This medicine may increase your risk of serious heart or blood vessel problems, including heart attack or stroke. Call your ... Smoker, current or past-May increase risk for serious side effects. Proper use of pacritinib. Take this medicine only as ... Blood tests will be needed to check for unwanted effects. Do not use this medicine together with clarithromycin (Biaxin®) and ...
The biggest risk was for pulmonary embolism (a blood clot in the lungs) which saw an 11-fold increase. Heart disease diagnoses ... We included this baseline risk and other key factors that could affect the results, such as BMI and blood pressure, in our ... particularly of pulmonary embolism and diabetes diagnoses. As the risk of diabetes remains high for at least three months, ... The risk of being diagnosed with heart disease and diabetes was most elevated in the first four weeks after contracting the ...
Keep Deadly Blood Clots at Bay Pulmonary embolisms can be an unwanted side effect after surgery. Learn the risk factors and how ... Seniors: How Healthy Feet Can Reduce Your Risk of Falling Not only are seniors more at risk for falls, when they do so, it ... Avoid Risks of Summer Heat to Diabetic Feet As public health officials take precautions to help seniors endure the summer ... Female Runners at Risk for Painful Neuromas ACFAS warns female runners that the combination of wearing narrow, pointed-toed ...
... it also brings a risk of deep vein thrombosis (DVT), a preventable condition in which blood clots form in the veins. ... A pulmonary embolism, or PE, is a blood clot that breaks off and travels from one part of the body to the lungs, where it ... Blood Clots. How to Prevent Blood Clots in Pregnancy. Pregnant women are 5 times more likely to get blood clots. Heres how to ... 7 Things That Raise Risks of Blood Clots and DVT. Your chances of developing a blood clot deep inside the body become much ...
If dosed too high, warfarin can increase the risk of bleeding; if dosed too low, it can increase the risk of blood clots. ... or pulmonary embolism. Though warfarin is an effective therapy for many people with cardiovascular problems, the drug poses ... Warfarin is the most commonly prescribed drug to prevent blood clots in conditions such as atrial fibrillation, deep vein ... used to prevent blood clots in the circulatory system, was no more effective in achieving stable anticoagulation than using ...
Side effects of NuvaRing may increase risk of blood clots, pumonary embolism, DVT, death. Lawsuits pending. ... that his wifes physician would have never prescribed the Nuvaring had the true risks of blood clots and pulmonary embolism ... Organon, a subsidiary of Merck, allegedly failed to conduct adequate studies that would have revealed the risk of blood clots ... As of the end of last year, more than 730 people had filed a lawsuit over blood clot injury from NuvaRing, and the number of ...
... may increase your risk for blood clots, including deep vein thrombosis and pulmonary embolism. Learn how to prevent blood clots ... Learn About Blood Clots. Airplane travel, especially flights longer than 4 hours, ... Check CDCs webpage for your destination to see what vaccines or medicines you may need and what diseases or health risks are a ...
... the blood begins to pool in the vein, increasing venous pressure and causing the vein to bulge and twist. READ MORE ... Am I at high risk for a blood clot or pulmonary embolism? How can I prevent these? ... ST also increases a patients risk for deep vein thrombosis (DVT), a potentially serious condition that involves a blood clot ... The inflammation may be caused by decreased blood flow through the vein, damage to the vein or blood clotting (known as ...
Blood clots (deep vein thrombosis (DVT) or pulmonary embolism). *Cirrhosis of the liver ... IBD increases the risk of developing:. *Anal fistula (an abnormal tunnel that connects the anal canal in the colon to the skin ... The risk of IBD being hereditary is greater with Crohns disease and when both parents had/have the disease. According to ... More common in Asia and the Middle East, Behçets is a type of autoimmune disease that causes inflammation in the blood vessels ...
... aimed at quantifying NuvaRing blood clot risk, indicated no significant difference in risk of venous thromboembolism when ... 1. Yasmin/YAZ (gall bladder disease, blood clots, deep vein thrombosis, pulmonary embolism) ... Along with Yaz, readers remained concerned about NuvaRing (etonogestrel/ethinyl estradiol) and blood clot risk even as a new ... 2. NuvaRing & Mirena (blood clots, infection, perforation of the uterus). 3. Pradaxa (uncontrollable bleeding, lack of an ...
  • It usually happens when a blood clot breaks loose and travels through the bloodstream to the lungs. (weitzlux.com)
  • Blood clots can travel to the lungs, heart, and brain. (weitzlux.com)
  • Permanent damage to the lungs - Lung tissue can be irreversibly damaged when blood cannot reach your lungs because of a blood clot. (weitzlux.com)
  • Pulmonary embolism (PE) may occur if the blood clot travels to the lungs, heart attacks may occur if blood clot travels to the heart and stroke can occur if a DVT travels to the brain. (drugdangers.com)
  • If a clot travels and lodges in the arteries supplying blood flow to the lungs, it is called a pulmonary embolus . (medlineplus.gov)
  • A blood clot from her injured knee had broken off and quickly went to her lungs. (kevinmd.com)
  • A PE is a blood clot that has traveled from its origin, likely a vein in the leg, and lodges in one or more arteries in the lungs. (kevinmd.com)
  • Pulmonary embolism is a blockage of an artery in the lungs by a blood clot, fat, air or clumped tumor cells. (sciencedaily.com)
  • One question I have wanted to answer for some time is: Why do certain clots embolise and cause pulmonary embolism (clots in the lungs) and others do not? (news-medical.net)
  • Blood clots in the lungs kill more than two thousand people each year in the UK alone yet how they form is still largely unknown until now. (news-medical.net)
  • We knew that clots in the lungs can arise from clots in the deep veins of the legs or arms, by breaking off from the site of thrombosis in the limbs, and then traveling in the bloodstream to the lungs to block a vessel there and cause difficulties in breathing. (news-medical.net)
  • Then we developed a new model of pulmonary embolism using powerful new imaging methods to analyze embolization of the clots to the lungs. (news-medical.net)
  • Then we found that in the absence of these crosslinks, clots that form in the vena cava (central vein) break off much more easily and generate more emboli in the lungs. (news-medical.net)
  • We know that patients with severe COVID-19 have a really high risk of thrombosis, with a particularly high risk of clots in the lungs. (news-medical.net)
  • A pulmonary embolism occurs when a blood clot becomes lodged in the lungs. (fronzutolaw.com)
  • The biggest risk was for pulmonary embolism (a blood clot in the lungs) which saw an 11-fold increase. (yahoo.com)
  • The fear is it will move to the heart or lungs and cause a pulmonary embolism, which can lead to death," says Daniel Roshan, MD , a maternal fetal medicine specialist and an assistant professor of obstetrics and gynecology at the NYU Grossman School of Medicine in New York City. (everydayhealth.com)
  • According to a study published in the Journal of the American Heart Association in December 2020 , pregnant Black women were found to have a 42 percent higher likelihood of developing a blood clot in the lungs compared with white women. (everydayhealth.com)
  • Blood clots during pregnancy that have moved to the heart or lungs can cause chest pain, shortness of breath , or both. (everydayhealth.com)
  • A clot that formed in his legs moved to his lungs, leading to a fatal pulmonary embolism. (today.com)
  • When a blood clot from the legs breaks free and move toward the lungs, it can become a pulmonary embolism. (today.com)
  • This can make it hard for blood to pass through the lungs to get oxygen. (radiologyinfo.org)
  • Diagnosing a pulmonary embolism can be difficult because half of patients with a clot in the lungs have no symptoms. (radiologyinfo.org)
  • If you have a pulmonary embolism, you need medical treatment right away to prevent a blood clot from blocking blood flow to the lungs and heart. (radiologyinfo.org)
  • Treatment typically includes medications to thin the blood or placement of a filter to prevent the movement of additional blood clots to the lungs. (radiologyinfo.org)
  • A pulmonary embolism can be life-threatening or cause permanent damage to the lungs. (radiologyinfo.org)
  • This non-invasive test uses x-rays and an iodine-containing contrast material to produce pictures of the chest highlighting the blood vessels in the chest and lungs. (radiologyinfo.org)
  • This nuclear medicine exam uses a small amount of radioactive material (called a radiotracer) and a special camera to create pictures that show how blood and air are flowing throughout the lungs. (radiologyinfo.org)
  • Treatment for a pulmonary embolism typically includes keeping blood clots from getting bigger, preventing clots from traveling to the lungs and preventing new clots from forming. (radiologyinfo.org)
  • The filter traps and prevents large blood clots or clot fragments from the lower half of the body from traveling to the heart and lungs. (radiologyinfo.org)
  • Deep vein thrombosis carries a risk of a blood clot traveling from the leg to the lungs and blocking a vital artery. (mayoclinic.org)
  • In patients who have deep vein thrombosis (blood clots in the veins of the legs or pelvis), the clots can break up and large pieces could travel to the heart or lungs. (baycare.org)
  • The device traps blood clots and stops them from moving into the lungs. (baycare.org)
  • A pulmonary embolism is potentially fatal as a blood clot in the legs moves to the lungs and gets embedded in a blood vessel. (baycare.org)
  • This clot can stop blood flowing into the lungs. (baycare.org)
  • pulmonary embolism - a clot that breaks free from a vein wall, travels to the lungs and blocks some or all blood supply. (health.gov.au)
  • Increased risk of blood clots in the legs (deep vein thrombosis) and lungs (pulmonary embolism) have been reported with raloxifene hydrochloride. (nih.gov)
  • Women who have or have had blood clots in the legs, lungs, or eyes should not take raloxifene hydrochloride. (nih.gov)
  • Before starting raloxifene hydrochloride, tell your doctor if you have had blood clots in your legs, lungs, or eyes, a stroke, mini-stroke (transient ischemic attack), or have an irregular heartbeat. (nih.gov)
  • have or have had blood clots in your legs, lungs, or eyes. (nih.gov)
  • have had blood clots in your legs, lungs, or eyes, a stroke, mini-stroke (TIA/transient ischemic attack), or a type of irregular heartbeat (atrial fibrillation). (nih.gov)
  • Research shows older adults who get infections of any kind - such as urinary, skin, or respiratory tract infections - are nearly three times more likely to be hospitalized for a dangerous blood clot in their deep veins or lungs, University of Michigan Health System research shows. (news-medical.net)
  • Sometimes they travel to an artery in the lungs and block blood flow. (medlineplus.gov)
  • Researchers with the University of Pennsylvania published findings earlier this month in the Annals of Internal Medicine , indicating that the risks of recurrent venous thromboembolism and bleeding events were higher with Xarelto than with Eliquis. (aboutlawsuits.com)
  • Doctors also refer to pulmonary embolism and deep vein thrombosis as venous thromboembolism (VTE) . (healthline.com)
  • A diagnosis of cancer can leave you and your loved ones feeling uncertain, anxious and overwhelmed, especially if you are at risk of venous thromboembolism (VTE). (cancercare.org)
  • Venous thromboembolism (VTE) refers to a blood clot in a vein. (cancercare.org)
  • The study, aimed at quantifying NuvaRing blood clot risk, indicated no significant difference in risk of venous thromboembolism when compared to oral contraceptives. (lawyersandsettlements.com)
  • Her quest to learn more about venous thromboembolism (VTE) lead her to the National Blood Clot Alliance Despite living in New York City, Leslie was shocked by the lack of information available to her after her PE. (stoptheclot.org)
  • Venous thromboembolism (VT) is a blood clot that starts in a vein. (health.gov.au)
  • The COBRRA trial is the comparison of bleeding risk between rivaroxaban and apixaban for the treatment of acute venous thromboembolism. (health.gov.au)
  • RARITAN, N.J., July 8, 2019 - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new results from the Phase 3 EINSTEIN-Jr study, showing pediatric patients (aged birth to 17 years) treated with XARELTO ® (rivaroxaban) had a similar low risk of recurrent venous thromboembolism (VTE) - or blood clots - and similar rates of bleeding when compared to current standard anticoagulation therapy. (jnj.com)
  • Some people who have sickle cell disease are at greater risk for developing abnormal blood clots (venous thromboembolism). (nih.gov)
  • This study will look at the blood of people who have sickle cell disease and venous thromboembolism, as well as healthy volunteers, to help researchers develop better treatments to prevent blood clots. (nih.gov)
  • This session of Grand Rounds explores Venous Thromboembolism (VTE), which consists of 2 related conditions caused by blood clots: Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). (cdc.gov)
  • Family history of venous thromboembolism (VTE) and risk of recurrent hospitalization for VTE: a nationwide family study in Sweden. (cdc.gov)
  • ABSTRACT To assess the risk of venous thromboembolism (VTE) associated with hyperhomocystein- aemia (hyper-Hcy) and hyperlipidaemia, we performed a case-control study. (who.int)
  • A pulmonary embolism (PE) is a sudden blockage in a lung artery. (weitzlux.com)
  • The cause of a pulmonary embolism "is usually a blood clot in the leg called a deep vein thrombosis that breaks loose and travels through the bloodstream to the lung. (weitzlux.com)
  • Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries. (aboutlawsuits.com)
  • While a lung transplant can be a life-saving surgery, this invasive procedure has a number of risks, including organ rejection. (healthline.com)
  • What are the risks of a lung transplant for COPD? (healthline.com)
  • You may be placed on a cardiopulmonary bypass machine (heart-lung machine) if your COPD prevents healthy blood flow to your other organs. (healthline.com)
  • Dec. 21, 2021 Pulmonary embolisms are dangerous, lung-clogging blot clots. (sciencedaily.com)
  • A pulmonary embolism (PE) is a blood clot that breaks off from a deep vein and travels to a lung artery, where it blocks blood flow. (healthline.com)
  • Pulmonary embolism (PE) is a blood clot in the lung, which can be life-threatening. (cancercare.org)
  • The most prevalent among them is pulmonary embolism (PE) , a blockage in the artery of the lung. (fronzutolaw.com)
  • Pulmonary embolisms are typically caused by a blood clot that travels to the lung from a large vein in the leg, a condition called deep vein thrombosis (DVT) . (fronzutolaw.com)
  • Blood clot in the lung ( pulmonary embolism ). (clevelandclinic.org)
  • The results of the Clarification of Optimal Anticoagulation through Genetics (COAG) trial, supported by the NIH's National Heart, Lung, and Blood Institute, were presented today at the American Heart Association (AHA) Scientific Sessions in Dallas. (nih.gov)
  • In David's case, the clot blocked an artery in his lung, proving fatal. (today.com)
  • Your doctor can confirm the presence of a pulmonary embolism with CT angiography, or a ventilation perfusion (V/Q) lung scan. (radiologyinfo.org)
  • The severity of symptoms depends on the size of the embolism, number of emboli, and a person's baseline heart and lung function. (radiologyinfo.org)
  • Blood clots in leg veins and lung arteries are a significant public health problem. (health.gov.au)
  • A novel oral anti-coagulant outperformed the injected standard therapy on important safety measures for initial and long-term treatment of pulmonary embolism - a blockage of lung blood vessels usually caused by a clot - and showed comparable efficacy, according to data from the EINSTEIN-PE trial presented today at the American College of Cardiology's 61st Annual Scientific Session. (news-medical.net)
  • The NHLBI leads or sponsors studies for patients who have heart, lung, blood, or sleep related diseases or disorders. (nih.gov)
  • This could be a blood clot in the leg (called deep vein thrombosis) or a clot that can break off and travel to the lung (called a pulmonary embolism). (nih.gov)
  • Shortness of breath is a symptom of a pulmonary embolism, PE or blood clot in the lung. (stoptheclot.org)
  • sudden blockage of an artery of the lung, usually by a blood clot) is a less common, but serious cause. (msdmanuals.com)
  • This may result in increased clot formation, particularly in the deep veins of legs and arms in a condition known as deep vein thrombosis (DVT). (drugdangers.com)
  • Arteries carry blood away from the heart while veins carry blood into the heart. (mountsinai.org)
  • Deep vein thrombosis occurs when a blood clot forms in the large veins of the arm or leg. (news-medical.net)
  • Veins are blood vessels that have valves to make sure the blood flows against the direction of gravity. (news-medical.net)
  • Usually, the clot formation starts around the valves in these veins. (news-medical.net)
  • Pregnancy brings more than morning sickness and fatigue - it also brings a risk of deep vein thrombosis (DVT) , a preventable condition in which blood clots form in the veins. (everydayhealth.com)
  • Your body has two types of blood vessels: arteries carry oxygen- and nutrient-rich red blood from your heart to your muscles and organs, while veins return the 'used' bluish blood back to your heart. (healthywomen.org)
  • The deep veins located beneath the muscles carry about 90 percent of the blood traveling from your legs back to your chest. (healthywomen.org)
  • While your leg muscles help your veins pump the blood upward, the real workhorse is an intricate system of one-way valves that prevent the blood from draining back down the leg under the force of gravity. (healthywomen.org)
  • And in some cases, varicose veins can signal a higher risk for other conditions involving the circulatory system. (healthywomen.org)
  • Spider veins, also referred to as telangiectasia or broken capillaries, are formed by the dilation of a small group of blood vessels located close to the surface of the skin and are most commonly found on the legs and face. (healthywomen.org)
  • In addition to hormonal changes, pregnancy causes both an increased volume of blood and increased pressure from the abdomen, which in turn causes veins to enlarge. (healthywomen.org)
  • DVT occurs when blood flow in your veins slows down. (today.com)
  • In a condition called deep vein thrombosis , clots form in the deep veins of the body, usually in the legs. (radiologyinfo.org)
  • Doppler ultrasound is a special technique that allows the doctor to see and evaluate blood flow through arteries and veins throughout your body. (radiologyinfo.org)
  • The scarring forces blood through healthier veins. (mayoclinic.org)
  • Typically, veins return blood from the rest of the body to the heart. (mayoclinic.org)
  • To return blood to the heart, the veins in the legs must work against gravity. (mayoclinic.org)
  • The weakened valves let blood pool in the veins instead of traveling to the heart. (mayoclinic.org)
  • When blood pools in the veins, the veins become larger, making them show under the skin. (mayoclinic.org)
  • The provider examines your veins and checks for blood vessel disease. (mayoclinic.org)
  • Blood clots most often happen in the veins, instead of the arteries, because blood travels slower than in the arteries. (medlineplus.gov)
  • This is because blood pressure in our veins is lower in the areas of the body that are farther away from the heart. (medlineplus.gov)
  • So, our leg veins are more susceptible to situations where blood flow can be interrupted. (medlineplus.gov)
  • The FDA is requiring new label warnings to alert patients and doctors to the risk of Ozempic intestinal blockage side effects. (aboutlawsuits.com)
  • The blockage starves tissues of blood and oxygen. (medlineplus.gov)
  • Blood clots can become lodged in other arteries, creating a partial or complete blockage. (fronzutolaw.com)
  • a clot that develops quickly and causes a lot of blood flow blockage and inflammation typically hurts more than one that develops slowly with minimal blood vessel obstruction or a clot that causes obstruction gradually, leaving time for collateral circulation to develop. (medscape.com)
  • This process may be triggered by an injury or it can sometimes occur inside blood vessels that don't have an obvious injury," according to the Mayo Clinic . (weitzlux.com)
  • A common source for an embolus is from areas of hardening (atherosclerosis causing plaque) in the aorta and other large blood vessels. (medlineplus.gov)
  • The vessels colored blue indicate the transport of blood with relatively low content of oxygen and high content of carbon dioxide. (mountsinai.org)
  • Narrow blood vessels. (clevelandclinic.org)
  • Angiography or heart catheterization to examine the heart's blood vessels. (clevelandclinic.org)
  • Vasodilators , medications that open narrowed blood vessels. (clevelandclinic.org)
  • More common in Asia and the Middle East, Behçet's is a type of autoimmune disease that causes inflammation in the blood vessels. (medicalert.org)
  • Coagulation is a normal process and necessary to stop bleeding and retain blood within the body's vessels if they are cut or injured. (radiologyinfo.org)
  • However, in some situations blood can abnormally clot (called a thrombosis) within the vessels of the body. (radiologyinfo.org)
  • A number of tiny red blood vessels. (mayoclinic.org)
  • In some cases, the tumor may be inoperable or impossible to remove without sacrificing important nerves, blood vessels or muscles. (froedtert.com)
  • A device called a transducer is positioned over the skin and sends images of blood vessels to monitor. (baycare.org)
  • According to the National Blood Clot Alliance (NBCA), 274 people die from blood clots on a daily average. (kevinmd.com)
  • The National Blood Clot Alliance (NBCA) holds the rights to all content that appears on its website. (stoptheclot.org)
  • I urge you to know the risks for blood clots, and the signs and symptoms of blood clots, so that you don't have to go through the same thing that I have been through. (stoptheclot.org)
  • According to the findings of a new study, patients who take the blood thinner Xarelto are more likely to suffer recurring and dangerous blood clots than those who take the competing drug Eliquis, both of which are part of a new generation of anticoagulants prescribed to reduce the risk of strokes due to atrial fibrillation. (aboutlawsuits.com)
  • Now that we know the molecular mechanism that helps to prevent pulmonary embolism, we can make sure that this mechanism remains fully functional when we try to treat the clots with new anticoagulants or new clot-busting drugs called thrombolytics. (news-medical.net)
  • Typically, when a patient is diagnosed with DVT or blood clots, physicians prescribe anticoagulants (blood thinners), which stop blood clots from growing and prevent future blood clots from developing. (fronzutolaw.com)
  • The trial, ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation), compared the effectiveness of two anticoagulants--apixaban and warfarin--on reducing the risk of stroke or systemic embolism in these patients. (eurekalert.org)
  • a combination of deep vein thrombosis and pulmonary embolism. (aboutlawsuits.com)
  • In May 2022, the Food and Drug Administration (FDA) limited the authorized use of the Johnson & Johnson (J&J) COVID-19 vaccine due to reports of a blood-clotting disorder called thrombosis with thrombocytopenia syndrome (TTS). (healthline.com)
  • Deep vein thrombosis (DVT) is a blood clot in a major vein that leads to the heart. (cancercare.org)
  • What role does deep vein thrombosis play in blood clot formation? (news-medical.net)
  • The majority of pulmonary embolisms begin with a blood clot in one of the large arteries in the legs, known as deep vein thrombosis (DVT). (fronzutolaw.com)
  • Pregnant women have a five times higher risk of deep vein thrombosis than women who aren't pregnant, according to the Centers for Disease Control and Prevention (CDC) . (everydayhealth.com)
  • Why is there an increased risk of deep vein thrombosis when a woman is expecting? (everydayhealth.com)
  • Roshan says that women with genetic clotting disorders, called thrombophilias, are at an even higher risk for deep vein thrombosis in pregnancy. (everydayhealth.com)
  • Warfarin is the most commonly prescribed drug to prevent blood clots in conditions such as atrial fibrillation, deep vein thrombosis, or pulmonary embolism. (nih.gov)
  • Airplane travel, especially flights longer than 4 hours, may increase your risk for blood clots, including deep vein thrombosis and pulmonary embolism. (cdc.gov)
  • ST also increases a patient's risk for deep vein thrombosis (DVT), a potentially serious condition that involves a blood clot in a deep vein. (healthywomen.org)
  • Being aware of deep vein thrombosis and how being restricted and sedentary can lead to blood clots can help people avoid their deadly complications. (today.com)
  • At the time, I was vaguely familiar with blood clots, but I had never heard of deep vein thrombosis or pulmonary embolisms. (today.com)
  • I learned that when a blood clot forms in the legs, it's called deep vein thrombosis. (today.com)
  • They are the mainstay of treatment for pulmonary embolism and deep vein thrombosis. (radiologyinfo.org)
  • Rarely, a blood clot can travel to a deeper vein in the leg, a condition known as deep vein thrombosis. (mayoclinic.org)
  • Pain in arms or legs can be a sign of a deep vein thrombosis , DVT or blood clots in the arms or legs. (stoptheclot.org)
  • For patient education information, see DVT (Blood Clot in the Leg, Deep Vein Thrombosis) . (medscape.com)
  • Title : A systematic review and meta‐analysis of venous thrombosis risk among users of combined oral contraception Personal Author(s) : Dragoman, Monica V.;Tepper, Naomi K.;Fu, Rongwei;Curtis, Kathryn M.;Chou, Roger;Gaffield, Mary E. (cdc.gov)
  • The use of estrogen-containing medications, such as oral contraceptives, increases the risk of thrombosis in women and female adolescents. (medscape.com)
  • Some advocate a search for occult malignancy in adults who develop thrombosis with few risk factors ("unprovoked thrombosis"), but this is not necessary in children since thrombosis is very rarely the first sign of cancer. (medscape.com)
  • [ 20 ] However, swelling and pain in an upper extremity may suggest thrombosis if a central venous catheter or other localized risk factors are present. (medscape.com)
  • Increased risk for venous thrombosis was found among those under 50 having both lipid abnormalities. (who.int)
  • According to the complaint, Alberta Horne, Eric Horne's wife, died due to blood clots in her pulmonary arteries in 2009. (aboutlawsuits.com)
  • However, blood clots in the arteries can also happen. (medlineplus.gov)
  • Whether you have had an inpatient or outpatient procedure, your health care provider should be on the lookout for potentially serious blood clots. (weitzlux.com)
  • Experts warn that those with a higher risk of serious blood clots who opt for the window seat on flights longer than four hours are potentially putting themselves in danger. (news-medical.net)
  • Usually, "blood clots start as a response to injury of a blood vessel. (weitzlux.com)
  • Even a slight injury to a blood vessel can activate your body's response. (weitzlux.com)
  • When an injury occurs to a blood vessel, the blood stays right there initially. (weitzlux.com)
  • They plug up the cut or hole in the blood vessel. (weitzlux.com)
  • A combination of factors can contribute to clot formation, including prolonged immobility, endothelial cell (cells that line the blood vessel) dysfunction, and a procoagulant state (heightened blood clotting activity) due to genetic or environmental factors. (news-medical.net)
  • Obesity in childhood sets the scene for heart and blood vessel disease in adulthood. (mydr.com.au)
  • A blood clot that breaks free and travels through a blood vessel is called an embolism . (radiologyinfo.org)
  • Under normal conditions, a thrombus is confined to the immediate area of injury and does not obstruct flow to critical areas, unless the blood vessel lumen is already diminished, as it is in atherosclerosis . (medscape.com)
  • Most deep vein blood clots happen in the lower leg or thigh. (medlineplus.gov)
  • A year later, my sister's life-long friend would suffer a PE after having abrupt shortness of breath, in which the doctors had placed her on life-long blood thinners for at that time. (kevinmd.com)
  • For pregnant women with a prior history of DVT or blood clots during pregnancy or with a genetic thrombophilia, doctors usually prescribe blood thinners in the lower preventive dose. (everydayhealth.com)
  • We usually monitor women taking blood thinners throughout their pregnancies because as the pregnancy progresses, they sometimes need higher doses," Roshan said. (everydayhealth.com)
  • This procedure is used in patients who don't respond to or cannot be given blood thinners. (radiologyinfo.org)
  • Aspirin, ibuprofen, naproxen sodium or blood thinners can increase the risk of bleeding. (mayoclinic.org)
  • If you are taking warfarin or other coumarin blood thinners, your doctor may need to do a blood test when you first start or if you need to stop taking raloxifene hydrochloride. (nih.gov)
  • Can the COVID-19 Vaccine Cause Pulmonary Embolism? (healthline.com)
  • Sheep acquire strong resist- most frequent location of the cyst is and can cause pulmonary embolism, ance against new cysts developing but the myocardial region, particularly pulmonary hypertension and death. (who.int)
  • Most often, pulmonary embolism is treated in a hospital or emergency room with thrombolytics (medicines that rapidly dissolve blood clots), a catheter to remove the blood clot or deliver on-site medicine to dissolve it, or emergency surgery to remove the blood clot. (fronzutolaw.com)
  • Rarely, drugs are used to dissolve the clot or a catheter-based procedure is done to remove or treat the clot directly. (radiologyinfo.org)
  • The history of thrombolytic therapy began in 1933, when it was discovered that filtrates of broth cultures of certain streptococcal strains (beta-hemolytic streptococci) could dissolve a fibrin clot. (medscape.com)
  • Other studies have shown that COPD is an independent risk factor for cardiovascular disease, but what hadn't been studied was whether COPD was an independent risk factor for stroke, specifically among patients with atrial fibrillation," said Michael Durheim, MD, a pulmonary and critical care fellow at Duke. (eurekalert.org)
  • Atrial fibrillation is itself a known risk factor for stroke and systemic embolism because clots more easily form when blood is pumped irregularly by the heart. (eurekalert.org)
  • The risk of stroke or mortality associated with COPD among patients with atrial fibrillation is not well understood. (eurekalert.org)
  • The objective of this study was to determine the risk of stroke or systemic embolism, all-cause mortality, and cardiovascular mortality associated with COPD among patients with atrial fibrillation and examine whether the effect of apixaban varies by presence of COPD. (eurekalert.org)
  • We analyzed patients from ARISTOTLE, a randomized trial of 18,206 patients with atrial fibrillation comparing the effects of apixaban and warfarin on risk of stroke or systemic embolism and bleeding events. (eurekalert.org)
  • Following his death, we learned that David had factor V Leiden, a hereditary gene mutation can increase your chance of developing abnormal blood clots. (today.com)
  • Obese people often have abnormal levels of cholesterol and other blood fats. (mydr.com.au)
  • Though it is 99 percent effective at preventing pregnancy, it may cause serious side effects including blood clots, stroke and heart attack which may be life-threatening. (drugdangers.com)
  • Severe NuvaRing side effects include blood clots, stroke, and heart attack. (drugdangers.com)
  • The clot can then move to an artery and block blood flow to the brain (stroke) or other organs. (medlineplus.gov)
  • If a blood clot becomes lodged in the brain, it can cause a stroke , while a blood clot that blocks an artery in the heart can cause a heart attack . (fronzutolaw.com)
  • Bloomberg reported Bayer AG settled about 500 Yasmin lawsuits over claims of blood clots that had, in some cases, led to stroke or heart attack. (lawyersandsettlements.com)
  • However, COPD is not by itself associated with increased likelihood of having a stroke or a systemic embolism, according to a new research study. (eurekalert.org)
  • They were also more likely to suffer from other diseases that would put them at higher risk for stroke, including coronary artery disease, a prior heart attack and heart failure. (eurekalert.org)
  • After adjusting for these and other patient characteristics, COPD was not associated with increased risk of stroke or systemic embolism (adjusted HR 0.86 [95% CI 0.61, 1.21], p = 0.382). (eurekalert.org)
  • Meanwhile, he notes one practical outcome of his study: the effect of apixaban compared with warfarin on stroke or systemic embolism did not differ between subjects with and without COPD (HR 0.92 vs 0.78, interaction p = 0.617). (eurekalert.org)
  • The association between COPD (as identified in the medical record) and risk of stroke or systemic embolism and mortality, adjusting for treatment allocation, smoking history and other risk factors, was assessed using Cox proportional hazards regression. (eurekalert.org)
  • Blood clots may then form, blocking the supply of blood to the brain and causing a stroke. (mydr.com.au)
  • Obesity is also associated with high blood pressure, another factor that increases the risk of stroke. (mydr.com.au)
  • High blood pressure may not cause any symptoms itself, but it increases the risk of heart attack and stroke. (mydr.com.au)
  • It's best to get down to a body mass index (BMI) of less than 25, but losing even approximately 5 kg can reduce your blood pressure enough to lower the risk of dying from stroke or heart disease. (mydr.com.au)
  • Women who have had a heart attack or are at risk for a heart attack may have an increased risk of dying from stroke when taking raloxifene hydrochloride. (nih.gov)
  • Plavix , which is prescribed for patients at higher risk for heart attack or stroke, is an anti-platelet drug that works by helping to prevent blood from forming clots. (lawyersandsettlements.com)
  • Chronic heart conditions, cancer, stroke, and paralysis (not being able to move) can also increase your chances of getting a clot. (medlineplus.gov)
  • Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster. (cdc.gov)
  • Having a cesarean delivery ( C-section ) nearly doubles a pregnant woman's risk of a dangerous blood clot, the CDC reports. (everydayhealth.com)
  • We treat the clot with a therapeutic dose for a few months and then lower it to a prophylactic (preventive) dose," he said. (everydayhealth.com)
  • Blood can change from a free flowing fluid to a semi-solid gel (called a blood clot or thrombus) in a process known as coagulation . (radiologyinfo.org)
  • During thrombus formation, circulating prothrombin is activated to the active clotting factor, thrombin, by activated platelets. (medscape.com)
  • an embolus is a blood clot that develops in one part of the body and travels to another part of the body through the bloodstream. (fronzutolaw.com)
  • The reason expectant women should be mindful of the link between pregnancy and DVT is that an untreated clot has the potential to break free and travel through the bloodstream. (everydayhealth.com)
  • Some blood clots can break off and travel through the bloodstream. (medlineplus.gov)
  • People with cancer are more likely to develop blood clots, compared with the general population. (cancercare.org)
  • It's important to know that people who have been diagnosed with cancer can be at risk for VTE after successful treatment, even years after treatment has ended. (cancercare.org)
  • After menopause, obese women are at a higher risk of developing breast cancer than women with a body mass index (BMI) in the healthy range. (mydr.com.au)
  • Weight gain after menopause seems to be especially important when it comes to increasing breast cancer risk. (mydr.com.au)
  • Obesity is also a risk factor for breast cancer in men. (mydr.com.au)
  • Obesity is strongly linked to cancer of the oesophagus - the higher your body mass index (BMI), the greater your risk. (mydr.com.au)
  • Groups at higher risk of VT are older people, people who have cancer, and people who are immobilised (for example, hospitalised). (health.gov.au)
  • If you have osteoporosis or are at high risk for breast cancer, raloxifene hydrochloride can be used to lower your chance of getting invasive breast cancer. (nih.gov)
  • You and your doctor should talk about whether the possible benefit of raloxifene hydrochloride in lowering your chance of getting invasive breast cancer is greater than its possible risks. (nih.gov)
  • More serious effects include blood clot risk, and worsening of preexisting conditions like sleep apnea and prostate cancer. (forthepeople.com)
  • The use of an injectable, clot-preventing drug known as Low Molecular Weight Heparin to treat patients with advanced cancer complicated by blood clots increased steadily between 2000 and 2007, according to a new study published in The Oncologist, funded by the National Cancer Institute and led by Kaiser Permanente Colorado. (news-medical.net)
  • Cancer is a risk factor for getting a blood clot. (stoptheclot.org)
  • Read more about cancer and blood clots . (stoptheclot.org)
  • Current surgically placed RVADs offer potential for rapid recovery, but are highly invasive and are associated with a host of complications including blood clots and bleeding. (inknowvation.com)
  • Significant racial disparities exist in heart-related complications, including blood clots, among pregnant and postpartum women in the United States. (everydayhealth.com)
  • The health risks associated with getting COVID-19 far outweigh the risk of getting TTS from a vaccine. (healthline.com)
  • There's a generous amount of research studies that show patients who suffer from Cushing's has an increase in certain clotting factors, which in turn increases their risk of developing blood clots. (kevinmd.com)
  • Acute right heart failure is a significant clinical problem which often occurs in patients affected by pulmonary embolism, pulmonary hypertension, or heart attack, as well as in patients who have been treated with cardiopulmonary bypass, heart transplantation, or left heart mechanical circulatory support. (inknowvation.com)
  • If we can reduce pulmonary embolism, this may also greatly help patients with COVID-19. (news-medical.net)
  • It is estimated that between 60,000 and 100,000 of these patients die from pulmonary embolisms. (fronzutolaw.com)
  • Approximately half of patients who have a pulmonary embolism have no symptoms. (radiologyinfo.org)
  • However, because they increase the risk of bleeding, some patients cannot use them. (radiologyinfo.org)
  • Low number of red blood cells (anemia): A reduction in the number of red blood cells can result in anemia, which can make patients feel extremely tired and experience shortness of breath. (lls.org)
  • Note: nonsteroidal drugs such as ibuprofen should be avoided in patients with myeloma, given the increased risk of kidney failure. (lls.org)
  • For example, it may be used for patients who have very recent or acute kidney failure due to high levels of antibody proteins in the blood. (lls.org)
  • This trial examined for the first time whether a direct oral anticoagulant could alleviate the burden of blood clots in young patients, which would allow them to focus on recovering from their other health challenges," said Christoph Male, M.D., Department of Pediatrics, Medical University of Vienna, Vienna, Austria. (jnj.com)
  • The efficacy of XARELTO ® was further demonstrated by reduction in clot burden on imaging tests that were conducted on patients both at baseline and at the end of the treatment period. (jnj.com)
  • Without clearly spelling out the risks, drug manufacturers are leaving patients in the dark about possible risks and putting drug users' safety on the line. (forthepeople.com)
  • Prescribers have a duty to warn patients about these risks so they can conduct a proper cost benefit analysis. (forthepeople.com)
  • Bleeding and clotting disorders affect a large number of patients annually and, while accurate diagnosis is important, timely and effective treatment for these disorders is key, as they have the potential to quickly become life-threatening. (news-medical.net)
  • Many VTEs can be prevented if hospitals educate providers and patients, systematically assess risks for clotting and bleeding, and prescribe risk-appropriate prevention strategies. (cdc.gov)
  • Introduction: Pulmonary embolism is one of the complications of COVID-19, with reported incidence ranging from 3 to 33 % in non-ICU patients to as high as 40% among ICU patients. (who.int)
  • This study aimed to assess the incidence of pulmonary embolism and associated factors among confirmed Covid-19 Patients in Ethi- opia. (who.int)
  • Methods: A nested case control study was conducted among 131 patients with COVID-19 (40 COVID-19 patients with Pulmonary embolism and 91 COVID-19 patients with no PE) who were on follow up from May, 2021 to May, 2022. (who.int)
  • bed into the left ventricle, from where or intramyocardial, However, when a Most patients with calcification of it could reach any part of the body cyst is located in subendocardial en- the cyst wall remain asymptomatic for through systemic circulation [1-3]. (who.int)
  • (1) If you or a loved one suffered serious injury or death because your health care provider failed to prevent a blood clot or pulmonary embolism, you may need to sue for compensation. (weitzlux.com)
  • Clotting is a necessary process that can prevent you from losing too much blood in certain instances, such as when you're injured or cut. (weitzlux.com)
  • If you suffered because a doctor failed to prevent a blood clot or pulmonary embolism, you may be eligible for compensation. (weitzlux.com)
  • They should know how to prevent clots and PEs from occurring. (weitzlux.com)
  • The cause of the clot, if found, should be treated to prevent further problems. (medlineplus.gov)
  • The NBCA states the most important thing a person can do to prevent a clot is to learn if they are at risk. (kevinmd.com)
  • bleeding complications are commonly a consequence of "blood-thinning" medication needed to prevent clots (anticoagulation). (wikipedia.org)
  • They are used to draw heparin, a blood thinning medicine used to prevent blood clots. (fda.gov)
  • Ask your doctor about whether you are at risk for VTE, what can be done to prevent it, and how to recognize symptoms. (cancercare.org)
  • We are now in a unique position to develop new drugs that prevent clots or break them down that can replace currently used drugs, which are not always effective and can cause a heightened risk of bleeding. (news-medical.net)
  • Due to the potentially life-threatening nature of pulmonary embolism, doctors and medical professionals must recognize risk factors and signs of DVT/PE and take immediate action to prevent complications. (fronzutolaw.com)
  • When the signs of pulmonary embolism are detected and PE is diagnosed, medical professionals must take appropriate measures to prevent severe complications. (fronzutolaw.com)
  • Combining genetic data with clinical information to determine the initial dosage of the blood thinner warfarin, used to prevent blood clots in the circulatory system, was no more effective in achieving stable anticoagulation than using only clinical information, according to a National Institutes of Health-funded clinical trial. (nih.gov)
  • Learn how to prevent blood clots during travel. (cdc.gov)
  • Now we know they have to live a lifestyle that will prevent their blood from becoming sluggish and more prone to clotting, including being active, maintaining a healthy weight, not smoking and staying hydrated. (today.com)
  • These drugs prevent clots from enlarging and new clots from forming. (radiologyinfo.org)
  • As Board President, Leslie is committed to raising public awareness so no person affected by blood clots is without the necessary information they need to prevent or successfully treat VTE, and that they also have the information they need to navigate the spectrum of lifestyle issues that can follow a blood clot diagnosis. (stoptheclot.org)
  • A protective clot begins to form from two substances: platelets and fibrin. (weitzlux.com)
  • Platelets are a type of blood cell. (weitzlux.com)
  • Those antibodies activate platelets, which help your blood clot. (healthline.com)
  • Bone marrow is constantly producing red blood cells, white blood cells and platelets. (lls.org)
  • Interestingly, the article says that the CDC cites the fact that the girl happened to be taking birth control pills, which increases the risk of blood clots, as the reason for her death. (naturalnews.com)
  • Women on birth control pills that contain estrogen are at a similar increased risk of DVT. (everydayhealth.com)
  • Percent by which FDA study found NuvaRing raised risk of blood clots vs. older birth control pills. (lawyersandsettlements.com)
  • While birth control pills are convenient and indeed effective at preventing unwanted pregnancies - studies claim they work more than 99 percent of the time when taken correctly, and less than one out of 100 women will get pregnant each year if they always take the pill each day as directed - many feel that as far as their mental and physical health go, the risks of birth control outweigh the benefits. (draxe.com)
  • 3 ) While the majority of women choose to take birth control pills so they don't risk becoming pregnant accidentally, a small percentage also take them for other reasons, including to regulate or temporarily stop their menstrual cycles or reduce symptoms associated with PMS and/or hormonal imbalances (such as acne, heavy bleeding during menstruation or painful cramps). (draxe.com)
  • There's a lot of estrogen circulating during pregnancy, and estrogen increases the risk of blood clots," Dr. Roshan says. (everydayhealth.com)
  • Low oxygen levels in your blood - This condition is called hypoxemia. (weitzlux.com)
  • If pulmonary embolism does not lead to death, it can cause permanent disability, organ damage, pulmonary hypertension, and low levels of oxygen in the blood. (fronzutolaw.com)
  • When it occurs, your heart is still working, but it cannot deliver oxygen-rich blood throughout your body. (clevelandclinic.org)
  • Emergency treatment for acute heart failure restores blood flow and oxygen levels. (clevelandclinic.org)
  • They took Jon in for his surgery, but they never proceeded past sedating him, because of his low blood pressure and low oxygen level. (stoptheclot.org)
  • The respiratory center in the brain speeds up breathing when blood levels of oxygen are low or blood levels of carbon dioxide are high. (msdmanuals.com)
  • The use of affected syringes may cause serious adverse health consequences, including blood stream infection (sepsis), or blood loss due to leakage. (fda.gov)
  • So in our new study , we sought to learn more about heart disease and diabetes risk for one year after COVID infection. (yahoo.com)
  • The risk remained elevated by 27% between four and 12 weeks after infection, and returned to baseline after 23 weeks. (yahoo.com)
  • We actually observed that the risk of heart disease fell below baseline levels during the year after COVID infection. (yahoo.com)
  • COVID infection could also reduce physical activity, another factor we know can affect blood sugar levels. (yahoo.com)
  • View the free LLS fact sheet Side-Effect Management: Reducing Your Risk of Infection . (lls.org)
  • risk of infection. (medscape.com)
  • All respondents understood that the goal of the questionnaire was to screen out those with blood that could transmit infection. (cdc.gov)
  • nearly all questions in the questionnaire, as respondents viewed each question as asking whether their blood could transmit infection. (cdc.gov)
  • sudden chest pain, shortness of breath, or coughing up blood. (nih.gov)
  • Plaintiffs alleged that the birth control device caused serious injuries including blood clots, heart attacks, strokes and included several deaths. (drugdangers.com)
  • Paradoxical embolization can take place when a clot in a vein enters the right side of the heart and passes through a hole into the left side of the heart. (medlineplus.gov)
  • 50mm and risk factors and connective tissue disease The goal of the operation is the improvement of life expectancy and treatment of heart failure as the consequence of dysfunction of the aortic valve. (wikipedia.org)
  • To help diagnose heart arrhythmia, health care professionals may use tests such as long-term ECG recording, exercise testing, heart rate variability, electrophysiological studies, echocardiography, Doppler ultrasound and blood tests. (mountsinai.org)
  • With acute heart failure, you experience a sudden, rapid decline in heart functioning and the amount of blood your heart can pump to the rest of your body. (clevelandclinic.org)
  • Echocardiogram to show heart movement and blood flow. (clevelandclinic.org)
  • BNP (biomarker) blood test to check for hormones that occur when pressures change inside the heart. (clevelandclinic.org)
  • The risk of being diagnosed with heart disease and diabetes was most elevated in the first four weeks after contracting the virus. (yahoo.com)
  • Regarding heart disease risk, similarly, there are probably a variety of factors at play. (yahoo.com)
  • The differences we observed in the timing of heart disease and diabetes risk are perhaps unsurprising given what we know about how these conditions typically present. (yahoo.com)
  • Heart conditions are associated with incidents (such as a heart attack) that may lead to more immediate diagnosis, whereas diabetes can take time to diagnose, possibly contributing to the more delayed decline in risk. (yahoo.com)
  • ATS 2015, DENVER -- Chronic obstructive pulmonary disease, or COPD, is associated with increased risk of dying from a cardiovascular disease such as heart failure or a heart attack, as well as diseases not associated with the heart. (eurekalert.org)
  • Recent illnesses or medical conditions, such as a heart condition or a history of blood clots. (mayoclinic.org)
  • The inferior vena cava (IVC) is the large vein in the abdomen that returns blood to the heart from the lower body. (baycare.org)
  • Studies have linked testosterone therapy to increased cardiovascular risk including heart attacks and pulmonary embolism. (forthepeople.com)
  • Low blood pressure can result from heart failure, and a PE can cause right ventricular hypertrophy (RVH) which would have shown up on a chest x-ray. (stoptheclot.org)
  • A fast heart rate can also be a symptom of a PE blood ct. (stoptheclot.org)
  • Pulmonary embolisms can lead to severe medical complications. (weitzlux.com)
  • However, both drugs have been linked to risks of severe and uncontrollable bleeding events, especially before reversal agents were introduced in 2018. (aboutlawsuits.com)
  • If you or your family member are at high risk for severe illness, wear a mask or respirator with greater protection in public indoor spaces if you are in an area with a high COVID-19 hospital admission level . (cdc.gov)
  • Healthcare professionals should see Underlying Medical Conditions Associated with Higher Risk for Severe COVID-19 for more detailed information. (cdc.gov)
  • The list below does not include all possible conditions that put you at higher risk of severe illness from COVID-19. (cdc.gov)
  • A person's risk of severe illness from COVID-19 increases as the number of underlying medical conditions they have increases. (cdc.gov)
  • Some of the risk factors noted by the NBCA are hospitalizations, major surgery, injury to a vein from a broken bone, obesity, family history, and severe trauma. (kevinmd.com)
  • As stated above, my sister had several risk factors: a broken bone of her lower extremity, inability to ambulate without crutches and severe pain, which caused a big decrease in her overall mobility, BMI of 30, and not mentioned above or by the NBCA was a known history of Cushing's Disease. (kevinmd.com)
  • In addition to severe respiratory illness and other issues, blood clots are a potential side effect of the virus itself. (healthline.com)
  • VT carries a high risk of severe health effects or death. (health.gov.au)
  • Long hospital stays, surgeries and trauma may significantly increase your risk of blood clots. (weitzlux.com)
  • NuvaRing may increase the risk of blood clot formation as hormones released by the device may alter the natural blood clotting chemicals. (drugdangers.com)
  • Risk factors are those occurrences that increase our chance of developing a particular disease or injury. (kevinmd.com)
  • Taking certain medications can also increase your risk of blood clots. (cancercare.org)
  • Side effects of NuvaRing may increase risk of blood clots, pumonary embolism, DVT, death. (aboutlawsuits.com)
  • As of the end of last year, more than 730 people had filed a lawsuit over blood clot injury from NuvaRing, and the number of cases is expected to continue to increase as NuvaRing lawyers continue to review new cases for women who have experienced problems. (aboutlawsuits.com)
  • if dosed too low, it can increase the risk of blood clots. (nih.gov)
  • Note: These drugs increase the risk of developing osteonecrosis of the jaw (ONJ). (lls.org)
  • Blood thinning agents reduce the chance of clotting, but they can also increase the chances of bleeding,' she says. (health.gov.au)
  • For example, if someone has a low chance of a second clot but a high chance of bleeding, we may not want to increase the bleeding risk by prescribing a blood thinner over the long term. (health.gov.au)
  • 3. Being still for a long time (such as sitting still during a long car or airplane trip or being in bed after surgery) can increase your risk of blood clots. (nih.gov)
  • Taking raloxifene hydrochloride may increase the risk of getting blood clots. (nih.gov)
  • have taken estrogen in the past and had a high increase of triglycerides (a kind of fat in the blood). (nih.gov)
  • A family history of blood clots can increase a person?s risk. (cdc.gov)
  • Along with Yaz, readers remained concerned about NuvaRing (etonogestrel/ethinyl estradiol) and blood clot risk even as a new study on non-oral hormonal contraception, published in the British Medical Journal (BMJ 2012;344:e2990), was presented at the annual meeting of the American College of Obstetricians and Gynecologists (May, 2012). (lawyersandsettlements.com)
  • Compared to the results of valve replacement there will be a minimal tendency towards clot formation after aortic valve repair, and anticoagulation is commonly not necessary, thus minimizing the possibility of bleeding complications. (wikipedia.org)
  • Research examining novel treatment techniques for bleeding and clotting disorders will be presented today at the 53rd Annual Meeting of the American Society of Hematology. (news-medical.net)
  • Also, I wanted to know what, if anything, crosslinking of the building material of the clot (a protein called fibrin) by a transglutaminase enzyme called factor XIII had to do with this. (news-medical.net)
  • What role does the protein fibrin play in blood clots? (news-medical.net)
  • Plasmin lyses clots by breaking down the fibrinogen and fibrin contained in a clot. (medscape.com)
  • The ability of these substances to catalyze the conversion of plasminogen to plasmin is affected only slightly by the presence or absence of local fibrin clot. (medscape.com)
  • According to a review of studies , potential risk factors for TTS may include being genetically female and being under 60. (healthline.com)
  • Other risks include the wrong heparin dosage, leading to blood clotting, embolism , and death. (fda.gov)
  • The symptoms include trouble breathing, chest pain or dizziness, or coughing up blood. (mayoclinic.org)
  • Other potential advantages of giving radiotherapy before surgery include shrinking the tumor and reducing the risk of tumor cell seeding at the time of surgery. (froedtert.com)
  • When asked why he failed to include a recent trip to Mexico in his response to the question about leaving the United States, one respondent from Los Angeles answered "well I was really only there for a day and it's not like I had contact with anything that would have gotten into my blood. (cdc.gov)
  • Race can also be a risk factor. (everydayhealth.com)
  • However, rapid weight loss (more than about 1.3 kg a week) is also a risk factor for gallstones, so more gradual weight loss is recommended. (mydr.com.au)
  • Decreased physical activity is a risk factor for a blood clot . (stoptheclot.org)
  • The risk is further increased in those who are heterozygous for factor V Leiden or have other prothrombotic risk factors. (medscape.com)
  • Research has shown that the overall incidence of DVT and pulmonary embolism is 30 to 60 percent higher in Black people than in white people. (everydayhealth.com)
  • More than 17,000 Australians every year will have an embolism, and the incidence is increasing as our population ages. (health.gov.au)
  • The heparin is then mixed with the blood in the hemodialysis machine using a mechanical syringe pump. (fda.gov)
  • Fresenius Medical Care is recalling its Sanxin Single Use Sterile Syringes due to blood or heparin leaking back or from the syringe. (fda.gov)
  • Could EKGs Help Doctors Use AI to Detect Pulmonary Embolisms? (sciencedaily.com)
  • Doctors must be aware of all of the potential risk factors for pulmonary embolism, as successfully treating blood clots can significantly reduce the risk of developing PE. (fronzutolaw.com)
  • We also know how important it is to make their doctors aware of this disorder and speak with them about the risks if they undergo surgery, become pregnant or take medications so they can best protect themselves. (today.com)
  • If you're at risk for a pulmonary embolism, you should strongly consider getting an mRNA vaccine, such as Moderna or Pfizer . (healthline.com)
  • An IVC filter traps these large pieces of blood clot and prevents them from traveling through the IVC, which could potentially cause death. (baycare.org)
  • The new study widens the statistical net, trawling through two large British prescription databases to take into account pill dosage, body fat, smoking and other factors, which affect risk. (medindia.net)
  • Experienced health care providers should know the most common blood clot signs and risk factors. (weitzlux.com)
  • We should instruct them on possible risk factors and available measures in order for them to make informed decisions. (kevinmd.com)
  • Mar. 2, 2023 Being overweight in childhood and in early adulthood are discrete risk factors for blood clots later in life, a University of Gothenburg study shows. (sciencedaily.com)
  • But research hasn't definitively proven these risk factors. (healthline.com)
  • Vaccine-induced TTS risk factors differ from risk factors for PE not caused by COVID-19 vaccination. (healthline.com)
  • We included this baseline risk and other key factors that could affect the results, such as BMI and blood pressure, in our analysis. (yahoo.com)
  • There are also changes in clotting factors in the blood that begin early in pregnancy and last until a woman is six weeks postpartum," she added. (everydayhealth.com)
  • Although studies are either pending, conflicting or inconclusive, other potential causes of and risk factors for developing IBD are thought to be environmental or lifestyle-related . (medicalert.org)
  • Your doctor will usually begin by obtaining your medical history, as this may provide information about factors that caused the clot. (radiologyinfo.org)
  • To identify factors associated with the development of Pulmonary embolism, a multivariable Binary Logistic Regres- sion model with sensitivity analysis was run. (who.int)
  • lism (VTE) associated with these factors in · for pulmonary embolism, combination our population, we performed a case-con- of compatible medical presentation, trol study. (who.int)
  • Conventional risk factors such as surgery · for clot in the inferior vena cava, Dop- do not account for all cases, and only a pler sonography or computed tomogra- fraction of those with these risk factors phy with venous phase contrast. (who.int)